¥xÆW¥¼¤W¥«ªÑ²¼ °]¸gºô 

¥¼¤W¥«  

¥¼¤W¥«ªÑ²¼¦æ±¡,¿³ÂdªÑ²¼¶R½æ,¥¼¤W¥«ÂdªÑ²¼¬d¸ß,§Ö³t´x´¤¥¼¤W¥«ªÑ²¼¶R½æ¯ß°Ê

Åwªï¨Ó¨ì¥²´Iºô ¤â¾÷ª© ¥[¤J·|­û µn¤J ­º­¶
¥¼¤W¥«ÂdªÑ²¼¦æ±¡¬d¸ß,¥¼¤W¥«ªÑ²¼¶R½æ¹L¤á,¿³ÂdªÑ²¼¦æ±¡¬d¸ß¡ã§K¥I¶O±M½u¡G0800-035-178
°Q½×°Ï>ªYÄ£¥ÍÂå
¥«³õ­º¨£·sÃÄ ±ÂÅv½Í¤¤     µoªí·s¸ÜÃD ¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Ghung120110149413  µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
¥«³õ­º¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009

6634 ªYÄ£

ªÑ¥»: 3.832»õ

¥D­n·~°È:

¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo

¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)

¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)

Ä~Äò©¹¤U¬Ý...!

=============================================================================

²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)

¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.µL¦w¥þ©Ê°ÝÃD

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x

¬ãµo¶¥¬q:

1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á

2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ

Àø®Ä¤ÀªR¡G

1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n

2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)

=============================================================================

²£«~02¡GSNP-630

¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡

4.µL¦w¥þ©Ê°ÝÃD

¬ãµo¶¥¬q:

1.Á{§É«e

2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C

3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C

Àø®Ä¤ÀªR¡G

1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05

=============================================================================

²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)

²£«~Àu¶Õ:

1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê

2.¸Ñ¨M­¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)

3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«

2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^

3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O

¬ãµo¶¥¬q:

1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç

2.¤w¥Ó½ÐUSFDA¼Ï&#32445;Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D

3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç

=============================================================================

²£«~04¡GSNP-830/ SNP-840

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B­««×¯kµh)

²£«~Àu¶Õ:

1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è

2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è

2.½Æ¤è¤w¥Ñ¬ü°êFDA­n¨D­°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä

3.¦³¨Ï¥Î±M§Q¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y

4.¥i¼W¥[¤AñQÓi×ô¾¯¶q

¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A­°§C¦¨Å}°Æ§@¥Î

5.¤GªÌ¾Ü¤@±ÂÅv

6.¥i¼W¥[¥«¦û²v

¬ãµo¶¥¬q:

1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç

SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ý­n¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç

µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ

=============================================================================

*****************************************************************************

SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G

1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

=============================================================================

*****************************************************************************

¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G

1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv

3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿­±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

=============================================================================

*****************************************************************************

¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@­p¹º

§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó

¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ù­È±o´Á«Ý¡A¦³¾÷·|¬O ¤U¤@­Ó ¦X¤@ ÄƪÑ

-----------------------------------------------------------------------------

¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)

·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/25 ¤U¤È 10:11:14²Ä 2016 ½g¦^À³
¤À¤l¹vÂICYP2E1 ¬Ofirst-in-class!!!

¤@ª½­W«ä³o¬q-[SNP-610¸gÀø®ÄÃÒ¹ê¡A¨ä¤G´Á¸ÕÅçµ²ªGÀu©ó¤wµoªí¨Ã¶i¤J¤T´Á¤§¦U°ê NASH ­Ô¿ïÃĪ«]ªº½t¥Ñ¡C

ª½¨ì³o½g·s½×¤å¥X²{-2022.5¤ë ttps://www.sciencedirect.com/science/article/pii/S2211383522000545

...·í CYP2E1 ¥¢¬¡®É¡A¤º·½©Ê PPAR £\¿E°Ê¾¯¥i¯à·|¼W¥[...

...¦³½ìªº¬O¡A¥þ²y¥NÁ²վǿz¿ïµo²{ CYP2E1 ªº¥\¯à³à¥¢¾É­P¨xŦ¤¤ LysoPC 22:4 ©M¤TºØ PUFA¡BDHA¡BAA ©M LCA ÅãµÛ¼W¥[¡A³o¬O PPAR £\°ªªí¹Fªº¦P¤@²Õ´¡A¥i¥H½Õ¸`¨xŦ FGF21 ÄÀ©ñ¤@¦¸¬¡©Ê¡C³o¨Ç¥Íª«¼Ð»xª«³Q¶i¤@¨BÅçÃÒ¥i§@¬° CYP2E1 酶©³ª«©Mª½±µ PPAR £\¿E°Ê¾¯¡C¤@¥¹ CYP2E1 ³Q§í¨î¡A¨xŦ¤¶¾Éªº CYP2E1 ¤º·½©Ê¥NÁª«¡]¥]¬A LysoPC 22:4¡BDHA¡BAA ©M LCA¡^ªº¥NÁ´N·|´î®z¡A±q¦Ó¨Ï³o¨Ç¤Æ¦Xª«¦b¨x²Ó­M¤¤¼W¥[¡AµM«á§@¬°ª½±µ PPAR £\¿E°Ê¾¯»¤¾É­ì¦ì¨x²Ó­M¬¡¤Æ.

¥Ñ©ó CYP2E1 ¥D­n¦b¥D­nµo¥Í¥NÁªº¨x²Ó­M¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{­ì¦ì¨x²Ó­M¤¤ªº PPAR £\¿E¬¡¡A³o¥i¥HÁקKÁ{§É¤¤°¸º¸µo¥Íªº«D²Õ´¯S²§©Ê PPAR £\¿E¬¡ªº°Æ§@¥Î

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/27 ¤U¤È 04:10:48²Ä 1753 ½g¦^À³

CYP2E1?

2017-05-24ªYÄ£«Å¥¬¨ä¦b NASH ¤è­±ªº­«¤j¬ð¯}

www.microbio.com.tw/news_detail.php?nwno=251

SNP-610¨ã¦³¦hºØ§@¥Î¾÷¨î(CYP2E1 + DGAT1)...¤À¤l¹vÂICYP2E1 ¬Ofirst-in-class¡A¤£¦P©ó¥@¬É¤W©Ò¦³¨ä¥L¦b¬ãÃĪ«¡C

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î`

108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·| mops.twse.com.tw/nas/STR/663420190724M001.pdf

Phase II study:

- The decreases in several clinical parameters from baseline to the end of treatment were greater in

SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib

treatment in literature, especially in ALT.

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/24 ¤U¤È 04:41:14²Ä 2015 ½g¦^À³
www.vdh.virginia.gov/content/uploads/sites/110/2022/04/Youth_SelfHarm_Suicide_Report.pdf

¬ü°êºû¦{ 9-18·³¨àµ£

±q 2016 ¦~¨ì 2020 ¦~¡A¤j¦h¼Æ«D­P©R©Ê¦Û¶Ë¦í°|¬O¥Ñ©óÃĪ«¤¤¬r¡]93%¡^¡A¨ä¦¸¬O5%¥Ñ©ó³Î¶Ë¡A4%¥Ñ©ó«DÃĪ«

¤¤¬r¡A¥]¬A°sºë¡]¹Ï 7¡^.....¦b¨º¨Ç¦]ÃĪ«¾É­Pªº¦Û´Ý¦í°|¤¤ 2016-2020 ¦~¤¤¬r¡]n=2,178¡^¡A³Ì±`¥ÎªºÃĪ«¬O4-®ò°ò­f×ô­l¥Íª«¡A¤SºÙ¹ï¤A酰®ò°ò×ô¡]28%¡^

-------------------------------------------------------------------------------------------------

9-18·³¨àµ£ APAP¤¤¬r 2178*28%=610¤H¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/24 ¤U¤È 04:26:43²Ä 2014 ½g¦^À³
¬ü°ê¨àµ£¦Û±þ¨Æ¥ó¼W¥[--->¤z¹w±¹¬I--->µL¨x¬rAPAP.

¥¬¬¥ªâ¹L¶q¤]«Ü±`¨£¡A¦ýÄY­«ªº¬r©Ê§@¥Î¨Ã¤£±`¨£¡AªvÀø«ü«n¤]«Ü²³æ(¤ñAPAP¹L¶q¤¤¬r¦nÂåªv¦h¤F)¡C

--------------------------------------------------------------------------------------------

2022.3.4 ¬ü°ê¬rª«¤¤¤ß³ø§iªº¨àµ£¦Û±þ¨Æ¥ó pubmed.ncbi.nlm.nih.gov/35240919/

µ²ªG¡G ¤ÀªR¤F 514,350 ¦WºÃ¦ü¦Û±þªº¨àµ£¡A¨ä¤¤ 10 ¦Ü 12 ·³¨àµ£ªººÃ¦ü¦Û±þ²v¼W´T³Ì¤j¡]109.3%¡Ap = 0.002¡^¡C13 ¦Ü 15 ·³¡]30.3%¡Ap < 0.001¡^©M 16 ¦Ü 19 ·³¡]18.1%¡Ap< 0.05)¡C³Ì±`¥Îªºª«½è¬O¥¬¬¥ªâ©M¹ï¤A酰®ò°ò×ô¡A¨ä¤¤¹ï¤A酰®ò°ò×ôªº¼ÉÅS²v¼W´T³Ì¤j¡C°Q½×¡G¸Ó¼Æ¾Úªí©ú¦Û§Ú¤¤¬r¯f¨Ò¦³©Ò¼W¥[¡A³oªí©ú¨à¬ì¤ß²z°·±d¦M¾÷¥¿¦b´c¤Æ¨Ã©µ¦ù¨ì¦~»´¤H¸s¡C¨à¬ì¤H¸s§ó®e©öÀò±o«D³B¤èÃÄ¡A³o¥i¯à¸ÑÄÀ¤F¦b¨à¬ìºÃ¦ü¦Û±þ±wªÌ¤¤¨Ï¥Î³o¨ÇÃĪ«ªº¥i¯à©Ê¡C

µ²½×¡GÀ³¦Ò¼{¦b³o¨Ç¦~»´¸sÅ餤±Ò°Ê¾A·íªº¤ß²z°·±d¿z¬d©M¤z¹w±¹¬I¡A¥H¨¾¤î¦Û§Ú¤¤¬r¯f¨Ò©M¬ÛÃöµo¯f²v©M¦º¤`²v¶i¤@¨B¤W¤É¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/24 ¤U¤È 03:37:19²Ä 2013 ½g¦^À³
·¸Ãº¬O¦Y¤U¤pªÑªF©ñ±ó»{Áʪº³¡¦ì¡C(ú´Ú´Á®É¨S¤°®t»ù)

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/9/25 ¤U¤È 02:24:54²Ä 1428 ½g¦^À³

¼W¸ê16000±i¡A¤pªÑªF¤j¬ù»{ÁÊ1781±i(16000-14219)¡C¦h¦h¤j«á¨Ó¦³¸Éú¦¨¥\¶Ü?

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/7/6 ¤U¤È 02:25:48²Ä 1289 ½g¦^À³

¯S©w¤H¿ãÅD¤£¿ãÅD? 7/26«á¨£¯u¾å!

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/7/3 ¤U¤È 12:02:11²Ä 1268 ½g¦^À³

2021¦~«×¼W¸ê­pµe

¦U¦ìªÑªF¡B§ë¸ê¤H¡G¤j®a¦n¡I

...¥Ñ©ó¥»¤½¥q¬ãµo¹Î¶¤¦b·sÃĶ}µo¡BÁ{§É¸gÅçÂ×´I¤§Àu¶Õ¤U¡A³°Äò¦b±M§Q¡B§Þ³N¡B¬ãµo¦¨ªG¤Î°ê»Ú¦X§@«´¬ùµ¥¼h­±§¡Àò±o·¥¬°Â׺Ӥ§¬ãµo¦¨ªG¡A¥Ø«e¦V¤½¥q¥D°Êªí¹F¦³·NÄ@ªø´Á§ë¸ê¤§¯S©w¤H¬Û·í¿ãÅD¡A±©­ìªÑªF¾Ö¦³ªk©wÀu¥ý»{ªÑÅv¡A¨C¥aªÑ¥i»{ÁÊ273.803ªÑ....ÁٽЪѪF­Ì¼f·Vµû¦ô¡B´x´¤§ë¸ê¥ý¾÷¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/24 ¤U¤È 02:15:38²Ä 2012 ½g¦^À³
4eª½¦b¿³Âd¶R¡A³o¤£ª¾­nöt¥h¨º

~~~~~~~~~~~~~~~

¼W¸ê»{ªÑ¦hú¥|»õ¡A¨S·N¥~À³¸Ó¤]¬O´I¨¹¶°¹Î

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/23 ¤W¤È 09:37:02²Ä 2011 ½g¦^À³
APAPÁöµM¦W¥s¤îµh¾¯¡A¦ý¬O¬G·N¤j¶qªA¥Î¡A¨­Åé¤Ï¦Ó¬O¼@µh§é¿i¥B¬Oªø´Á©Ê¡A¬O³Ì¤£©ú´¼ªº¿ï¾Ü!

¥xÆW2003~2012¡A3235¦WAPAP¤¤¬r--> ¦~§¡¬ùµo¥Í323¥ó¤¤¬r¡C(«C¤Ö¦~¤×¬Æ)

--------------------------------------------------------------------------------------------

2018 ©_¬üÂå°| sjtrem.biomedcentral.com/articles/10.1186/s13049-017-0468-8

¥xÆW¤@¶µ°ò©ó¥þ°ê¤H¤fªº¶¤¦C¬ã¨s¡A¬°´Á10¦~ªº¸ò踪½Õ¬d¹ï¤A酰®ò°ò×ô¤¤¬rªºªø´Á¦º¤`²v

¤èªk:§Ú­Ì³q¹L¦b 2003 ¦~¦Ü 2012 ¦~¶¡¦b¥þ°ê¤¤¬r¼Æ¾Ú®w©MÁa¦V°·±d«OÀI¼Æ¾Ú®w2000¤¤¡A½T©w¥xÆW 3235 ¦W APAP ¤¤¬rªº°Ñ»PªÌ...

µ²ªG:241 ¦W APAP ¤¤¬r°Ñ»PªÌ¡]7.5%¡^©M 94 ¦W¹ï·Ó²Õ¡]1.0%¡^¦bÀH³X´Á¶¡¦º¤`...APAP¤¤¬r°Ñ»PªÌªº¥þ¦]¦º¤`­·ÀI§ó°ª ¤×¨ä¬O¦b20·³¤Î¥H¤U...

µ²½×:APAP ¤¤¬r»Pªø´Á¦º¤`²v¼W¥[¦³Ãö¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/5/21 ¤U¤È 07:34:44²Ä 2010 ½g¦^À³
¬Ý¨ì®³´¶®³¯kÁý¦Ñ¹«¦º¤`¹êÅç«á¡AÃļtº¡Áy¨§ªá¡I¡mªYÄ£¤@©w¤£¬O¬G·Nªº¡n´¶®³¯k¯«ÃĪ±¤£¤U¥h¤F¡I¨S¦³¤Æ¼Ä¬°¤Í¤£¦æ¡AÃø©Ç²Ä¤@­Ó½Í¦X§@¡C§Ú²{¦b­n¤jÁn»¡¡G¡i³o±ÂÅv®×ÅK¦¨¤F¡I¡j¤j®aµ¥¦n®ø®§§a¡I
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/21 ¤W¤È 10:32:50²Ä 2009 ½g¦^À³
¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r!

¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r!

¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r!

§ó¥¿:¦Û±þ¶É¦Vªº±wªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q20g (500mg *40Áû)¡A

¤£¤p¤ß·N¥~ªA¥Î¹L¶qªÌ¬O12g(500mg*24Áû).

¦³¦Û±þ¶É¦Vªº±wªÌÄá¤Jªº¹ï¤A酰®ò°ò×ô´X¥G¬O·N¥~¹L¶q²Õ±wªÌªº¨â­¿¡]¤¤¦ì¼Æ:20g VS. 12 §J¡FP = 0.009¡^

www.nejm.org/doi/full/10.1056/nejm199710163371602

...The suicidal patients had ingested almost twice as much acetaminophen as those in the accidental-overdose group (median, 20 vs. 12 g; P = 0.009).

¦³5¦W±wªÌ¡]·N¥~¹L¶q²Õ 3 ¦W¡A¦Û±þ²Õ 2 ¦W¡^¦b 24 ¤p®É¤º©úÅãÄá¤J 4 §J©Î§ó¤Öªº¹ï¤A酰®ò°ò×ô¡AÆ[¹î¨ì©úÅ㪺¬r©Ê§@¥Î¡A¥i¯à»P¸T­¹¡B¹L¶q¶¼°s¦³Ãö...

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 09:15:05²Ä 2008 ½g¦^À³

¥H«áªA¥ÎAPAP¦Û±þÃø¤F! (SNP-810¦Y1²~200ÁûÁÙ¤£·|¤¤¬r)

§Ú¬Ý¹L¤@½gªA¥Î´¶®³¯k¦Û±þªº¸ê®Æ¡A¦Û±þªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q¦n¹³¦b25g(50Áû)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/20 ¤U¤È 09:15:05²Ä 2008 ½g¦^À³
¥H«áªA¥ÎAPAP¦Û±þÃø¤F! (SNP-810¦Y1²~200ÁûÁÙ¤£·|¤¤¬r)

§Ú¬Ý¹L¤@½gªA¥Î´¶®³¯k¦Û±þªº¸ê®Æ¡A¦Û±þªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q¦n¹³¦b25g(50Áû)¡C

¦¨¤H³æ¦¸Äá¤J¹ï¤A酰®ò°ò×ôªº³Ì¤p¬r©Ê¾¯¶q¬° 7.5 ¦Ü 10 g¡F¦¨¤H«æ©ÊÄá¤J >150 mg/kg ©Î 12 g ¹ï¤A酰®ò°ò×ô³Q»{¬°¬O¦³¬r¾¯¶q¡A¨Ã¨ã¦³«Ü°ªªº¨x·l¶Ë­·ÀI¡C

1 ¦Ü 6 ·³ªº°·±d¨àµ£¤¤¡A³æ¦¸Äá¤J¹ï¤A酰®ò°ò×ôªº³Ì¤p¬r©Ê¾¯¶q¬° 150 mg/kg¡A«æ©ÊÄá¤J≥250 mg/kg ¹ï¤A酰®ò°ò×ô¤Þ°_ªº¨x¬r©Ê¨ã¦³ÅãµÛ­·ÀI¡C

--------------------------------------------------------------------------------------------------

2019.6.12 health.ettoday.net/news/1465329

17·³¤k²r§]¡u110Áû´¶®³¯k¡v¸¡µh±¾«æ¶E¡@ÂåÅå¡G14Áû´N¤¤¬r¤F (14Áû*500mg=7g)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/20 ¤U¤È 08:51:40²Ä 2007 ½g¦^À³
¦~³øªÑªF«ùªÑ

¤d±i¦³15¤H¡A¦@40052±i¡A¦û58%¡C

10¤jªÑªF¡A¦@33430±i¡C

¤d±i³o2­Ó¤ë¦@´î½X1%¡A§âªÑ»ù©¹¤U¥´¡C

¶°«O¤½¥q«ùªÑ

¤d±iÁÙ¬O12¤H¡A«ùªÑ4¸U1¤d¦h±i¡C

¨ì©³¬O½Ö¿ù¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/20 ¤U¤È 08:44:53²Ä 2006 ½g¦^À³
¬Ý¨Ó[¦Y¤@²~=100g]¤]¤£·|¤¤¬r¬O¯u¦a!

¨Ì¨C¤é«Øij¶q4g*20­¿=80g

¦~³ø74­¶:¥»¤½¥q©Ò¶}µo¤§µL¨x¬r¤îµh·sÃÄ¡AªA¥Î¥i¹F¦w¥þ¾¯¶qªº [20­¿] ¤´¤£·|¤¤¬r¡A¥¼¨Ó¬Æ¦Ü¦³¥i¯à¥i¥H§¹¥þ¨ú¥N²{¦³ªº¤AñQÓi×ô¤îµhÃÄ¡A¬G¥Ø«e¥«³õ¤Wªº¦U¤jÃļt¥i¯à¬O¥»¤½¥q¼ç¦b¦X§@¹Ù¦ñ§í©Î¬OÄvª§ªÌ¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:28:55²Ä 1958 ½g¦^À³

08_·sÃĬãµo¦¨¥\®×¨Ò_·s¦¨¤À(ªø®Ä¤î¼@µh¤£¦¨Å})

­J¤j¯«¦b19:00¬í°_»¡:..²{¦b§Ú­Ì¥i¥H[¦Y¤@²~]®@ ³£¤£·|¦³¨x¬r©Ê³á ¨ì³oºØ¦a¨B¤F ·íµM ³oÁٻݭn¤@¬q®É¶¡¤~·|¤W¥«

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/5/20 ¤U¤È 06:22:14²Ä 2005 ½g¦^À³
¨L¥°¶v¬O´I¨¹´xÂd¡A¼W¸ê»{ªÑ¦hú¥|»õ¡A¨S·N¥~À³¸Ó¤]¬O´I¨¹¶°¹Î
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/20 ¤U¤È 06:18:17²Ä 2004 ½g¦^À³
¼öÄËÄ˪ºªÑªF·|¦~³ø¥X¨Ó¤F¡A·s¤jªÑªF¥X²{

¥H°¨¤º§Q§ë¸ê¦³­­¤½¥q¡A¥Nªí¤H:½²©Ó¾§

­ôù¦è¹ê·~ªÑ¥÷¦³­­¤½¥q¥Nªí¤H:¨L¥°¶v

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/5/20 ¤W¤È 11:29:09²Ä 2003 ½g¦^À³
´²¤áªí¹F¼¥¼©¼ÖÆ[¥¼¨Ó½}¤F¡F¤@¤Á¤j¤H»¡¤Fºâ¡A«e´ºÁö¬ü¦n¤]¤£®e©ö¹ê¦ô»ù¦ì¡F­Y¬O¥~°ê¨ÖÁʬü¤¸­pºâ¤]¤@©w·|Åý¤j®a¯º¼H¼H¡I¨ÖÁÊ·Qªk¬O¯¸¦b¥~°ê¤jÃļt¨¤«×¦³§Q¬Ý¡F¤½¥q¤jªÑªF¸³¨Æ¤@ÂI¤]¬Ý¤£¥X·Q³Q¨ÖÁʪº·Qªk¡CÁ`»¡¤@¥y¸Ü¡Aªø´Á«ù¦³ªÑ²¼¡A·|ÁÈ¿úªº¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/20 ¤W¤È 10:47:06²Ä 2002 ½g¦^À³
³Q¤¤¤Ñ¿ö¤F §C¦ô ¤ß¤¤ªºµh¤S³Q´£°_ ¤Ö¤F¦Ü¤Ö¤dw

¨S«H¥Îªº¸ôxx(´N¬O©U§£)¡A­«ÂI¤£¬O·¸»ù ¬O¥ý¨Ö¤F ¦A´«¦X¤@

©ú©ú´N¦b½Í±ÂÅv/³o¤£¬O¤º½u ¤°»ò¬O¤º½u ´N·|¥h§ä¯E¹©ªº³Â·Ð

¨S¿úªº¤pªÑªF ÁÙ­n³Q¶Êµ|

¨S¤°»ò¤£¦P·N¦X¨Ö¡A´N¬O¥~°ê¥Xªº°÷¤£°÷ »¡­Ó¤§«e¸gÅç ¬ü¤è¥X20¬ü¦¬ ¥x¹ô600 §A½æ¤£½æ ¯º¤F §Ú·í¤Uºâ¨ì¤â»Ä ÁÙµ¥­Ó3`5¦~ ¤]½ü¤£¨ì§A¦P¤£¦P·N ¤jªÑªF­n±j«Á§A ¹J¨ì¤Õ©ú§A¥u¯à­ú­ú ¬ë¨ì20¬ü §A´N¯º¯º

+++++++++++++++++

³Q°ê¥~Ãļt¨ÖÁʧÞÂàok¡A³Q°ê¤ºÃÄ¥ø·¸»ù­Ó2-30%¦¬Áʤ£¦æ!!

²ö§Ñ¬u²±!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/19 ¤U¤È 02:06:51²Ä 2001 ½g¦^À³
¹w­p 2029 ¦~¥þ²y«D°sºë©Ê¯×ªÕ©Ê¨xª¢ (NASH) ÃĪ«¥«³õ³W¼Ò±N¹F¨ì 843.4 »õ¬ü¤¸¡A¦b 2022-2031 ¦~´Á¶¡¥H 39.13% ªº½Æ¦X¦~¼Wªø²v¼Wªø

www.marketwatch.com/press-release/non-alcoholic-steatohepatitis-nash-drugs-market-size-2022-2031-to-reach-at-cagr-of-3913-2022-05-17?mod=search_headline

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/5/19 ¤U¤È 01:48:59²Ä 2000 ½g¦^À³
§Ú¯uªº­n¾K¤F¡I¥H³Ì¥O¤H¹Ú·Qªº­°¯×ªÕ¨x¤T¦Ê»õ¬ü¤¸¡A810¤@¦Ê»õ¬ü¤¸¡A­p¥|¦Ê»õ¬ü¤¸¡A¤@¦¨¤À¼íª÷40»õ¬ü¤¸¡A1200»õ¤¸¥x¹ô¡A¨CªÑÁÈ1700¤¸¡A¥»¯q¤ñ20´N¦n¡A¤W¬Ý34000¤¸¡C¥ú¸Õºâ´N¥O¤H§Ö¼Ö¡I¥´¤@§é3000¤¸ªÑ»ù´N¬OªÑ¤ý¤F¡C¦³¿úµ{¡I
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GNtumgk10151447  µoªí®É¶¡:2022/5/19 ¤U¤È 01:23:40²Ä 1999 ½g¦^À³
³Q°ê¥~Ãļt¨ÖÁʧÞÂàok¡A³Q°ê¤ºÃÄ¥ø·¸»ù­Ó2-30%¦¬Áʤ£¦æ!!

²ö§Ñ¬u²±!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/19 ¤U¤È 01:04:27²Ä 1998 ½g¦^À³
½²¤j

à­ªÕ¨xªº¥«³õ¬O±Ð±Â¦ôªº

¥L¦³­«½Æ»¡ª÷ÃB

¶W¹L3¦Ê»õ¬ü¤¸

¦pªG¦³¤j¼tÄ@·N°ª»ù¨ÖÁÊ

¦óÀ|¤£¬O¬ü¨Æ¡I

¦pªG³£°µ¨ì3´Á®É¡A»ù½X·|§ó°ª¡C

¦ý¬O¡A¬Û¹ï®É¶¡¦¨¥»·|§ó°ª¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/5/19 ¤U¤È 12:37:44²Ä 1997 ½g¦^À³
¦Ñ¹«¹êÅç¸ê°T¹ï810§ó¥[±À±R¡I¦V«e¤j­°¯×ªÕ¨xÃĤG¦Ê»õ¬ü¤¸±À¦ô¡A§ó¬OÅåÆv³s³s¡I±q¦U¦ì¤j¤jªñ¤é´£¨Ñ¸ê°T¡A·P¿E¡I¤ß¤¤·Pı«¥ªYÄ£±N¨Ó·|Åý§Ú­Ì¼Æ¿ú¼Æ¨ì»Ä¡I°í©w¤Ï¹ï³Q¨ÖÁÊ¡I
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/19 ¤W¤È 10:18:40²Ä 1996 ½g¦^À³
§t¤A²mÓi×ô¤îµhÃĥثe¥«³õ³W¼Ò´N¶W¹L¦Ê»õ¬ü¤¸

¥[¤Wà­ªÕ¨xÃĪº¹w¦ô°ª¹F3¦Ê»õ¬ü¤¸

°ê»Ú¤jÃļt®³´X¤Q»õ¬ü¤¸¨ÖÁʪYÄ£

¥u¯à»¡¬O®³¥X¹sÀY¦Ó¤w

¥H¤W¬O­Ó¤H¬Ýªk

¶È¨Ñ°Ñ¦Ò

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/19 ¤W¤È 09:42:41²Ä 1995 ½g¦^À³
­Ó¤Hı±o

¹ï°ê»Ú¤jÃļt¨Ó»¡

ªYÄ£ªÑ¥»«D±`¤p

¤£¶Ë¨x¤Îà­ªÕ¨xªºÃĪ«¶}µo

¤w¸g¦³¬Ý¨ì®ÄªG¤Î¦¨ÁZ

¥B¦¹2ºØÃÄ¥«³õ³£«D±`¤j

¥Ø«e¤]ÁÙ¨S¦³¥ô¦ó¤@ºØÃĪ«¤W¥«

¨ú±o±ÂÅv¬Û¹ïÀ³§Q¯q¤Ï¦Ó¤£§¹¾ã

ª½±µ¨ÖÁʳ̦Eºâ

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/19 ¤W¤È 09:36:59²Ä 1994 ½g¦^À³
Q:½Ð°ÝSNP-810²{¦b¬ãµoªº¶i«×¦p¦ó?

A:SNP-810¬°µL¨x¬r©Ê¤îµh¡u·sÀø®Ä·sÃÄ¡v....¬ü°êFDA»{¬°¡A»Ý­nGLP¹êÅç«Ç¨ÓÃÒ©ú¨ä°Êª«Àø®Ä(µL¨x¬r©Ê)...

--------------------------------------------------------------------------------------------------

www.facebook.com/watch/?v=3194947797458964

³o±i¤j¹«­P¦º¾¯¶q¹ÏªíÀ³¸Ó´N¬O¥ÑGLP¹êÅç«Ç§¹¦¨ªº¸ÕÅç?

P2000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú / (S2000(SNP-810)6°¦¤j¹«¦Ü14¤Ñ¥þ¬¡µÛ.

...

P8000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1¤p®É¤º¥þ¦º /(S8000(SNP-810)1°¦¤j¹«¦b4¤p®É¦º¥h¡A5°¦¤j¹«¨ì14¤Ñ¬¡µÛ.

­J³Õ»¡¦A°µ¤@¦¸¹êÅç(S8000(SNP-810)6°¦¨ì14¤Ñ¥þ¬¡µÛ.

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/19 ¤W¤È 08:34:05²Ä 1993 ½g¦^À³
§Ú»¡[°ê»Ú¤j¼t¨ÖÁʪYÄ£¬°¤W¡AÅý¤pªÑªF¤@¦¸¤J³U¡C]

¥i¬O¤j¤û­J³Õ:±z­n´N¶Rcompound ±z·Q¶R[¤½¥q] §Ú­Ì¤£½æ±z!

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/13 ¤U¤È 08:50:10²Ä 1784 ½g¦^À³

---°ê»Ú¤j¼t¨ÖÁʪYÄ£¬°¤W¡AÅý¤pªÑªF¤@¦¸¤J³U¡C

----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/10 ¤U¤È 01:35:06²Ä 1961 ½g¦^À³

±q³o2¥yÃöÁä¦r:[«e10¦W°ê»Ú¤jÃļt]»P[§Ú¿Ë¦Û¨ì¤Fheadquarter¥h]¡AÀ³¸Ó¬O«üªYÄ£µL»~!!!

05_·sÃĶ}µo_¿ïÃD

13.10~14:30’:

.....³o¬O¨Æ¹ê®@ [«e10¦W°ê»Ú¤jÃļt] ........§Ú­É¨ä¤¤¤@®a [§Ú¿Ë¦Û¨ì¤Fheadquarter¥h] ½Í¨ì³Ì«á ¥L»¡±z­Ì¯à¤£¯à ³o®a.§Ú´N¶R±z­ÌªºªÑ²¼°Ú.§ë¸ê±z­ÌªºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±z­n´N¶Rcompound ±z·Q¶R[¤½¥q] §Ú­Ì¤£½æ±z....½Í¨ì³o¼Ë£²...

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/19 ¤W¤È 08:24:44²Ä 1992 ½g¦^À³
SNP-610ªº2­Ó¤G´ÁÁ{§É:

1.Àø®Ä±´¯Á¸ÕÅç(¤w§¹¦¨)

SNP-610 [¶}©ñ¦¡]Á{§É¤G´Á¬ã¨s¤wÀò±oÅãµÛ¤HÅéÀø®ÄÃÒ¾Ú¡C¾Ú109¦~7¤ë´Á¤¤¤ÀªRµ²ªG¡A35¦ì NASH¯f¤H¡A¥]§t17¦ì°ª¾¯¶q

²Õ©M18¦ì¤¤¾¯¶q²Õ¡A¸g12¶gªvÀø«á¡A¥D­nÀø®Ä«ü¼Ð¨xŦ¾¢Ói»Ä¤þ଻ÄÂà®ò°ò»Ã¯À(ALT)¦b°ª¾¯¶q²ÕÅãµÛ­°§C¹F

-29.5¡Ó33.0 U/L, p=0.002¡A¤¤¾¯¶q²ÕÅãµÛ­°§C¹F -18.9¡Ó27.3 U/L, p=0.009¡C

2.¬dÅçµn°O¥ÎÁ{§É¸ÕÅç

2022.3.9¤½¥q¦³§ó·sFDAÁ{§É¶iµ{:2022.12.1 ~2023.12.30:SNP-610ªvÀø«D°sºë©Ê¯×ªÕ©Ê¨xª¢±wªÌÀø®Ä©M¦w¥þ©ÊªºÀH

¾÷¡B[Âùª¼]¡B¦w¼¢¾¯¹ï·Ó¬ã¨s(80¤H)

clinicaltrials.gov/ct2/show/NCT03468556?term=SNP-610&draw=2&rank=1

¥D­nµ²ªG´ú¶q¡G

¤þ®ò»Ä®ò°òÂಾ酶 [®É¶¡®Ø¬[¡G12 ¶g]: ¦å²M¤þ®ò»Ä®ò°òÂಾ酶 (ALT/GPT) ¬Û¹ï©ó°ò½uªºµ´¹ïÅܤÆ

¦¸­nµ²ªG´ú¶q¡G

MRI ¨xŦ FF [®É¶¡½d³ò¡G12 ¶g] ¨xŦ¯×ªÕ§t¶q¬Û¹ï©ó°ò½uªºµ´¹ïÅܤÆ

MRI ¨xŦ FF [®É¶¡½d³ò¡G12 ¶g]¨xŦ¯×ªÕ§t¶q¬Û¹ï©ó°ò½uªºÅܤÆ

...

...

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/18 ¤U¤È 07:28:24²Ä 1991 ½g¦^À³
µL©Ò¿×¡A¤Ï¥¿¬n°ê¤H¦³¿ú¡A¬Ý¥X¦h¤Ö¡A12eÁâ¤]¦n¡C¥_·¥³£­n¤W¤F¡C

²ö«D¬O¤£¤WÂd¤F¡A³Qªü°Â°Ú¾ã¸JºÝ¨«...? ¤p§Ì­J¨¥¶Ã»y¦U¦ì¤j¤j»~»{¯u

1.2021.11.10 ½÷·ç¯{ 12.4»õ¬ü¤¸¶R°¾ÀYµhÃĪ«Rimegepant(°ß¤@¤ä¤fªACGRP药ª«)

www.taiwanlab.com.tw/news/show.asp?id=24440

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GNtumgk10151447  µoªí®É¶¡:2022/5/18 ¤U¤È 02:06:44²Ä 1990 ½g¦^À³
¤£ª¾¹D¬°¦ó¨ú±o®Ö­ã¨ç«á¿ð¿ð¨S¦³¶i®i¡A¤½¥q¨ì©³¦bµ¥¤°»ò...

²ö«D¬O¤£¤WÂd¤F¡A³Qªü°Â°Ú¾ã¸JºÝ¨«...? ¤p§Ì­J¨¥¶Ã»y¦U¦ì¤j¤j»~»{¯u

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/17 ¤U¤È 12:02:02²Ä 1989 ½g¦^À³
·Ç!!!!!!!!

ªYÄ£´N¹³¡u³Âò­¡v£¸¼Ë³n¡I

½L¤F¥b¦~¡A¤S§Ö¶^¨ì¥h¦~9¤ëªº²{¼W»ù75¤¸¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/16 ¤U¤È 02:05:08²Ä 1988 ½g¦^À³
§Ú³s0.1»õ³£¨S¦³¡A¤£´±²q4eªº·Qªk
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/16 ¤U¤È 12:22:31²Ä 1987 ½g¦^À³
¬O­nÅý²{¼W75¤¸¨S¦³¶R¨ì©Ò°h¦^ªº4»õ¤¸

³£¦³¾÷·|¤W¨®¶Ü¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/16 ¤W¤È 11:59:28²Ä 1986 ½g¦^À³
Âà¤J¤j¾ð ¥s¦n¤£¥s®y ·|ª£¤~¬O¤ý¹D ¤£­n©M¶¶­n¤@¼ËªºªÑ»ù´Ngg
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/16 ¤W¤È 11:51:54²Ä 1985 ½g¦^À³
ªYÄ£´N¹³¡u³Âò­¡v£¸¼Ë³n¡I

½L¤F¥b¦~¡A¤S§Ö¶^¨ì¥h¦~9¤ëªº²{¼W»ù75¤¸¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/16 ¤W¤È 06:40:15²Ä 1984 ½g¦^À³
½Ð°Ý¤j®a¦³ª`·N¨ì¤½¥q¥h¦~©³¦³¥Ó½Ð2­Ó°Ó¼Ð¡A¤À§O¬OCEPLENITOL©MCORDYCEPLEN
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/14 ¤U¤È 01:38:49²Ä 1983 ½g¦^À³
TGA±N¹ï¯«ÃÄ´¶®³¯k¥X­«¤â?!

2022.5.12 ¿D¤j§Q¨ÈªºÃÄ«~ºÊºÞ¾÷ºc(TGA)¥¿¦b¦Ò¼{­­¨î¨Ï¥Î¥@¬É¤W³Ì±`¥Îªº¤îµhÃÄ¡C

...³ø§i±N¦b 7 ¤ë«e§¹¦¨³ø§i

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/27 ¤U¤È 10:04:52²Ä 1252 ½g¦^À³

±N¨C¤é¾¯¶q¥Ñ4g­°¦¨3§J¡A¹ïÃļtªº¾P°â¶q¼vÅT´N¬O¥´¤F75§é! ¥t¥~¡A¿D¬w/¯Ã¦èÄõªººÊºÞ¾÷ºc¦³·N¹ï¥]¸Ë®e¶q­­¨î¡A¹ïÃļtªº¾P°â¶q¼vÅT¤]¬Û·í¤j¡C©Ò¥HSNP-810ªº[¥i¼W¥[¾¯¶q]¡A¤]ªí¥ÜÃļtªº¾P°â¶q¥i¥HÅܤj!

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:13:39²Ä 1215 ½g¦^À³

...¤µ¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ¡A³Ì«Ü¤j¦]¯À´N¬OGSKªº´¶®³¯k¨ÑÀ³µu¯Ê

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/5/13 ¤U¤È 01:19:41²Ä 1982 ½g¦^À³
ªñ´ÁªYÄ£®ø®§­±§ó²M·¡¤]¥¿¦V¡F¦³¤@¦ì¥Í§Þ»â°ì³Õ¤h»¡ªYÄ£¦³¨â­Ó¥­¥x¡A³o¥­¥x¬O¬ã¨s³õ°ì¡A»ù­È«Ü°ª¡IªÑ²¼©ñ­Ó¤­¦~¡A¨â¤j¨t²ÎÃĦ¨ªG®i²{¡B±ÂÅv¡AµP­±±È§¹«á¡A¨º®ÉªÑ»ù¤~¬O¯u¥¿¤ÏÀ³ªYÄ£»ù­È¡Cµu®É¶¡ªÑ»ù¤£¦p¹w´Á¡A¤j®a¤£¥²®ð¾k¡A±N¨Ó·|¶¥±è¦¡¤@¶¥¤ñ¤@¶¥°ª¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¶ø¥ì´µ¯S10031727  µoªí®É¶¡:2022/5/12 ¤U¤È 05:58:06²Ä 1981 ½g¦^À³
¼v¤ù¤º®e¦³´£¨ì TB ªºªvÀø§xÃøÂI¤Î¥Ø«eÁ{§É¤W¤£¶Ë¨xªºªvÀø¤è¦¡¡C³o­Ó®×¤l¥xÆW¦¬®× 556 ¤H¡A¦]¬°¦¬®×³t«×¤£§Ö¡AÁ{§É®É¶¡¤~·|³o»ò¤[¡A¦ý·Ó­J±Ð±Âªº»¡©ú¡A±q¥Ø«eªº¼Æ¾Ú¤w¯à©úÅã¬Ý¥X¸¨®t¡A¬Û«H¦¨¥\ªº¾÷²v·¥°ª¡C

¾ã­ÓºtÁ¿ªº¼v¤ù¡AÁöµM¨S¦³´£¨ì¤½¥q¦WºÙ¡A¦ý§Ú­Ó¤Hı±o´X¥G´N¬O¦bÀ°ªYÄ£¦æ¾P°Ú! ­J±Ð±Â¦b°ê»Ú¤W¨É¦³¦WÁn¡A°µ·sÃĪºÅÞ¿è²M´·¡A¤S«á­±¤j¤O«ü¾É¡BÀ°¦£ªYÄ£¡A¬Û«HªYÄ£¤é«á¤j¦³¥i¬°¡C

¼v¤ù¤¤´£¤Î¡A610/630 «D°sºë¯×ªÕ©Ê¨xª¢¤Î°sºë¯×ªÕ©Ê¨xª¢³£¬O¾A¥Îªº¡A³o¬O¤@¤j«GÂI¥B GSP ­Y¯à¸ò FDA °Q½×¥X¦bÁ{§ÉÀ³¥Îªº¼Ò¦¡¡A¦¬®×ªº³t«×À³¸Ó·|§Ö¤W¬Æ¦h¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/12 ¤U¤È 12:39:00²Ä 1980 ½g¦^À³
辉·ç»¨掷116亿¬ü¤¸¡A¤@©w¤£¬O¦]为¥h¦~赚¤Ó¦h¡A¦Ó¬O¦]为BiohavenÚ̦³独¨ì¤§处¡A°£¤F产«~ºÞ线¥~¡A¬Û«H¨ä独¯Sªº°¾头µh药ª«¬ã发¥­¥x¤]¬Oɲ­È©Ò¦b¡C

¦b¥Ø«e资¥»¥«场热«×¤U­°ªº±¡úG¤U¡A拥¦³®tÉݤƪº¤½¥q¤~¯à§ó¦nªº¦s¬¡¤U来¡A¥­¥x§Þ术«¬¥ø业会¦b¨ä¤¤¦³þӫܦhªºÉ¬势¡C

从¤Ñºt&赛诺µá¡A©M铂&ªü´µ§Q±d¡A¦Ê奥赛图&Àq§J¡A¨ì现¦bªºBiohaven&辉·ç¡A¥i¥H¬Ý¨ì¡A§Þ术¥­¥xªºÉ²­È¥¿¦bºCºC¥Y显¡C

这对¤_¤@¨Ç­P¤O¤_开发§Þ术¥­¥xªº¥ø业¡A©Î许¬O§ó¤jªº¿E励¡C

--------------------------------------------------------------------------------------------------

ªYÄ£ªº¥D­n§Þ³N¥­¥x¬O¨Ï¥Î¦w¥þªº½Æ¦Xª«¨Ó½Õ±±¨xŦ»Ã¯À¤Î°ò¦]¡A¦¹ºØ§Þ³N¥iÀ³¥Î©ó¥i¯à¾É­P¨x¬r©Ê¤§ÃĪ«¥H¤Î¨xŦ¯e¯f(¦p¯×ªÕ¨x)¤§ªvÀø¡C

µL¨x¬r§Þ³N¥­¥x¦ó®Éµo¥úµo¼ö°Ú?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/12 ¤U¤È 12:34:05²Ä 1979 ½g¦^À³
½÷·ç±q·s«aÃĪ«Áȱo¬Öº¡²Úº¡¡A°®¯Üª½±µ¦Y±¼!

2022.5.11 ½÷·ç¥H116»õ¬ü¤¸²{ª÷¦¬ÁÊ°¾ÀYµhÃÄ°ÓBiohaven(°¾ÀYµhÃĪ« Rimegepant)

news.cnyes.com/news/id/4870079

ªvÀø«æ©Ê°¾ÀYµh¤@½uÃĪ«¤AñQ®ò×ô¡]acetaminophen¡^.

-----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/28 ¤U¤È 10:14:42²Ä 1756 ½g¦^À³

SNP-810±ÂÅv«á¦A°µ´X­Ó°¾ÀYµhÁ{§É¹êÅç¡A°£¤F»´¯g¡A©Î³\¤¤­«¯g¤]¯à¦¨¬°¤@½uÃĪ«!

1.2021.11.10 ½÷·ç¯{ 12.4»õ¬ü¤¸¶R°¾ÀYµhÃĪ«Rimegepant(°ß¤@¤ä¤fªACGRP药ª«)

www.taiwanlab.com.tw/news/show.asp?id=24440

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/12 ¤W¤È 10:44:35²Ä 1978 ½g¦^À³
±Ð±Â©Ò»¡ªº¡u¶Ë¨x¡v¦¨¥÷¬O¤°»ò

¨Ã§ä¨ì¥i¥H¥NÁ¦¨¡u¤£¶Ë¨x¡vªº²Õ¦X

¸g°Êª«¡B¤HÅé¸ÕÅç«á¡AÃÒ©ú¥\®Ä

¦p¦ó¨ú±o¬ü°êOTC¤Î¥xÆWÃÄÃÒ

³s³e¤U¨Ó¡A«üªº´N¬O810¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/12 ¤W¤È 10:13:54²Ä 1977 ½g¦^À³
2022.5.11 FDA¦P·N¤£»Ý­nÃB¥~ªº¥\®Ä¬ã¨s©Î¦w¥þ¼Æ¾Ú¨Ó¤ä«ù EUA ªº½Ð¨D-Veru­p¹º¦b 2022 ¦~²Ä¤G©u«×´£¥æ EUA ½Ð¨D

finance.yahoo.com/news/fda-states-veru-submit-request-103000648.html

-------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/11 ¤W¤È 06:25:36²Ä 1967 ½g¦^À³

¥Ó½ÐFDA pre-EUA meeting¡AFDA¦P·N»P§_±oªá¦h¤[?

¥u­n6­Ó¤u§@¤Ñ!!!

Veru contacted on MAY 2 about FDA willing to meet on EUA and granted meeting MAY 10, TODAY, only 6 (SIX) BUSINESS DAYS AFTER!

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³

°ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1­Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting.

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/12 ¤W¤È 09:28:12²Ä 1976 ½g¦^À³
¶ø¥ì´µ¯S¤j¬O·~¤º¤H¤h? ¦³ªÅ½Ð¤W¨Ó¦h²á²á¡A§Ú¯à»´ÃP¦h¤F¡C

HUEXC030 = HUYPS-2(mannitol¥ÌÅS¾J)´NSNP-810ªº½á§Î¾¯¦¨¤À¤§¤@

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/28 ¤W¤È 10:56:48²Ä 617 ½g¦^À³

±q(§Üµ²®ÖÃĪ«+HUEXC030 )-¸Ñ¨M§Üµ²®ÖÃĪ«¨x¬r©Ê »P (APAP+SNP-820)=SNP-810-¸Ñ¨M§ÜAPAP¨x¬r©Ê¡A

¦P²z½×·íµM¯à­l¥Í¸Ñ¨M¨ä¥LÃĪ«ªº¨x¬r©Ê!

ALF«æ©Ê¨x¥\¯à°IºÜ: 1¤äAPAPÃĪ«(46%) VS 1,036¤äÃĪ«(11%)---³Ì¤j°¦ªº·íµM¬OÀu¥ý¸Ñ¨M¡A©Ò¿×¡u®¾¤}·í®¾±j¡A¥Î½b·í¥Îªø¡C®g¤H¥ý®g°¨¡A¾à¸é¥ý¾à¤ý¡C¡v

------------------------------------------------------------------------------------------

³o¬OªYÄ£¥ÛªF¤¸¸g²zªº³Õ¤h½×¤å (¹Á¸Õ¸Ñ¨M§Üµ²®ÖÃĪ«ªº¨x¬r©Ê)

ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi?o=dnclcdr&s=id=%22101NDMC0105024%22.&searchmode=basic

...§Q¥Î¤H¨x»P¹«¨x·L²ÉÅé¿z¿ïCYP2E1§í¨î¾¯¡A¬D¿ï§í¨î²v¥i¹F60-88%ªºHUEXC030 (mannitol¥ÌÅS¾J)¶i¦æ¤p¹«ÃÄ®ÄÃİʸÕÅç....

§Üµ²®ÖÃĪ«³y¦¨¨x¬r©Ê¤§°Êª«¼Ò¦¡¡A¨Ã¦¨¥\¦Û111ºØ±`¥Î¤¤¿z¿ï¤F¦hºØCYP2E1¤Îamidase§í¨î¾¯¡A¥Ñ²Ó­M¡B°Êª«©MÁ{§É

------------------------------------------------------------------------------------------------

-·|­û¡GROGER588910148151 µoªí®É¶¡:2021/7/18 ¤W¤È 09:59:28²Ä 1331 ½g¦^À³

SNP-810­n¥þ­±¨ú¥N¥«³õ¤W«Ü«K©y¦ý¦³¨x¬r©ÊªºAPAP¡A¤W¥««á°â»ù¤]¬OÃöÁä¡C

¥ÌÅS¾J©M¤T´â½©¿}§¹¥þ²Å¦X:[¬ü°êFDA®Ö­ã]¡B[±`¥Î¥B¦w¥þ]¡B[«K©y­t¾á±o°_]¡B[¤HÅé¥i­¹¥Î¦w¥þ¤Æ¦Xª«]

¥xÆWSafeTynadol ¦w®õ®³¯kªº¥é³æ¤¤½á§Î¾¯¦¨¤À

file:///C:/Users/USER/Downloads/1.6.1+%E4%BB%BF%E5%96%AE-110-07-16.pdf

...HUYPS-2(Mannitol)¡BHUYPS-4(Sucralose)...

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¶ø¥ì´µ¯S10031727  µoªí®É¶¡:2022/5/12 ¤W¤È 09:04:29²Ä 1975 ½g¦^À³
¼v¤ù¤¤­J±Ð±Â´£¨ìªºÁ{§É¤T´Áªñ§ÀÁn¡A¬O«üªÍµ²®Ö TB ¥ÎÃÄ¡A³o¬O¤ÍÀM¥Í§Þ¦b°µªºÁ{§É¡A¤£¬OªYÄ£¡C¦ý¨ä¤¤ªº HUEXC030 ¦¨¥÷¡A¥i¯à¸ò 810 / 610 / 630 ¦³¤@ÂIÃö«Y¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/12 ¤W¤È 09:03:09²Ä 1974 ½g¦^À³
¨S²Ó¨s¤¤°êÁ{§É¸ÕÅç(ª`®gªø®Ä¯Ç¯k¸Ñ)¡A¤£¦n»¡¡C¦ý±qÀÙ¥Á¥i«H±N³z¹L­«·s³]­pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C

±ÀÂ_¬O°_©lªºÁ{§É¸ÕÅç³]­p¤£¬¢·í¡A¤wºØ¤U­«¤j°ÝÃD¡A¸ÕÅçª`©wµLªk¦³®Ä¡C

§Ú¯d·NÃö¤ßªº¬O©³¤U:SNP-810+ (¤fªAªø®Ä¯Ç¯k¸Ñ)ªº½Æ¤è¤îµhÃĸÕÅç¡C

-------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 09:35:49²Ä 784 ½g¦^À³

²Ä 3 ²ÕAAP 1000 mg+¯Ç¯k¸Ñ 20 mg???

[­«·s§Q¥Î]SNP-810 1000mg+¯Ç¯k¸Ñ20mgªº(½Æ¤è)¤îµhÃÄ¡A­n¥´¯}2014¦~FDA¤½§i°Ç¥O°±¤î»s³yAcetaminophen§t¶q¶W¹L325 mgªº [½Æ¤è] ¤îµhÃĸT¥O???

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/25 ¤U¤È 10:28:31²Ä 574 ½g¦^À³

»O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©e­û·|(¤@)²Ä 131 ¦¸·|ij¬ö¿ý ¤½§iª©

¶}·|®É¶¡¡G109 ¦~ 11 ¤ë 2 ¤é¤U¤È 2 ®É¥¿

­pµe¥D«ù¤H¡G³¯¥¿Â×

­pµe¦WºÙ¡G·s±j®Ä¤£¦¨Å}¤îµh²Õ¦XÃÄ Sebacoyl Dinalbuphine Ester ¤Î [µL¨x¬r¤AñQÓi×ô]¥Î©óÂù

°¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY­«¯kµhªvÀø

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/12 ¤W¤È 08:39:28²Ä 1973 ½g¦^À³
R¤j

²³øªº2¤p®É26¤À-31¤À

³£¦b½Í¡u¶Ë¨x¡v¡A¨Ã¤£¬O¤îµh¡C

³o¬q®É¶¡ªº¤º®e±z¥i¥H¦AÅ¥¤@¦¸¡A§Ú¤]¤£ª¾¹D±Ð±Â«ü¨ººØÃÄ¡H

¦pªG¬O3´Á¡H¬O§_¬O¼Ï¶s¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/12 ¤W¤È 08:13:12²Ä 1972 ½g¦^À³
¥xÆW®õ°ê·s¥[¬Á³£¤W¥«¡A´N¤¤°ê¨S¹L¡A¬Oµû¦ô«ü¼Ð³]­p¤£¦P¶Ü??

=====================

1.08 ==>20¤À ¬Ý¬ÝP­È---³o¬O¶¶ÃĪø®Ä¤îµh°w¾¯LT1001(¯Ç¯k¸Ñ)¼Æ¾Ú==>À³¸Ó¨S¿ù

=====================b.¸ÕÅç­pµe¨ü¸ÕªÌ¤H¼Æ¡G120¤H¡]¹ê»Ú¦¬®×¤H¼Æ: 124¤H¡^

c.¥D­nµû¦ô«ü¼Ð¡G¸ÕÅçµ²ªGÅã¥Ü³N«á48¤p®É¤º¶Ü°Ø·í¶q¦b±µ¨üLT1001ªø®Äª`®g²G²Õ¬°21.76¡A¦b±µ¨ü¦w¼¢¾¯ªº¹ï·Ó²Õ¬°18.36¡A¥¼¹F¨ì²Î­p¤WÅãµÛ®t²§(p=0.86)¡C

d.¦¸­nÀø®Ä«ü¼Ð¡G

1.³N«á48¤p®É¤º¯kµhµ{«×µøı¼ÒÀÀµû¤À¦±½u¤U­±¿n¡A¦b±µ¨üLT1001ªø®Äª`®g²G²Õ¬°1164.56¡A¦w¼¢¾¯¹ï·Ó²Õ¬°1124.25¡A¥¼¹F¨ì²Î­p¤WÅãµÛ®t²§(p=0.76)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/12 ¤W¤È 06:55:16²Ä 1971 ½g¦^À³
1.08 ==>20¤À ¬Ý¬ÝP­È---³o¬O¶¶ÃĪø®Ä¤îµh°w¾¯LT1001(¯Ç¯k¸Ñ)¼Æ¾Ú

2.¤j®aÀ³¸Ó¦³¬Ý¨ì­J±Ð±Â´£¤w§Ö±µªñ3´Á¸Ñª¼(§Ú¨SÅ¥¨ì³o¬q¸Ü!)--- ªYÄ£ÁÙ¨S¶i¤J¤T´ÁÁ{§É¡A¦p¦ó±µªñ3´Á¸Ñª¼?

±q®É§Ç¤W§Ú²q­J´£ªº¬OLT1001:

2022.2.25¶¶ÃÄLT1001ªø®Ä¤îµh°w¾¯©ó¤¤°ê¤T´ÁÁ{§É¸Ñª¼¤ÀªRµ²ªG¡G¥D­nµû¦ô«ü¼Ð¥¼¹F²Î­p¤WÅãµÛ®t²§

www.moneydj.com/kmdj/news/newsviewer.aspx?a=5753e28c-53cf-4517-b95d-ca74d807e4dc

...LT1001©ó¤¤°ê¦a°Ï¤§¶}µo¤Î°Ó·~¤ÆÅv§Q±ÂÅv¤©¦¿¦èÀÙ¥Á¥i«H¡A¥Ñ¨ä­t³d¦b¤¤°ê¤W¥««e¥²­n¤§Á{§É¸ÕÅç..

ÀÙ¥Á¥i«H±N¤ÀªR¥¼¹F¼Ð­ì¦]¡A¥Ø¼Ð³z¹L­«·s³]­pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C

[ÀÙ¥Á¥i«H±N¤ÀªR¥¼¹F¼Ð­ì¦]¡A¥Ø¼Ð³z¹L­«·s³]­pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C]

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/11 ¤U¤È 07:03:47²Ä 1970 ½g¦^À³
­Ó¤H¥HªÑªF·|ij¨Æ¿ýµ¥¤å¥ó±À¦ô

­×§ï«Ü¦h³W©w¡A¥i¯à­n²Å¦X¡u¤º±±¡vªºªk¥O³W©w¡C

¤j®aÀ³¸Ó¦³¬Ý¨ì­J±Ð±Â´£¤w§Ö±µªñ3´Á¸Ñª¼¡H

®É¶¡¤w¦A¹L¥b¦~¤F¡AÁÙ¬O¨S¦³®ø®§¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/5/11 ¤U¤È 06:54:41²Ä 1969 ½g¦^À³
To ¤p¨k¤H¤j

3/15¤½§i¥»¤½¥q¨ú±o¸gÀÙ³¡¤u·~§½¥X¨ã¤§¡u«YÄݬì§Þ¨Æ·~¥B¨ã¥«

³õ©Ê¡v¤§·N¨£®Ñ¡C

6.¦]À³±¹¬I:¥»¤½¥q±N¨Ì³W¹º®Éµ{´£¥XªÑ²¼¤WÂd¤§¥Ó½Ð§@·~¡C

²ö«D¤SÅܧó­pµe¡A§ï¬°¥Ó½Ð¤W¥«¡A©Ò¥HÁÙ¨S´£¥X¤º±±¼f¬d?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/11 ¤U¤È 04:06:57²Ä 1968 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:41:53²Ä 1959 ½g¦^À³

10_·sÃĬãµo¦¨¥\®×¨Ò_GSP¨x¥\¯à©w¶qªk

1:18 avalon hepaPOC ¤z¯à¿}---GSP¦X§@¼t???

---------------------------------------------------------------------------------------------

2018.6.29 ATHENEX THERAPEUTICS LIMITED»PAVALON HEPAPOC LIMITED ñ±ÂÅv¬ù

¹w¥I¶O¥Î¡Cñ¸p¥»¨óij«á¡AAthenex À³¥ß§Y¦V Avalon ¤ä¥I 500,000 ¬ü¤¸¡C

5.2¨½µ{¸O¥I´Ú¡C

(a) Athenex ±N¦bµo¥Í¥H¤U¨Æ¥ó®É¡]¦pªG¦³¡^¦V Avalon ¤ä¥I¥H¤Uª÷ÃB¡G

(i) ¦b Avalon ¦¬¨ì¦b¥xÆW¾P°â°Ó«~¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§å­ã«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F

(ii) ¦b Avalon ¦¬¨ì¦b¬ü°ê¾P°â³fª«¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§å­ã«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F

(iii) ¦b Avalon ¦¬¨ì¦b¼Ú·ù¾P°â³fª«¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§å­ã«á¤T¤Q (30) ¤Ñ¤º¬ü¤¸***¡F

(iv) ¦b Avalon ¦¬¨ì¦b¤¤µØ¤H¥Á¦@©M°ê¡]¬°²M·¡°_¨£¤£¥]¬A­»´ä¡B¥xÆW©M¿Dªù¡^¥Î©ó¦b³õ¦a;

(v) ¦b Athenex ¦b¬ü°ê­º¦¸°Ó·~¾P°â³\¥iªA°È«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F©M

(vi) ¦b Athenex ¦b¼Ú·ù­º¦¸°Ó·~¾P°â³\¥iªA°È«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F©M

©Ò¥H¬O¥ÑATHENEX THERAPEUTICS­t³d¥þ²y¦æ¾P!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/11 ¤W¤È 06:25:36²Ä 1967 ½g¦^À³
¥Ó½ÐFDA pre-EUA meeting¡AFDA¦P·N»P§_±oªá¦h¤[?

¥u­n6­Ó¤u§@¤Ñ!!!

Veru contacted on MAY 2 about FDA willing to meet on EUA and granted meeting MAY 10, TODAY, only 6 (SIX) BUSINESS DAYS AFTER!

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³

°ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1­Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting.

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤W¤È 07:44:08²Ä 1896 ½g¦^À³

..±q¸Ñª¼¼Æ¾Ú¥ÎÃIJջP¹ï·Ó²Õ¨S¦³®t²§¡A§Ú±ÀÂ_°ê¹©¨S¦³Pre-eua meeting!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/10 ¤U¤È 08:55:13²Ä 1966 ½g¦^À³
ªYÄ£¹ê¦¬¸ê¥»ÃB¬O6e9,Ãø¹D¬O«áªÌ¡H

-------------------------

¡´À³¥Ó³ø­^¤åª©

¡¹¡uªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R

¸ê®Æ¡v

¡¹¡uªÑªF·|¦~³ø¡v

¡¹¡u¦~«×°]°È³ø§i¡v

¡´¡u110¦~©³¹ê¦¬¸ê¥»ÃB¹F20»õ¤¸¥H¤W¡v ©Î

¡u110¦~¥l¶}ªÑªF±`·|®ÉªÑªF¦Wï¥~(³°)¸ê«ùªÑ¤ñ²v¦X­p¹F

30%¥H¤W¡v

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/10 ¤U¤È 08:45:11²Ä 1965 ½g¦^À³
¦Û©ú¡]108¡^¦~«×°_¡A²Å¦X¤@©w±ø¥ó¤§¤W¥«¤½¥qÀ³¥Ó³ø­^¤åª©ªÑªF·|ij¨Æ¤â¥U¡B¦~³ø¤Î¦~«×°]°È³ø§i

µo¥¬®É¶¡¡G¥Á°ê107¦~08¤ë29¤é

(ÃÒ¥æ©Ò·s»D½Z)

¬°°t¦X¥DºÞ¾÷Ãö·sª©¤½¥qªv²zÂŹϬFµ¦¡AÃÒ¥æ©Ò¤w·s¼W³W©w¡A¦Û©ú¡]108¡^¦~«×°_²Å¦X¤@©w±ø¥ó¤§¤W¥«¤½¥qÀ³¥Ó³ø­^¤åª©ªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡BªÑªF·|¦~³ø¤Î¦~«×°]°È³ø§i¡C

ÃÒ¥æ©Òªí¥Ü¡A¬°´£ª@¸ê°T´¦ÅS«~½è¤Î³Ð³y°ê»Ú¤Æ¤§§ë¸êÀô¹Ò¡A¤Z¹ê¦¬¸ê¥»ÃB¹F·s¥x¹ô¤@¦Ê»õ¤¸©Î¥~¸ê«ùªÑ¤ñ²v¹F¦Ê¤À¤§¤T¤Q¥H¤W¤§¤W¥«¤½¥q¡A§¡À³©ó¦¸¤@·|­p¦~«×¤º¥Ó³ø­^¤åª©ªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡BªÑªF·|¦~³ø¤Î¦~«×°]°È³ø§i¡C¥H¾ä¦~¨î¤§¤W¥«¤½¥q¬°¨Ò¡A107¦~12¤ë31¤é¤§¹ê¦¬¸ê¥»ÃB¹F·s¥x¹ô¤@¦Ê»õ¤¸©Î107¦~¥l¶}ªÑªF±`·|¤§ªÑªF¦Wï°O¸ü¤§¥~¸ê«ùªÑ¤ñ²v¹F¦Ê¤À¤§¤T¤Q¥H¤WªÌ¡AÀ³©ó108¦~¥l¶}ªÑªF±`·|«e¡A¥Ó³ø«e­z¸ê°T¤§­^¤åª©¹q¤lÀÉ¡F­YªÑªFÁ{®É·|©ó108¦~«×´Á¶¡¥l¶}ªÌ¡A¥çÀ³¤ñ·Ó¿ì²z¡C

ÃÒ¥æ©Ò¥tªí¥Ü¡A¸g²Î­pºI¦Ü107¦~6¤ë¤î¡A¥~¸ê«ù¦³§Ú°ê¤W¥«¤½¥q¤§ªÑ¥÷¥«­È¤wªñ¥|¦¨¡A±©¤W¥«¤½¥q´¦ÅS­^¤å°]°È·~°È¸ê°T¤´¥¼´¶¹M¡]106¦~«×¥Ó³ø­^¤åª©Ä³¨Æ¤â¥U­p¦³267®a¡B­^¤åª©ªÑªF·|¦~³ø­p¦³193®a¡^¡AÃÒ¥æ©Ò·~¤w­×¥¿¡u¹ï¦³»ùÃÒ¨é¤W¥«¤½¥q¤Î¹Ò¥~«ü¼ÆªÑ²¼«¬°òª÷¤W¥«¤§¹Ò¥~°òª÷¾÷ºc¸ê°T¥Ó³ø§@·~¿ìªk¡v¬ÛÃö³W©w¡A½Ð²Å¦X±ø¥ó¤§¤W¥«¤½¥q¤Î¦­¦]À³¡A¥H´£ª@¸ê°T´¦ÅS«~½è¤Î±j¤Æ§ë¸ê¤HÃö«Y¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/10 ¤U¤È 08:28:05²Ä 1964 ½g¦^À³
©_©Ç¤F §Ú³£¨S¦¬¨ì³qª¾

­^¤å¬Oµ¹­n±ÂÅvªº¦Ñ¥~¬Ýªº¶Ü?©ú¤Ñ¨Óº²Â_¤U

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/10 ¤U¤È 04:45:28²Ä 1963 ½g¦^À³
½Ð±Ð¤j®a¡A§Úª`·N¨ì¤@¥ó¨Æ¤£ª¾­ì¦]¥i¯à¬°¦ó:

¶}©l¥X²{­^¤åª©ªº¶}·|³qª¾¤Îij¨Æ¤â¥U¡A¬O§_¬°¤WÂd»Ý­n?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/10 ¤U¤È 02:54:15²Ä 1962 ½g¦^À³
08 ==>20¤À ¬Ý¬ÝP­È «¢«¢ ªÑ»ù§Ö¶W¹L¨SP­Èªº§r Åܤdª÷
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/10 ¤U¤È 01:35:06²Ä 1961 ½g¦^À³
±q³o2¥yÃöÁä¦r:[«e10¦W°ê»Ú¤jÃļt]»P[§Ú¿Ë¦Û¨ì¤Fheadquarter¥h]¡AÀ³¸Ó¬O«üªYÄ£µL»~!!!

05_·sÃĶ}µo_¿ïÃD

13.10~14:30’:

.....³o¬O¨Æ¹ê®@ [«e10¦W°ê»Ú¤jÃļt] ........§Ú­É¨ä¤¤¤@®a [§Ú¿Ë¦Û¨ì¤Fheadquarter¥h] ½Í¨ì³Ì«á ¥L»¡±z­Ì¯à¤£¯à ³o®a.§Ú´N¶R±z­ÌªºªÑ²¼°Ú.§ë¸ê±z­ÌªºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±z­n´N¶Rcompound ±z·Q¶R[¤½¥q] §Ú­Ì¤£½æ±z....½Í¨ì³o¼Ë£²...

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 09:21:39²Ä 1957 ½g¦^À³

­J¤j¯«¬OªYÄ£ªºSAB¡A«ö²z·|¥X®u¤U¦Cªº¦X§@¬¢½Í¡A©Ò¥H±z·Q¶R[¤½¥q]¡A©Ò¿×ªº[¤½¥q]8¦¨´N¬OªYÄ£¡C

---------------------------------------------------------------------------------------------

·|­û¡G«ä¦Ò¤¤10147262 µoªí®É¶¡:2020/7/23 ¤U¤È 09:36:18²Ä 195 ½g¦^À³

2019/04 »P¸ó°ê«e¤­¦W¤§»sÃĤ½¥q¡A¬ãµo¹Î¶¤¦@¤E¦ì¤£¦P³æ¦ì°ÆÁ`µô¤Î¨Mµ¦¤H¤h¡A¦b¬ü°êÁ`³¡³sÄò¤K¤p®É¡A

2019/04 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ãµo¹Î¶¤¡A¦b¬ü°êÁ`³¡¡A¬¢½Íªø¹F¥|¤p®É¦³Ãö¤îµhÃÄSNP-810¦X§@¨Æ©y¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/10 ¤W¤È 11:49:25²Ä 1960 ½g¦^À³
¹Ú«Ü¬ü ¥i±¤ªÑ»ù¤£¶R±b
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/9 ¤U¤È 10:41:53²Ä 1959 ½g¦^À³
10_·sÃĬãµo¦¨¥\®×¨Ò_GSP¨x¥\¯à©w¶qªk

1:18 avalon hepaPOC ¤z¯à¿}---GSP¦X§@¼t???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/9 ¤U¤È 10:28:55²Ä 1958 ½g¦^À³
08_·sÃĬãµo¦¨¥\®×¨Ò_·s¦¨¤À(ªø®Ä¤î¼@µh¤£¦¨Å})

­J¤j¯«¦b19:00¬í°_»¡:..¦ý¬O§Ú¦Û¤v³£¦b¦Y°Ú §Ú¤£¦Y¨º­Ó¦³¨x¬r©Êªºpanadol ´N¬O´¶®³¯k §Ú¤]¤£¦Y¦³¨x¬r©Êªºtylenol

²{¦b§Ú­Ì¥i¥H[¦Y¤@²~]®@ ³£¤£·|¦³¨x¬r©Ê³á ¨ì³oºØ¦a¨B¤F ·íµM ³oÁٻݭn¤@¬q®É¶¡¤~·|¤W¥« ¦ý¬O...

-----------------------------------------------------------------------------------------------------

­J¤j¯«²{¦b¥u¦YªYÄ£ªºSAFETYNADOL¡A[¦Y¤@²~=100g]¨S¤¤¬r³o»ò¸Ø±i???

dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b956d527-7ea7-e084-e053-2a95a90a866d&type=display

500mg *200Áû/²~=100g

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/9 ¤U¤È 09:21:39²Ä 1957 ½g¦^À³
­J¤j¯«¬OªYÄ£ªºSAB¡A«ö²z·|¥X®u¤U¦Cªº¦X§@¬¢½Í¡A©Ò¥H±z·Q¶R[¤½¥q]¡A©Ò¿×ªº[¤½¥q]8¦¨´N¬OªYÄ£¡C

---------------------------------------------------------------------------------------------

·|­û¡G«ä¦Ò¤¤10147262 µoªí®É¶¡:2020/7/23 ¤U¤È 09:36:18²Ä 195 ½g¦^À³

2019/02 »P¸ó°ê«e¤Q¦W»sÃĤ½¥qñ¸p¦³Äv·~¸T¤î¤§«O±K¨ó©w¡A°Ó°QSNP-810¦X§@¨Æ©y¡C

2019/04 »P¸ó°ê«e¤­¦W¤§»sÃĤ½¥q¡A¬ãµo¹Î¶¤¦@¤E¦ì¤£¦P³æ¦ì°ÆÁ`µô¤Î¨Mµ¦¤H¤h¡A¦b¬ü°êÁ`³¡³sÄò¤K¤p®É¡A

2019/04 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ãµo¹Î¶¤¡A¦b¬ü°êÁ`³¡¡A¬¢½Íªø¹F¥|¤p®É¦³Ãö¤îµhÃÄSNP-810¦X§@¨Æ©y¡C

2019/07 »P¸ó°ê«e¤Q¦W»sÃĬü°ê¤½¥q¹Î¶¤Á|¦æ²Ä¤G¦¸¹q¸Ü·|ij¡A²`¤J°Q½×¥þ²y­º¨ÒµL¨x¬r¤îµhSNP-810¤§¬ì§Þ¡B¬ãµo¶i«×¤Î¦X§@¨Æ©y¡C

2019/12 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ü°ê¡B¼Ú¬w¡B·ç¤h¤§°Ó·~µo®i¡B¬ãµo³¡¤Î±M§Q«ß®v¡AÄ~«e¤T¦¸§¹¦¨¬ì§Þ¤Î¬ãµo¶i«×«á¡A²Ä¥|¦¸Á|¦æ¦¸¹q¸Ü·|ij¬¢½ÍSNP-810¦X§@¡B±ÂÅv¡B°Ó·~µo®i¨Æ©y¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/9 ¤U¤È 08:52:57²Ä 1956 ½g¦^À³
05_·sÃĶ}µo_¿ïÃD

­J¤j¯«¦b14:15¬í°_:...½Í¨ì³Ì«á ¥L»¡±z­Ì¯à¤£¯à ³o®a.§Ú´N¶R±z­ÌªºªÑ²¼°Ú.§ë¸ê±z­ÌªºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±z­n´N¶Rcompound ±z·Q¶R[¤½¥q] §Ú­Ì¤£½æ±z....½Í¨ì³o¼Ë£²...

±z·Q¶R[¤½¥q]ªº[¤½¥q]¤£¾å±o¬O¤£¬OªYÄ£???

ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C

---------------------------------------------------------------------------------------------------

·|­û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/9 ¤U¤È 05:41:54²Ä 1951 ½g¦^À³

§ä¨ì¤@­ÓLinkingPros³X½Í­J¤j¯«ªº¤½¶}¼v¤ù»P¤j®a¤À¨É:

www.facebook.com/watch/108155710567674/1041370163073318

------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 11:37:52²Ä 1835 ½g¦^À³

ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/9 ¤U¤È 08:49:36²Ä 1955 ½g¦^À³
°¨¤W§ó·s??

¤½¥q¬ãµo¤H­ûªº¬ãµo¸gÅç¦X­p306/¤H¦~¡AªYÄ£®Ö¤ß§Þ³N¨Ó¦Û¥]§t¬ì§Þ³¡µ¥¬ã¨s¾÷ºc±MÄݱÂÅv¡A¤½¥q¬ãµo¹Î¶¤«h¥ÑÀò±o¡u¬ü°ê°ê®aµo©ú®a¾Ç°|¡v°|¤h³Ì°ªºaÅA¡B²{¾»O¥_Âå¾Ç¤j¾ÇÁ¿®y¡B¤¤¬ã°|«È®yÁ¿®y±Ð±Âªº­J¥®®E³Õ¤h«ü¾É¤U¡A¦Û¦æ«Ø¸m¥H¡u¨xŦ¥NÁȕÀ¬¡©Ê¡v¤Î¡u°ò¦]½Õ±±¡v¤G§Þ³N¥­¥x¡A¶}µo¥X¤»¶µ®Ö¤ß²£«~¡C¥»¤½¥q±Mª`¥H¤HÅé¥NÁȕÀ¬¡©Ê½Õ±±µ¥¬ÛÃö±M§Q§Þ³N¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/9 ¤U¤È 08:36:42²Ä 1954 ½g¦^À³
R¤j

¤w°µ200¤H¡H¬O¯uªº¶Ü¡H

°µ¥X¨Óªºµ²ªG·Ç½T¶Ü¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/9 ¤U¤È 07:43:27²Ä 1953 ½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:28:41²Ä 1948 ½g¦^À³

¨xŦ¬ï¨ë¬¡²Õ´À˹ï¶}µoNASHÃĪ«ªºÃļt¨Ó»¡¬O¤jÅ]¤ýÃö¥d!

--------------------------------------------------------------------------------------------

«D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)---¥Ø«e¤w°µ§¹200­Ó¯f¤H.....

Æg°Õ!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/9 ¤U¤È 07:01:02²Ä 1952 ½g¦^À³
¤p¨k¤H¤jµ¹±z«öÆg°Õ!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/9 ¤U¤È 05:41:54²Ä 1951 ½g¦^À³
©ÓR¤j©Ò»¡ªº¤j¯«¡A§ä¨ì¤@­ÓLinkingPros³X½Í­J¤j¯«ªº¤½¶}¼v¤ù»P¤j®a¤À¨É:

www.facebook.com/watch/108155710567674/1041370163073318

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/9 ¤U¤È 12:56:37²Ä 1950 ½g¦^À³
108¦~«×¡u½ÃºÖ³¡¡P¸gÀÙ³¡ ÃĪ«¬ì§Þ¬ã¨sµo®i¼ú¡v±o¼ú¦W³æ ¥Ó½Ð¤H:­J¥®®E ¼ú¶µ:»É½è¼ú

²£«~¦WºÙ:§Ö³tºë·Ç´ú¶q(Point-of-Care, POC)¨x¥\¯à¤§·s¥b¨Å¿}ÀË´ú¨t²Î

Point-of-Care Determination System for Quantitative Liver Function Test

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:23:14²Ä 1947 ½g¦^À³

(¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)³o¬O¤j¤û¾ÇªÌ­J¥®®E³Õ¤hªºµo©ú

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/8 ¤U¤È 09:48:18²Ä 1949 ½g¦^À³
2019.4.12 ¡m2019¼Ú¬w¨xŦ¦~·|¡nNASH¤j¼tGileadµoªí«D«I¤J©Ê¶EÂ_¨ú¥N¶Ç²Î¤Á¤ù

www.genetinfo.com/investment/featured/item/25302.html

-----------------------------------------------------------------------------------------------

§Ú°O±oFDA©|¥¼®Ö­ãGileadªº«D«I¤J©Ê¶EÂ_ªk!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/8 ¤U¤È 09:28:41²Ä 1948 ½g¦^À³
¨xŦ¬ï¨ë¬¡²Õ´À˹ï¶}µoNASHÃĪ«ªºÃļt¨Ó»¡¬O¤jÅ]¤ýÃö¥d!

¥Ø«eÁ{§É¶EÂ_¤W¡A¨ã[«I¤J©Ê]¥B [ªá¶O°ª]ªº¨xŦ¬ï¨ë¬¡²Õ´Àˬd¬°FDA°ß¤@®Ö­ãªºÀËÅç¤èªk¡A¤]¬Oµû»ù·sÃĸÕÅ禳®Ä©Êªº¡§ª÷¼Ð·Ç¡¨¡C

¦³¨Ç±wªÌ¤£Ä@·N¶i¦æ¤Á¤ùÀˬd¡A©Ò¥HNASHÃĪ«Á{§É¤£¦n©Û¦¬±wªÌ¡C ¦]¦¹ÃļtÄv¬Û§ë¤J¶}µo[«D«I¤J]©Ê¥Íª«¶Ç·P¾¹¨ÓºÊ´ú©M°lÂÜNASH¡A§Æ±æ¯àÀò±oFDA®Ö­ã¬°NASHÀø®ÄÀËÅç¼Ð·Ç!!!

2020.11.17(¬ü°ê¨x¯f¬ã¨s¨ó·|¦~·|) Glympse Bio¶}µoNASH«D«I¤J¦¡¶EÂ_13ºØ¥Íª«¼Ð°O¥i±æ¨ú¥N¬ï¨ëÀˬdnews.gbimonthly.com/tw/article/show.php?num=34577

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/8 ¤U¤È 09:23:14²Ä 1947 ½g¦^À³
(¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)³o¬O¤j¤û¾ÇªÌ­J¥®®E³Õ¤hªºµo©ú

ªYÄ£©|¦³¦¬¿ý¦bUSFDA«ü¤Þ¤¤¡A¥H«D«Iŧ©Êªº©w¶q´ú©w³Ñ¾l¨x¥\¯àªº¤èªk¡u¥b¨Å¿}³æÂIªkGSP (galactose single point)¡v¡A¥¿µo®i¬°¶EÂ_ªvÀøNASHªº¥Íª«¼Ð°O(biomarker)¡A¦p¦¹¥i±æ¸Ñ¨M¨ä¥LNASHÃÄ­n¥Î¨x¬ï¨ë¤~¯à¨Ï¥ÎNASH ÃĨӪvÀøªº§x¹Ò¡CSNP-6¨t¦C²£«~¦]¦³¨}¦nªº¦w¥þ©Ê¤ÎÅãµÛÀø®Ä¡A¤wÀò°ê»Ú¤j¼tÆf¥Ø¡A²`«×°Q½×¨Ã±K¤ÁÁpôµû¦ô°Q½×¤¤¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2020/7/11 ¤W¤È 06:03:29²Ä 112 ½g¦^À³

...ªYÄ£SNP6/SNP8--­J¥®®E³Õ¤h(2016¦~Àò¿ï¬°¬ü°êÃľǬì¾Ç®a¾Ç·|°|¤h¤Îµo©ú®a³Ì°ªºaÅA¤§¬ü°ê°ê®aµo©ú®a¾Ç°|Âù°|¤h)

www.microbio.com.tw/tw/news_detail.php?nwno=264

­J¥®®E³Õ¤hµo©úªº¥b¨Å¿}³æÂIªk¤w³Q¦¬¿ý¦bUSFDA«ü¤Þ¤¤...¥¿µo®i¬°¶EÂ_ªvÀøNASHªº¥Íª«¼Ð°O(biomarker)¡A¦p¦¹¥i±æ¸Ñ¨M¨ä¥LNASHÃÄ­n¥Î¨x¬ï¨ë¤~¯à¨Ï¥ÎNASH ÃĨӪvÀøªº§x¹Ò¡C

1.www.sinewpharma.com/news_detail.php?nwno=35

2.www.cna.com.tw/news/ahel/201911130336.aspx

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/8 ¤U¤È 06:19:08²Ä 1946 ½g¦^À³
¦V¤j¡A¥t¥~µo²{

¨Î®mªºªL¡¯·ì­Ý¶ê²»¥Í§Þ¸³¨Æ

¶ê²»¦n¹³¤S¬O¯E¹©ªº¤l¤½¥q

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/8 ¤U¤È 06:04:12²Ä 1945 ½g¦^À³
Page19,³o¬q¤]ÆZ¦³½ìªº¡G¤£¾å±o¬O¤£¬O¸ò110/12¤ëñ¬ùªº¦³Ãö

(¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP)¡G

¥¼¨Ó¤]³W¹º¦X§@¶}µo GSP¡A¥H¨ó§UÁ{§É¶Eªv¯×ªÕ¨xª¢¡C³Ñ¾l¨x¥\

¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP)¤w©ó 2003 ¦~¯Ç¤J¬ü°ê FDA ¶EÂ_«ü¤Þ¤Î±Ð¬ì

®Ñ¡A²{¤w¦³¦b±Ä¼Ë²{³õ§Q¥Î¥iÄ⦡ªº¤ÀªR»ö¾¹¤Î®M²Õ§Ö³t±o¨ìÀË´úµ²

ªG(point-of-care)¡A¤w³q¹L¤W¥«¡A¥¿»P¥»¤½¥q³W¹º¦X§@¤¤¡C¯×ªÕ¨xª¢¨t

¦C·sÃÄ¡A¥¼¨Ó±N¦¹²£«~ÂX®i¨ì¡u°sºë©Ê¯×ªÕ¨xª¢¡v¤Î¡u¯×ªÕ¨x¡v¡A¦p

¦¹¥«³õ¦û¦³®É¶¡¥i©µªø¡A©Ôªø¾P°â¾Ô½u

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/5/8 ¤U¤È 04:59:09²Ä 1944 ½g¦^À³
111¦~«×Àç¹B­p¹º

(¤T)»P°ê»Ú¤j«¬Ãļt¬¢½Í§Þ³N±ÂÅv¤§¦X§@­pµe

¤½¥q¦³©ú½T¼g¤W¡A§Æ±æ¯à¦pÄ@

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/8 ¤U¤È 04:33:22²Ä 1943 ½g¦^À³
¤p¨k¤H¤j

­Ó¤H¤]ı±o¸ê®Æ«Ü©_©Ç¡H

Áp¹©»P¨Î¯C³£¤£¬O¸³¨Æ¡A«o¦C¡u¸³¨Æ±Æ°£Äv·~¡v¡C

Áp¹©ªº¥Nªí¤H¡G°¨XµY¬O§_¬°´I¨¹ªº¤H°¨¡H

±©¤@«GÂI¡A75¤¸²{¼W¦³¶WÃB·Q»{5¤d¦h±i¡A

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/8 ¤U¤È 01:12:45²Ä 1942 ½g¦^À³
20200415 ¼¶½Z¢¬¯Î©s·O¡]»O¤jÂå¾Ç°|Âå¾Ç¨t§U²z±Ð±Â¡^

...ÄY­«ªº°sºë©Ê¨xª¢¬Æ¦Ü¦b¶EÂ_«á90¤Ñ¤º¡A¦³°ª¹F75%ªº¦º¤`²v¡C¥Ø«eÄY­««æ©Ê°sºë©Ê¨xª¢ªºªvÀø¥u¦³¥Ö½èÃþ©T¾J«j±j³Q»{¬°¥i¯à¦³®Ä¡C¨xŦ²¾´Ó¬O°ß¤@¥i¥Hªv¡ªºÀøªk¡A¦ýµ¥«Ý´«¨xªº¤H¤Ó¦h¡A¥u¦³¤Ö¼ÆÂå¾Ç¤¤¤ß¤Î¦³­­ªº±wªÌ¦³¾÷·|±µ¨ü¨xŦ²¾´Ó¡C

www.liver.org.tw/journalView.php?cat=65&sid=878&page=1

-------------------------------------------------------------------------------------------------

¥x¤jªº75%¦º¤`²v»P·s¥[©Y30%¦º¤`²v¡A2²Õ¼Æ¾Ú®t¶Z¦n¤j¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/8 ¤U¤È 01:03:58²Ä 1941 ½g¦^À³
§Ú¤§«e»´µø¤FSNP-630ªº[°sºë©Ê]¨xª¢¥«³õ!!!

·s¥[©YSZN-043¥HÄY­«°sºë©Ê¨xª¢¬°ªvÀø¯f¯g( ¤£°µAPAP¤¤¬r¸ÑÃÄ) www.surrozen.com/programs/pipeline

¬ü°ê¨C¦~¬ù¦³ 100,000 ¤H¦][ÄY­«°sºë©Ê] ¨xª¢¦í°|¡A³o¨Ç±wªÌ¦b 90 ¤Ñ¤ºªº¦º¤`²v¬ù¬° 30%¡AªvÀø¿ï¾Ü«Ü¤Ö¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 11:04:17²Ä 1660 ½g¦^À³

ªYÄ£ºô­¶:

²£«~¶i«×SNP-630:·sªvÀø¾AÀ³¯g±´°Q-°£¤F¹ï«D°sºë©Ê¯×ªÕ¨xª¢(NASH)¦³®Ä¡A¤]¦P®É¶i¦æ°Êª«¹êÅç¡A±´°QªvÀø°sºë©Ê¯×ªÕ¨xª¢(ASH)¤§Àø®Ä

................................................................................................

¦³½ì¤F!

µn¿ý¦b®×ªºASHÁ{§É©tªù¿W¥«´N1¥ó 1¥ó 1¥ó(ÁÙºM®ø¨S°õ¦æ)---³oªí¥ÜASHÀ³¸Ó¨S¥«³õ§a¡A¤£¸ÑªYÄ£·F¹À±´°Q???

clinicaltrials.gov/ct2/results?cond=ASH+alcoholic+Steatohepatitis&term=&cntry=&state=&city=&dist=

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/30 ¤U¤È 03:40:36²Ä 1257 ½g¦^À³

...2021.6.25 (2021¦~°ê»Ú¨xŦ¤j·|™ 2021 (ILC))

Surrozen ¦b 2021 ¦~ Wnt ½Õ¸`§ÜÅé SZN-043 °ê»Ú¨xŦ·|ij¤W¤½§G¼Æ¾Ú¡¨ ¡§§Ú­Ì´Á«Ý¦b 2022 ¦~±N¨ä±À¦VÁ{§É¬ã¨s®ÉÄ~Äòµû¦ô SZN-043¡C¡¨¦bÃD¬°¡§SZN-043¡A¤@ºØ¹v¦V R-spondin ªº¨x²Ó­M¼ÒÀÀª«¡A¦b«æ©Ê¹ï¤A酰®ò°ò×ô»¤¾Éªº¨x·l¶Ë¼Ò«¬¤¤»¤¾É¨x²Ó­M¼W´Þ¡¨ªº®ü³ø®i¥Ü¤¤¡A¼Æ¾Ú´£¨Ñ¤F¤ä«ùÃÒ¾Ú¡A§Y SZN-043 ¥i¥H»¤¾É¨x²Ó­M¯S²§©Ê¦A¥Í¡C¹ï¤A酰®ò°ò×ô¹L¶q¡A¥i¥H§ïµ½¨x¥\¯à¡A¥i¥H´î¤ÖÃa¦º­±¿n¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/5/7 ¤U¤È 06:59:26²Ä 1940 ½g¦^À³
½Ð±Ð¤j®a¡A§Ú¬Ý¨ìªººÃ°Ý¦p¤U

1.Áp¹©¸ê¥»§ë¸ê¦³­­¦X¹Ù¡G¬O§_¬°·s¸³¨Æ

2.¼W¸ê°h¤F4eµ¹»{¤£¨ìªºµL½tªÑªF¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/5/7 ¤U¤È 06:19:32²Ä 1939 ½g¦^À³
R¤j

ªYÄ£¦Û¤v®Ú¥»µL¦æ¾P¯à¤O

µL½×¬O¡u§C¨x¬r¡v¡B¡u·P«_ÃÄ¡v

¨S¸ÕÃĮĹLÃö¡A±ÂÅv¤jÃļt¦æ¾Pªº¸Ü¡I

³£¬O§@¹Ú¶¥¬q¡I

ÃĮĸըº麽¤[¤F¡AÁöÁÙ¨S¦³§¹¦¨¥Ø¼Ð¡A¦ý¤j¤è¦VÀ³¸Ó¦³ÃФF¡C

¤u·~§½¬°¦ó­ã¤F¦P·N¨ç¡H¤½¥qÀ³¸Ó¦³¸q°È§i¶DªÑªF­Ì¤~¹ï¡I

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/7 ¤U¤È 12:23:54²Ä 1938 ½g¦^À³
¦pªG§Ú¬OIntercept¤½¥qCEO¡A¦b®³¨ì²Ä1±iNASHÃÄÃÒ«á¸êª÷¤ô¦ìº¡·¸¡A­nµÛ¤âOcalivaªº¤U¤@¥N·sÃÄ(§ó¨ã¦w¥þ©Ê»PÀø®Ä)¡A¨º»òª½¨úSNP-630§@ÁpÃĶ}µo´N¬O³Ì¨Î³Ì§Ö³t¿ï¶µ¤§1 !

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 09:45:43²Ä 1934 ½g¦^À³

²×§½¤§¾Ô¦³¤H©ã¤F 4.05»õ¬ü¤¸!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/7 ¤U¤È 12:13:53²Ä 1937 ½g¦^À³
¤j¹Ú·Q®a¤jªº¹Ú·Q °_¯è!

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/21 ¤U¤È 06:24:47²Ä 1230 ½g¦^À³

¦pªG¤j¶O©P³¹¥u®³¾Ç¦WÃÄÃÒ§ð¦û1¦¨¥«¦û²v(¾Ç¦WÃÄÃÒ·Q10%¥«¦û¤]¤£¥i¯à)¡A«hSNP-810¤j¹Ú¸Ó¿ô!!!

ÁÙ¦³¥xÆW¤H©R¤£«Ü­È¿ú...

-------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:42:03²Ä 1936 ½g¦^À³

....¤½¥q«áÄò¤´¦³³W¹º¹ï©ó¬ü°ê¥«°â 600ºØ§t¦³¤AñQÓi×ô¤§·P«_Ãĵ¥½Æ¤è¡A­Y¥Ñ SNP-810 ¨Ó´À´«

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/7 ¤W¤È 10:42:03²Ä 1936 ½g¦^À³
¤G) µL¨x¬r©Ê¤îµh·sÃÄ(OTC)¡G

SNP-810 µ¦²¤¹B¥Î...¤§Äw½X¡C¦Ò¶qÅçÃÒ SNP-810 ¬°µL¨x¬r©Ê®É¶¡¸ûªø¡A§Ú­Ì­pµe¤À¶¥¬q¨Ó§¹¦¨¡A²Ä¤@¶¥¬q¥ý¥H¡§§C¬r©Ê¤AñQÓi×ô¡¨¤W¥«¡A²Ä¤G¶¥¬q¦A¥H Phase IV¸ÕÅç¡A±À¼s¦Ü¡§µL¨x¬r©Ê¤AñQÓi×ô¡¨¡C

(¤T) µL¨x¬r©Ê¤îµh½Æ¤è·sÃÄ(³B¤èÃÄ)¡G

...¤½¥q«áÄò¤´¦³³W¹º¹ï©ó¬ü°ê¥«°â 600ºØ§t¦³¤AñQÓi×ô¤§·P«_Ãĵ¥½Æ¤è¡A­Y¥Ñ SNP-810 ¨Ó´À´«¡A¥ç¥i¨ü°U¶i¦æÃİʤÎÃĮĸÕÅçÅçÃÒÀø®Ä¡C

------------------------------------------------------------------------------------------------

¥þ­±¶}¾Ô«Ü¯Ó®É¡A¯à¦¬Ã¬º¡º¡? «¥®a¡uÀY³£¬~¸¨¥h¨o¡AµL«c°L¨Ï±o¡C¡v¡A¬Ý¤U¥h...

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/7 ¤W¤È 10:02:17²Ä 1935 ½g¦^À³
FDA¹ïOcalivaªººÃ¼{¦b¦w¥þ©Ê(¨x¬r)!

Ocaliva +SNP-630ÁpÃĦ³ÅãµÛªº¨ó¦P§@¥Î¡AOcaliva ¾¯¶q­°§C¡AÀø®Ä»P¦w¥þ©Ê§ó°ª§ó¨Î!

SNP-610 / SNP-630 °Êª« PK/PD ¸ÕÅç

¦b SNP-630 ¨Ö¥Î¨ä¥L¤T´ÁÃĪ«ªº´ú¸Õ¤¤¡A§Ú­Ìµo²{ SNP-630 »P¤T´ÁÃĪ« Ocaliva ¨Ö¥ÎªvÀø NASH ¤p¹«¡A¦b¦å¿}¡B¦åÁx©T¾J¡B¨xŦ¤T»Ä¥Ìªo¯×µ¥¶µ¥Øªº­°§C®ÄªG¬ÒÀu©ó³æ¿W¨Ï¥Î Ocaliva ©Î SNP-630(p<0.05)¡A¦³ÅãµÛªº¨ó¦P§@¥Î¡AÅã¥Ü SNP-630 µo®i½Æ¤èÃĪ«ªº¼ç¤O¡C

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/11/20 ¤W¤È 11:34:58²Ä 1477 ½g¦^À³

²×§½¤§¾Ô!

2021.8.2

Intercept ø»sOcalivaÀò±oNASH §å­ãªº·s³~®|:¥u­n«O«ù¦w¥þ©Ê

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/7 ¤W¤È 09:45:43²Ä 1934 ½g¦^À³
²×§½¤§¾Ô¦³¤H©ã¤F 4.05»õ¬ü¤¸!!!

1/18 16.56¤¸ ; 5/6 19.27¤¸

2022.5.5 :Intercept Pharmaceuticals ±N¦VÁ`³¡¦ì©ó­^°êªº Advanz Pharma ¥X°â¨ä¦b¬ü°ê¥H¥~ªº¨x¯fÃĪ« Ocaliva ªºÅv§Q¡A«áªÌ¦P·N¦b¨â®a¤½¥q¶g¥|«Å¥¬ªº¥æ©ö¤¤ [¹w¥I] Intercept 4.05 »õ¬ü¤¸

-----------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/18 ¤W¤È 07:49:34²Ä 1600 ½g¦^À³

·Q[½ä]¤@©]­P´I?³o®aIntercept pharmaceuticalsªº[²×§½¤§¾Ô]¦³¼Éº¦10~20­¿ªº¹ê¤O»P¾÷·|?!

­ì¦]:

1.ªÑ»ù¾ú¥v°ª 2014.1.6 $497¡A¾ú¥v§C:2021.8.16 $11.6

2.¬Q¤é¦¬½Lº¦7.96% ¦¬$17.76----¬ü°ê§ë¸êªÌ¶}©l©ãª`Ocalivaªº[²×§½¤§¾Ô]

2022.1.7---2022 ¦~¤£¥i¿ù¹Lªº 3¶µ....¹ï©ó³o¨Ç»sÃÄ°Ó¨Ó»¡¡A³o¥i¯à¬O«D±`¿E°Ê¤H¤ßªº¤@¦~¡C

3.¤@¾Ô¨M¥Í¦º®É¶¡:2022¦~¤W¥b¦~

2021.12.20 Intercept ¥i¯à·|¦b 2022 ¦~¤W¥b¦~»P FDA ­«·s´£¥æ·|ij¡C

4.­Ó¤H¤£·|©ãª`³o³õ½ä§½¡A°lÂÜFDA§å­ãªº²Ä1¤äNASHÃĪ«¥Î¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/11/20 ¤W¤È 11:34:58²Ä 1477 ½g¦^À³

²×§½¤§¾Ô!

2021.8.2

Intercept ø»sOcalivaÀò±oNASH §å­ãªº·s³~®|:¥u­n«O«ù¦w¥þ©Ê

www.fiercepharma.com/pharma/intercept-still-sees-fda-approval-pathway-for-nash-hopeful-ocaliva-as-long-as-safety-holds

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/5/7 ¤W¤È 06:55:37²Ä 1933 ½g¦^À³
5/6¤w¤W¶Çij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡A

À³¸Ó´N¬O¦~³ø¤º®e¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¶ø¥ì´µ¯S10031727  µoªí®É¶¡:2022/5/5 ¤U¤È 03:19:41²Ä 1932 ½g¦^À³
¸ò¤j¼tñªº 810 confirmation study ¡A­Y¼Æ¾Ú²Å¦X¤j¼tªº¹w´Á¡A«áÄò±ÂÅv½Í§Pªº§ð¨¾¡A¨ä¹êº¡¯Ó®Éªº¡C

­Ó¤H¬Oı±o¡A¦b IPO «eÀ³¸Ó¤£·|¦³µ²ªG¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/5/5 ¤W¤È 10:01:10²Ä 1931 ½g¦^À³
¨xª¢°Ê°_¨Ó¤F?!

©ñ±ó¤F¤îµh?!

ÁÙ¬O¤îµh¦¨¥\¤F¡A¦æ¦³¾l¤O¨Ó¬Ý¨xª¢

104·s¾¯Ê

¬ã¨sÅ@²z®v(Á{§É¸ÕÅç¬ãµo³B)

1.¨ó§UÁ{§É¸ÕÅ禬®×»P°õ¦æ¸ÕÅç¬ÛÃö¨Æ©y¡C

2.»Ý¦³Å@¤h/Å@²z®v/ÂåÀË®v°õ·Ó(¯à°t¦X©â¦å)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/5/3 ¤U¤È 09:44:32²Ä 1930 ½g¦^À³
104·s¾¯Ê

¬ã¨sÅ@²z®v(Á{§É¸ÕÅç¬ãµo³B)

1.¨ó§UÁ{§É¸ÕÅ禬®×»P°õ¦æ¸ÕÅç¬ÛÃö¨Æ©y¡C

2.»Ý¦³Å@¤h/Å@²z®v/ÂåÀË®v°õ·Ó(¯à°t¦X©â¦å)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³
°ê¹©Pre-EUA·|ij»»»»µL´Á!

VERU¤£¥Î1­Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting.

2022.5.2

Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today announced that the FDA has granted the Company a pre-Emergency Use Authorization (EUA) meeting on May 10, 2022,

finance.yahoo.com/news/fda-granted-veru-pre-emergency-123000144.html

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤U¤È 03:04:48²Ä 1897 ½g¦^À³

¬Q¤é¦A¼W1®a¤¤«×¦Ü­««×¦í°|±wªÌ¤fªAÃÄ¥Ó½ÐEUA ¡A[°ß¿W°ê¹©¼B¸³«ÅºÙ¤£¥ÎP­È¹F¼Ð]!!!

2022.4.11 ¬ü°êÁÚªü±KVeru¤½¥q¤fªA§Ü¯f¬rÃĪ« sabizabulin¡A P3¤¤´Á¼Æ¾ÚÅã¥Ü¡A»P¦w¼¢¾¯¬Û¤ñ¡A¦b¤¤«×¦Ü­««×¦í°|±wªÌ¤¤ªº¦º¤`²v­°§C¤F 55%¡C¡]p=0.0029¡^µ²ªG³Q»{¬°¨ã¦³²Î­p¾Ç·N¸q©M²Î­p¾Ç·N¸q¡C

--------------------------------------------------------------------------------------------

Veru ªí¥Ü¡A¥Ñ¤_¡§压­Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/30 ¤U¤È 09:09:24²Ä 1928 ½g¦^À³
2022.4.19 ¥[®³¤jªº¬ã¨sµ²ªG»P¬ü°ê¬Û¦P¡A¼W´T¸û¤p¦Ó¤w¡C

§ó§ï¼ÐÅÒ»P¥[µù¨x¬rĵ»y¨Ã¤£¯à¨¾¤î¹ï¤A酰®ò°ò×ô¹L¶q·N¥~!(»Ý­n±Ä¨úÃB¥~±¹¬I¨Ó´î»´·N¥~¹ï¤A酰®ò°ò×ô¹L¶q)

www.cmaj.ca/content/194/15/E542

¥[®³¤j©ó 2009 ¦~ 10 ¤ë¹ï²£«~¼ÐÅÒ¶i¦æ¤F§ó§ï¡A¥Hĵ§i¥i¯à¦s¦b¨x·l¶Ëªº­·ÀI¡C2016 ¦~¡A¥L­Ì§ó·s¤F¦w¥þ¾¯¶qªºªþ¥[¼ÐÅÒ¡A¨ÃÃѧO§t¦³¹ï¤A酰®ò°ò×ôªº²£«~¡C

µM¦Ó¡A¦b³o¶µ°w¹ï 2004 ¦~¦Ü 2020 ¦~¶¡¥[®³¤j 9 ­Ó¬Ù©M 3 ­Ó¦a°Ïªº 12000 ¦h¨Ò¹ï¤A酰®ò°ò×ô·N¥~¹L¶q¤J°|ªº¬ã¨s¤¤¡A¬ã¨s¤H­ûµo²{§ó·sªº¼ÐÅÒ¹ï¤J°|¨S¦³¼vÅT....

Ų©ó¹ï¤A酰®ò°ò×ô·N¥~¹L¶q¹ï¤½¦@½Ã¥Í©M½Ã¥Í¨t²Îªº¼vÅT¡A¥H¤Î¥þ²y¬Fµ¦¨î©wªÌ¹ï«P¶i¦w¥þ¨Ï¥Î¹ï¤A酰®ò°ò×ôªº¿³½ì¡A§Ú­Ìªº¬ã¨sµ²ªGªí©ú¡A»Ý­n±Ä¨úÃB¥~±¹¬I¨Ó¹w¨¾³o¨Ç¨Æ¥ó¡C

-------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/23 ¤W¤È 10:18:43²Ä 1916 ½g¦^À³

§ó·s¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä...2022.4.21---FDA ...¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/26 ¤U¤È 10:55:44²Ä 1927 ½g¦^À³
¬üªÑ¤S±Y¤F~`

©ú¤Ñ¨«µÛÁ@¤F

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/26 ¤U¤È 12:01:34²Ä 1926 ½g¦^À³
«¢«¢ º¦¨S¥÷¡A¶^¦³¥÷

³oªi¨S·f¤W¡A¶^µ¥¨ì¤W¥««e

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/25 ¤W¤È 10:54:17²Ä 1925 ½g¦^À³
¦ý¬O¸ô¸³§Ú¤£´±­e¦P¤H®æ(¬ì¾Ç¤W¥i¥H»{¦P)¡Aµ}ÄÀ¤]Ä묹¤F¬u²±ªÑªFªºÅv¯q!·íµM¦ÑÁó¦û¤jªÑ¡A¤pªÑªF¤]¬O»¡¤£¥X¸Ü¡A

A 2019¦~3¤ë7¤é ¡X ¬°§§¤j·sÃĬãµo¹ê¤O¡A´£¤É°ê»Ú¥«³õÄvª§¤O¡A¤¤¤Ñ

B 2019¦~¾P°âÃB¤w¹F23.2»õ¬üª÷¡A©Ò¥H¥þ²y³£¦b¬Ý³o­Ó¾AÀ³¯g¡C

¡u¦X¤@¸òLEO Pharma¬O¦b¼¯®Ú¤j³qÂåÀø²£·~¤j·|¤W°t¹ïªº¡C§Ú­Ì¦b­u¬ü°Ñ¥[¤§«e´N¦³±µ¤f¤£¤Ö¼t°Ó¡C¼¯®Ú¤j³q«D±`¤Íµ½¡AÀ°§Ú­Ì°t¹ï§ë¸ê¤H»P¼t°Ó¡C¤@¤ëªì¸òLEO Pharma½Í§¹¤§«á¡A¥L­Ì¦^¥h¬ã¨s§Ú­Ì´£¨Ñªº¸ê®Æ¡C¨º®É­Ô§Ú­Ìªº¤@´ÁÁ{§É¸ÕÅç©M¤HÅé±´¯Á¸ÕÅçµ²ªGªºÃÒ¾Ú¤w¸g«D±`©ú½T¡A¦P®ÉÁÉ

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/25 ¤W¤È 10:28:39²Ä 1924 ½g¦^À³
¥D­nÁÙ¬O¤â¤W³¡¦ìªº°ÝÃD¡A¸êª÷°÷©ñªø·íµM¨S°ÝÃD¡C¸êª÷¤£¨¬´N~

¤§«eÄ_0/¬u²±¨ì¦X¤@/¤O¿n¹q¡A¨ä¹êÁȨì¤jªiªº³£¬O©ñ¤[ªº¡C

¬Ý¨ìªÑ»ù¨Ó¨Ó¦^¦^¡A®e©ö§ìÀt¨«Å¾¡C

§Æ±æ¦U¦ì«ù¦³¤H(¦³²´¥úªº¤H)¤jÁÈ¡C³o¼Ë¤~¦³¦¨´N·P¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/4/25 ¤W¤È 09:53:53²Ä 1923 ½g¦^À³
dk¤j¡A§JªA¤ßÅ]¤§«á¡A¥¼¨Ó§ë¸ê·|¤@¦|­·¶¶ªº;

¦³¤@¥y¸Ü»P§A¦@«j¡A§ë¸ê¬O¥H¦~¬°³æ¦ìªº;

³o½g¸ô¸³ªº±M³X±z¤]¥i¥H°Ñ¦Ò:www.qtumic.com/insights/1427825968822616064

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/25 ¤W¤È 09:43:05²Ä 1922 ½g¦^À³
R¤j ¨ü±Ð¤F

¤ßÅ]Ãø¹L

¥u¯à§¤µ¥ÃD§÷µo»Ã¡A¤T¤ÑªÑªF¥i¥H¼W¥[1w¥H¤W¡C

±q¸ê¥»ÃB/ªÑªF¤H¼Æ:ªYÄ£(6.9»õ/ 2271¤H) :Ä_ÄÖ(8.5»õ/ 29736¤H):°ê¹©(14.2»õ/ 18372¤H):¦X¤@(38.8»õ/ 45737¤H)

¥Ø«e©úÅã¤H®ð¤£¨¬¡A­«§Q´N¦b½G¥ÐµL¤H¯Ñ¡A¯Ñ¶}¦³¤Hª§(¤H¨ú§Ú±ó)!

¤H±ó§Ú¨úªº§NªùªÑ§ë¸ê­õ¾Ç

¦pªG§ë¸ê³£¸òµÛ¤j³¡¤À¤H°µ¤@¼Ëªº¨Æ±¡¡A¨ºªÖ©w¥u¯à±o¨ì¥­±eªºªí²{¡A¦]¬°¤j³¡¤À¤H¥Nªíªº´N¬O¥­§¡ÁZ®Ä¡C­Y§Æ±æ¯à¨ú±oÀu©ó¥­§¡ªº³ø¹S¡A¦ÛµM¥²¶·´±©ó©M²³¤H¤Ï¦V¾Þ§@¡A³o¤]´N¬O¤Úµá¯S©Ò»¡ªº¡A¦b§O¤H³g°ý®É®£Äß¡A¦b§O¤H®£Ä߮ɳg°ý¡C¦P®É¡A¤H±ó§Ú¨ú¤]¬O­nªí¹F¤@ºØ¿W¥ß¦Û¥Dªº¬ã¨sºë¯«¡A¦Ó¤£¬O¯S¥ß¿W¦æ¡A¬°¤F¤Ï¹ï¦Ó¤Ï¹ïªº§¾«Äºë¯«¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/25 ¤W¤È 09:32:32²Ä 1921 ½g¦^À³
¦X¤@SNS812¬OªvÀø»P¹w¨¾®ÄªG¡A½÷·ç»PÆQ³¥¸qªº¤fªAÃĬOªvÀø!

¬Ý¬ÝÆQ³¥¸q¬O¦nÃÄ(Àu©ó½÷·ç)¡A¬ü°ê¤]¶R³æ¡C

MoneyDJ·s»D 2022-04-22 11:17:58 °OªÌ ½²©Ó±Ò ³ø¾É

¤é¥»ÆQ³¥¸q»sÃÄ(Shionogi¡B4507.JP)¬ãµo¤¤ªº¤fªA¦¡·s«aªÍª¢(COVID-19)ªvÀøÃĶǥX¬ü°ê¬F©²·Q¶R¡B¥¿©MÆQ³¥¸q¶i¦æ¨ó°Ó¡C¦ÓÆQ³¥¸qÃÒ¹ê¡A¡u¥¿©M¬ü°ê´N¥Í²£Åé¨î¡B¨ÑÀ³µ¥¨Æ¶µ¶i¦æ¨óij¡v¡A¿EÀy¤µ¤éªÑ»ùÅw¼y°f½Ä¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 11:39:56²Ä 1882 ½g¦^À³

»´¤¤¯g¯à¤j´T´î¤Ö¯f¬r¶q´N¬O§Ö³t¨úÃÒ¤§¹D!

2022.4.6 ¡nÆQ³¥¸q»sÃĤfªAÁ{§ÉÀø®Ä§ó³Ó½÷·ç»PÀq§J¡I

www.genetinfo.com/international-news/item/57850.html

...90%¥H¤Wªº¨ü¸ÕªÌ©ó²Ä4¤ÑÅ餺¤wÀË´ú¤£¥X¯f¬r¶q....

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/24 ¤U¤È 06:13:46²Ä 1920 ½g¦^À³
§ÚÀ£¦X¤@[»ó]Ãú¼Q¾¯ªº²z½×°ò¦ (Omicron¶Ý»ó©Ê·¥¤Ö­«¯g¡A Delta¶ÝªÍ©Ê­«¯g¦h)

2020.11.26 www.nature.com/articles/s41385-020-00359-2

°w¹ï¤W©I§l¹D·P¬V¡A¨¾·P¬V³Ì¨Îªº¬Ì­]¬O¡u»ó¤º¬Ì­]¡v¡A¦Ó¥Ø«eªº¡uª`®g«¬¬Ì­]¡vÁöµM¥i¥H¹w¨¾­«¯g¡A¦ý¤´Ãøªý¤î¤W©I§l¹D¶Ç¼½¡A¤£ºÞ´X¾¯¥[±j¡A¤j¬ù¹L¤F¥|­Ó¤ë«á¡A´N·|¥¢®Ä¡A¨Ã¥i¶Ç¼½¥L¤H¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:31:34²Ä 1853 ½g¦^À³

§ÚÀ£:

1.¥þ²y­º¤ä[»óÃú¼Q¾¯] ¦X¤@SNS812¼s®Ä«¬§Ü·s«a¬y·P¤p®Ö»Ä·sÃÄ¡A¤w­n¥Ó½ÐP1

2.¦A¯}¥xÆW·sÃıÂÅv¬ö¿ýªºON101

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/24 ¤U¤È 05:38:46²Ä 1919 ½g¦^À³
¤µ¤Ñ¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù128~129¡A½æ»ù150¡C(¹w­p250¤¸¥H¤W¤H¨ú§Ú±ó)

³o®a¤½¥q¥h¦~µ|«áÁÈ6.8¤¸¡A¦¨ªø>100%¡A¶i¤JÀ禬Ãzµo´Á....

9¦~«e«Ü¦h¤H¥ÎÁ«·l»ù½æ¥X¡A«Ü¦nij»ù¦b¤Q¶ôªì¦¨¥æ¡C

·|§ë¸ê³o®a¤½¥q¬Oª¾¹D¨ä²£«~ªùÂe·¥°ª(¥xÆW«ÜÃø¦A¦³²Ä2®a¥X²{)¡C

(¿ù»~)ªº¨M©w---³o¬O±q¤µ¤ÑªºÀò§Q»PªÑ»ùµ²ªG¨Ó¬Ý¡A¦ý¦b·í®É¬O(¹ï)ªº¨M©w¡A¦]¬°¨S¦h¤[¶Ç¥XÁ`¸g²zµ¥¤HÂ÷¾...

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/20 ¤W¤È 10:58:06²Ä 1226 ½g¦^À³

...²{¦b¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù65~70(§Ú±µ¹L2¦¸¹q¸Ü¥X~70¤¸¶R)¡A½æ»ù120~140¡C

¦pªG¤£¬O5¦~«e»P¤@¦ì¬ãµo¸g²z²á¤Ñ«á³B²z1¥b«ùªÑ(¿ù»~ªº¨M©w)¡A²{¦b¤â¤W>300±i¡C

-------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2020/5/10 ¤W¤È 06:53:42²Ä 2536 ½g¦^À³

[·|­û¡GROGER588910148151 µoªí®É¶¡:2019/11/11 ¤U¤È 04:33:19²Ä 1500 ½g¦^À³

¥¢±Ñ¨Ã¤£¥i©È¡A¤ßºA¨M©w¤F§Ú­Ì·|¦p¦ó¦^À³!§ë¸êµJÂI»P§ë¤J»ù¦ì¤£¦P¡A©Ò¯à©Ó¨üÀ£¤O´N¤£¤@­P¡C

....................................................................................

´¿¸g¤â¤W«ù¦³3®a¥¼¤W¥«¤½¥q¡A¤@®a´ó·À(·l¥¢15¸U)¡C2019¦~¤@®a¤W¿³Âd(«ù¦³18¦~Åo¡A§ë¤J¦¨¥»¦­®³¦^¡A»P´ó·À¨º®a¤½¥q¦P¤@²£·~)¡C²{¦b¤â¤WÁÙ«ù¦³1¤ä¥¼¤W¥«¤½¥q(«ù¦³6¦~¡A§ë¤J¦¨¥»¤]¦­®³¦^)¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/24 ¤U¤È 05:12:20²Ä 1918 ½g¦^À³
±q¸ê¥»ÃB/ªÑªF¤H¼Æ:ªYÄ£(6.9»õ/ 2271¤H) :Ä_ÄÖ(8.5»õ/ 29736¤H):°ê¹©(14.2»õ/ 18372¤H):¦X¤@(38.8»õ/ 45737¤H)

¥Ø«e©úÅã¤H®ð¤£¨¬¡A­«§Q´N¦b½G¥ÐµL¤H¯Ñ¡A¯Ñ¶}¦³¤Hª§(¤H¨ú§Ú±ó)!

¤H±ó§Ú¨úªº§NªùªÑ§ë¸ê­õ¾Ç

¦pªG§ë¸ê³£¸òµÛ¤j³¡¤À¤H°µ¤@¼Ëªº¨Æ±¡¡A¨ºªÖ©w¥u¯à±o¨ì¥­±eªºªí²{¡A¦]¬°¤j³¡¤À¤H¥Nªíªº´N¬O¥­§¡ÁZ®Ä¡C­Y§Æ±æ¯à¨ú±oÀu©ó¥­§¡ªº³ø¹S¡A¦ÛµM¥²¶·´±©ó©M²³¤H¤Ï¦V¾Þ§@¡A³o¤]´N¬O¤Úµá¯S©Ò»¡ªº¡A¦b§O¤H³g°ý®É®£Äß¡A¦b§O¤H®£Ä߮ɳg°ý¡C¦P®É¡A¤H±ó§Ú¨ú¤]¬O­nªí¹F¤@ºØ¿W¥ß¦Û¥Dªº¬ã¨sºë¯«¡A¦Ó¤£¬O¯S¥ß¿W¦æ¡A¬°¤F¤Ï¹ï¦Ó¤Ï¹ïªº§¾«Äºë¯«¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/24 ¤U¤È 04:09:55²Ä 1917 ½g¦^À³
¤H®ð¤£¨¬´N¬O¤£¨¬ ÃD§÷³£¨Sµo´§¨ì

±µ¤U¨Ó¯}¸U«Üªñ¤F

²{¦b¤£º¦«Ý¦ó®É

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/23 ¤W¤È 10:18:43²Ä 1916 ½g¦^À³
§ó·s¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä!!!

2009¦~7¤ë¡A¬ü°êFDA«Å¥¬¹ï¤A酰®ò°ò×ô¥[µùĵ§i¼ÐÅÒ¡A¥H´î¤Ö¥i¯à³y¦¨¹L¶qªAÃĪº±¡§Î¡Aµ²ªG¤£¨}¨Æ¥ó±q2009~2021¤´²r¼W440%!!!

-------------------------------------------------------------------------------------------------

2022.4.21---FDA ĵ§i¯kµh¸É¥R¾¯§t¦³¥¼¥Ó³øªºÃĪ«

...¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä

...2009 ¦~¡AFDA ´N¹ï¤A酰®ò°ò×ô¾É­P¨x·l¶Ëªº­·ÀIĵ§i¬ü°ê®ø¶OªÌ...³o¨Ç¦æ°Ê¹ï¹w¨¾¹ï¤A酰®ò°ò×ôªº¤£¨}¤ÏÀ³§@¥Î¬Æ·L¡C®Ú¾ÚFDA ªº¤£¨}¨Æ¥ó³ø§i¨t²Î¡A2009 ¦~³ø§i¤Fªñ 2,800 °_¯A¤Î¹ï¤A酰®ò°ò×ôªº¤£¨}¨Æ¥ó¡C¨ì 2021 ¦~¡A¤£¨}¨Æ¥óªº¼Æ¶q¤w¼Wªø¨ì 15,000 ¦h°_¡A¼Wªø¤F 440%¡C±q 2009 ¦~¨ì 2021 ¦~¡A³ø§i¤F¶W¹L 27,000 ¨Ò¯A¤Î¹ï¤A酰®ò°ò×ôªºÃĪ«¦º¤`¡C

www.painnewsnetwork.org/stories/category/Pain+Medication

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gonly10135877  µoªí®É¶¡:2022/4/21 ¤W¤È 10:49:02²Ä 1915 ½g¦^À³
¤îµhÃĪº¬G¨Æ

www.youtube.com/watch?v=obRnwe68VR4

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GNtumgk10151447  µoªí®É¶¡:2022/4/21 ¤W¤È 09:46:49²Ä 1914 ½g¦^À³
ªYÄ£©|»Ý¤º³¡±±¨î±M®×¼f¬d³ø§i¤~¯à¥Ó½Ð¤WÂd¡A¤º±±Án©ú®Ñ¬O¨C­Ó·|­p¦~«×²×¤F®É³£­n¥Ó³øªº¶µ¥Ø¡A­Y¥h¬d¸ß¨ä¥L®a¤½¥q¤]¯àµo²{¤j¦h¼Æ©ó4¤ë«e³£·|§ó·s¡ã©Ò¥H·Ç½T¤£¯à»¡¬O¤WÂd¦³·s¶i®i
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/20 ¤U¤È 10:55:46²Ä 1913 ½g¦^À³
¬Ý¨Ó¨S¤H¤F¸Ñ ¨S¤Hª£

ªYÄ£¤]ºâ¨¾¬Ì·§©ÀªÑ°Ú.

µL½×¥´¬ÌÐt©Î¬V¬Ì³£·|¥Î¨ì¤îµhÃÄ

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/4/20 ¤U¤È 04:02:40²Ä 1912 ½g¦^À³
¤½¥q³£¦³¦b¤@¨B¤@¨B¬°¤WÂd°µ·Ç³Æ¡A¤j®a¦w¤ßµ¥«Ý;

­Ë¬O§Ú¤ñ¸û¦n©_630ªº¤G´ÁÁ{§É¦ó®É·|¶}©l?¦³¤H¦³¸ê°T¶Ü?

-----------------------------------------------------------------------------

¤½¥q¥N¸¹ ¤½¥q²ºÙ ¤½§i¤é´Á ¤º±±Án©ú®Ñ¤§Ãþ«¬ ¥D¦®

6634 ªYÄ£ 111/03/30 Án©ú¤º³¡±±¨î¨î«×³]­p¤Î°õ¦æ§¡¦³®Ä-¿í´`ªk¥O³W³¹³¡¤À±Ä¥þ³¡ªk¥O³W³¹§¡Án©ú 110¦~«×¤º³¡±±¨î¨î«×Án©ú®Ñ¤½§i

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gonly10135877  µoªí®É¶¡:2022/4/20 ¤U¤È 03:07:52²Ä 1911 ½g¦^À³
ªYÄ£¤]ºâ¨¾¬Ì·§©ÀªÑ°Ú.

µL½×¥´¬ÌÐt©Î¬V¬Ì³£·|¥Î¨ì¤îµhÃÄ

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/20 ¤U¤È 02:00:54²Ä 1910 ½g¦^À³
¨¾¬Ì·§©À³£¤W¤Ñ¤F¡A·sÃÄÁÙ¦b¦aªO¨S·R

¯u·Ð§r~~~

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/4/19 ¤U¤È 11:26:39²Ä 1909 ½g¦^À³
°ò¥»¤W¤£¥Î¤Ó¾á¤ß¡A¬Û«H¦n®ø®§¦bªñ´X­Ó¤ë¤º·|¨Ó¨ì¡IªYÄ£¥ú¥Ø«e²{¦³¨â±iÃÄÃÒ¢w¥x¬ü¡A±N¨Ó¦~Àò§Q¦Ü¤Ö10¢w60¤¸¤§¶¡¡i«ü¦Û¤v©e¥N¤u¦Û½æ¡j¡AªÑ»ù´N¦³300¢w1200¤¸¹ê¤O¡A±N¨ÓÁÙ¦³«Ü¦h¦n®ø®§¡CÁÙ¬Oíí©ê¦í©ñ­Ó10¦~¡A¤@©wµo¤j°]¡I¤£­n¤Ó«æºCºC¨Ó¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/19 ¤U¤È 06:05:34²Ä 1908 ½g¦^À³
µL®øµL®§~~µ¥«Ý¬Oº©ªøªº

§Æ±æ¦³¦nµ²ªG

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/16 ¤U¤È 04:14:17²Ä 1907 ½g¦^À³
ÁÙ¤£½Ä¤@ªi

­n§ä²Ä¥|¥xÁÙ¬Olineªº¥D¤O¨Ó©Ô¤@¤U

---------------------------

»´¯g¦b®a¸Õ¿ì ¬_¤å­õ¡G´¶®³¯k¸Ñ¨M

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/4/15 ¤U¤È 09:55:02²Ä 1906 ½g¦^À³
©_©Ç¡I

«ç»ò¨ì²{¦bÁÙ¨S¦³¤½§i¡H

¨ú±o·|­p®vªº¡u¤º±±³ø§i¡v

³o¤£¬O¤WÂdªº¥²­nµ{§Ç¶Ü¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/15 ¤U¤È 07:14:55²Ä 1905 ½g¦^À³
ªk·½¨Ì¾Ú¡G¨Ì¾·~¦w¥þ½Ã¥ÍºÞ²z¿ìªk²Ä86±ø³W©w¡A勞¤u¤H數¦b¤T¤Q¤H¥H¤W¤§¨Æ·~³æ¦ì¡A¨Ì²Ä¤G±ø¤§¤@¦Ü²Ä¤T±ø¤§¤@¡B²Ä六±ø³W©w³]ºÞ理³æ¦ì©Î¸mºÞ理¤H­û®É¡AÀ³¶ñ¨ã¾·~¦w¥þ½Ã¥ÍºÞ理³æ¦ì¡]¤H­û¡^³]¸m¡]ÅÜ更¡^³ø³Æ®Ñ¡]¦pªþªí¤T¡^¡A³¯³ø勞°ÊÀˬd¾÷ºc³Æ¬d¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/4/15 ¤U¤È 06:19:20²Ä 1904 ½g¦^À³
½Ð°Ý104¼x¤~¡A¤A¯Å¾·~¦w¥þ½Ã¥ÍºÞ²z¤H­û

¨S¦³¤u¼t¤]»Ý­n¤u¦w?ÁÙ¬O¤WÂdªk³W³W©w

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/14 ¤W¤È 05:28:18²Ä 1903 ½g¦^À³
1.¦p¹w´Á¬FªvÀ£¤O¤j¹L¤@¤Á¤U¡Apublic health emergency¦A©µªø90¤Ñ¨ì7/15

2022.4.13

www.reuters.com/business/healthcare-pharmaceuticals/us-renews-covid-19-public-health-emergency-2022-04-13/

...This could be the last time HHS Secretary Xavier Becerra extends it, policy experts have said.

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 03:25:28²Ä 1872 ½g¦^À³

1.¹w´ú¤U¶g4/15¦A©µªø90¤Ñ¨ì7/15¡A«ôµn§Y·|«Å¥¬²×¤îpublic health emergency¡C

2.°ê¹©¼B¸³¦b1/5»¡¦a[¸Ñª¼¦¨¥\]¦A¹L21¤Ñ§Î¦¨±j¯P»ä­·¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/13 ¤U¤È 01:50:33²Ä 1902 ½g¦^À³
§Ú¬O½¼¦Ì1°¦¡A¤£¬O³Û¤ô·|µ²­á¡A³Û¦ÌÅܦ׺ꪺ¤H¡A§æ¤£°ÊªÑ»ù¤W¤U¡C

¦Û¤v¿W¥ß§PÂ_¼f·V§ë¸ê¡A¦Û­t­·ÀI¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/13 ¤U¤È 01:26:16²Ä 1901 ½g¦^À³
¯E¹©¸Ñª¼ª§Ä³P­È­×¥¿±ø´Ú???

2016.2.22¡i¥»³ø¥x¥_°T¡j¥Í§ÞªÑªÑ¤ý¯E¹©¡A¬Q¤Ñ¤½¥¬¨ÅÀùªvÀø©Ê¬Ì­]·sÃÄOBI-822Á{§É¸ÕÅç¸Ñª¼µ²ªG¡A¡u¥D­nÀø®Ä«ü¼Ð¥¼§e²{²Î­p¾Ç¤WÅãµÛ·N¸q¡v¡A¦ý¯E¹©±j½Õ¡A³o¬O¤@¦¸«D±`¦¨¥\ªº¸Ñª¼¡A¤ñ¹w´Á¦n¡A¨S¦³©Ò¿×®À±Ñ¡AÃÒ¹ê¡uÀù¯g§K¬ÌÀøªk¤w¸g¤£¬O¹Ú¡A¬O¥i¥H¹ê²{ªº·sÀøªk¡v¡C

--------------------------------------------------------------------------------------------

¥]¬A¦ý¤£­­©ó:©Ò¿×¡u¥]¬A¦ý¤£­­©ó¡v¡A¹ê¬°§t¡]¥]¬A¡^¡u¦CÁ|ªÌ¡v¡A¦ý¤£¥H¡u¦CÁ|ªÌ¡v¬°­­¦Ó¨¥¡C

Âd¶R¤¤¤ß:¤W(¿³)Âd¤½¥q­«¤j°T®§µo¥¬À³ª`·N¨Æ¶µ°Ñ¦Ò°Ýµª¶°¡v­×¥¿¹ï·Óªí

www.tpex.org.tw/storage/eb_data/10805/108005569311-1.pdf

...´¦¥Ü¥D­n¤Î¦¸­nµû¦ô«ü¼Ð¤§²Î­pµ²ªG(¥]§t¦ý¤£­­©ó P ­È)¤Î²Î­p¤W¤§·N¸q(¥]§t¦ý¤£­­©ó¬O§_¹F¦¨²Î­p¤WÅãµÛµ²ªG)¡C­Õ«ª©ó¨ä¥L­«­n­ì¦]¾É­P¤½¥qµLªk´¦¥Ü²Î­p¸ê®Æ¡A«hÀ³±Ô©ú²z¥Ñ»¡©ú¤§¡A±©¦]¥¼¥R¤À´¦ÅS­P·l¤ÎªÑªFÅv¯q©Î¤Þµoª§³^¨Æ¥ó¡A¤½¥qÀ³¦Û­t¨ä³d¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/13 ¤W¤È 09:08:24²Ä 1900 ½g¦^À³
³Ìªñ½L¶Õ¤S¤£¦n¤F¡A¿\¥É¦ó®Éµo¥ú?
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GSunny10149577  µoªí®É¶¡:2022/4/12 ¤U¤È 11:05:13²Ä 1899 ½g¦^À³
R¤j:¦n ! ¬J¬OªYÄ£°Q½×ª© ´Á«Ý¦h¸ÑŪªYÄ£ªº¸ÕÅç¶i«× ¦Ü©ó¨ä¥L¤½¥qªºµû½×´NÂI¨ì¬°¤î
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/12 ¤U¤È 03:10:34²Ä 1898 ½g¦^À³
Veru ªí¥Ü¡A¥Ñ¤_¡§压­Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C

Veru ªí¥Ü¡A¥Ñ¤_¡§压­Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C

Veru ªí¥Ü¡A¥Ñ¤_¡§压­Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³

1¤äÃĪ«ªºÁ{§É¹êÅç«ç»ò¸ÑŪ?

1.¦pªG©úÅãÀu©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA·|´£«e²×¤î

2021.07.28¥_·¥¬P - KY(6550-TE) ¤µ (28) ¤éªí¥Ü¡A¦¬¨ì¬ü°ê FDA ¨Ó¨ç³qª¾¡AªvÀø´c½èªÍ¶¡¥ÖÀù·sÃÄ ADI-PEG20 ¤T

´ÁÁ{§É¸ÕÅç¡A¥i°±¤î¦¬¨ú¯f±w¡B´£¦­µ²§ô¸ÕÅç¨Ã¶i¦æ¸Ñª¼¡A«Ý§¹¦¨Á{§É¸Ñª¼«á¡A±N¥Ó½ÐÃÄÃÒ¡C

2.¦pªG©úÅã®t©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA¤]·|´£«e²×¤î

2017.7.6 ¸ÕÅçªÌ¦º¤` FDA ©R¥OÀq§J°±¤î¤T¶µ Keytruda ÃöÁä¬ã¨s

read01.com/Q3Aogyk.html#.Ycvx0GhBzcs

FDA «Øij¨ü¸ÕªÌ¥ß¨è©ñ±ó°Ñ»P Keytruda ªº¨â¶µ III ´Á¬ã¨s¡A¨Ã©R¥OÀq§J¥ß§Y°±¤î KEYNOTE-023 ¶¤¦C 1 ¤¤ªº±wªÌ¹ê

Åç¡C

3.¤ð¶·­×§ïÄ~ÄòÁ{§É¬O¥­Ã­

2021.8.31--¥ÍµØ¬ì·sÃÄSilmitasertib(CX-4945)¥Î©ó·s«aªÍª¢¤G´Á­«¯g¤HÅé¡A¤µ(31)¤é«Å¥¬Á{§É¸ÕÅç´Á¤¤¼Æ¾Ú¡A¸g¿W

¥ßÁ{§É¼Æ¾ÚºÊ¹î©e­û·|(Data Monitoring Committee¡ADMC)¼f¬d³q¹L¡A¤ð¶·­×§ï¥ô¦óÁ{§É¸ÕÅç³]­p¡A¥i«ùÄò¶i¦æ·s«a­«

¯g±wªÌ¦¬®×¡C

4.¶·­×§ï¤Ï­Ë¦³¤F¤£½T©w? (»´¤¤¯g¦º¤£¤F¤H¡A©Ò¥H¤£¥i¯à³Q²×¤î)

°ê¹©:DMC«Øij¼W¥[¦¬ªv»Ý­n®ñ®ð¤ä«ù¤§­«¯g¦í°|¯f±w¡C(«D«I¤J©Ê³q®ð¡B°ª¬y¶q®ñ®ð©Î¸­§J½¤)

³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J­«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É¬Ý¬Ý¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/12 ¤U¤È 03:04:48²Ä 1897 ½g¦^À³
¬Q¤é¦A¼W1®a¤¤«×¦Ü­««×¦í°|±wªÌ¤fªAÃÄ¥Ó½ÐEUA ¡A[°ß¿W°ê¹©¼B¸³«ÅºÙ¤£¥ÎP­È¹F¼Ð]!!!

2022.4.11 ¬ü°êÁÚªü±KVeru¤½¥q¤fªA§Ü¯f¬rÃĪ« sabizabulin¡A P3¤¤´Á¼Æ¾ÚÅã¥Ü¡A»P¦w¼¢¾¯¬Û¤ñ¡A¦b¤¤«×¦Ü­««×¦í°|±wªÌ¤¤ªº¦º¤`²v­°§C¤F 55%¡C¡]p=0.0029¡^µ²ªG³Q»{¬°¨ã¦³²Î­p¾Ç·N¸q©M²Î­p¾Ç·N¸q¡C

--------------------------------------------------------------------------------------------

Veru ªí¥Ü¡A¥Ñ¤_¡§压­Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C

Veru ªí¥Ü¡A¥Ñ¤_¡§压­Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C

Veru ªí¥Ü¡A¥Ñ¤_¡§压­Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/12 ¤W¤È 07:44:08²Ä 1896 ½g¦^À³
¨S¦³Pre-EUAªºsubmission number¨ü²zÃÒ¸¹¡Aªí¥ÜFDA¤£¦P·N¥Ó½ÐEUA!

¦A¤T©IÆ~Âd¶R­n¨D°ê¹©¤½§i1¤ë¥÷»PFDA Pre-EUA·|ijµ²ªG¡A¦³¨S¦³¦¬¨ìFDA ªºpre-eua acknowledgment letter?

»¡¥Õ¤F­n¬OFDA¦P·N¥Ó½ÐEUA¡A°ê¹©¦Ñ¦­Ær¹ª³Ù¤Ñ³Û¥X¸¹½X¡C

±q¸Ñª¼¼Æ¾Ú¥ÎÃIJջP¹ï·Ó²Õ¨S¦³®t²§¡A§Ú±ÀÂ_°ê¹©¨S¦³Pre-eua meeting!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/12 ¤W¤È 05:15:17²Ä 1895 ½g¦^À³
¬JµM±Nµ²§ôPHE¡AFDA·|Ä~Äò±ÂÅvEUA???

¡§¤Z¤H¤§´¼¡A¯à¨£¤wµM¡A¤£¯à¨£±NµM¡C¡¨

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/4 ¤W¤È 09:30:58²Ä 1862 ½g¦^À³

Adagio»PRevive¥Ó½ÐEUA¤]¦³¨Ç±ß¡A¦]¬°±q¦U¤è·s»D®ø®§¨Ó¬Ý¡A«ôµn¤£¤é´N·|«Å¥¬²×¤îpublic health emergency¡C

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤W¤È 06:25:02²Ä 1663 ½g¦^À³

¬°¤°»ò­n¬ÝPHE©µªø©Îµ²§ô?

©³¤U­Ë¹L¨Ó¡A¤@¥¹HHS«Å¥¬ºò«æª¬ºA(PHE)µ²§ô¡AFDA§Y¨S¦³EUAÅv¤O¡C

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 05:28:06²Ä 1657 ½g¦^À³

µo¥¬EUAªºµ{§Ç¯A¤Î¤­­Ó¨BÆJ¡G¤@¬O½T©w¬O§_¶i¤Jºò«æª¬ºA¡A¥Ñ°ê¨¾³¡¡B°ê¤g¦w¥þ³¡©Î½Ã¥Í©MºÖ§Q³¡¡]Health and Human Services¡AHHS¡^½T©w¡F¤G¬OHHS«Å¥¬¶i¤Jºò«æª¬ºA¡F¤T¬OFDA¹ïEUA½Ð¨D¶i¦æ¼fµû¡F¥|¬OHHSµo¥¬¡]©Î©e°UFDA¥Nµo¡^EUA©Î©Úµ´EUA½Ð¨D¡F¤­¬OHHS²×¤îEUA¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/12 ¤W¤È 05:06:56²Ä 1894 ½g¦^À³
2022.4.11 HHS µo¥X¤F¤½¦@½Ã¥Íºò«æ¨Æ¥ó³vº¥µ²§ôªº©ú½T«H¸¹

www.healthcarefinancenews.com/news/hhs-giving-clear-signals-wind-down-public-health-emergency

Áp¨¹¬F©²Ãö«Y­t³d¤HMichael P. Strazzellaªí¥Ü..¡A·í«eªº¤½¦@½Ã¥Íºò«æª¬ºA±N©ó 4 ¤ë 16 ¤éµ²§ô¡AÁp¨¹¬F©²¤w¸gµ¹¥X¤F PHE §Y±Nµ²§ôªº©Ò¦³¸ñ¶H¡C...½Ã¥Í»P¤½²³ªA°È³¡³¡ªø¿Aºûº¸¡P¨©¶ë©Ô¦b¹wºâÅ¥ÃÒ·|¤W©ú½Tªí¥Ü¡A¸Ó°ê§Y±Nµ²§ô³o³õ¤½¦@½Ã¥Íºò«æ¨Æ¥ó¡C

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 03:25:28²Ä 1872 ½g¦^À³

1.¹w´ú¤U¶g4/15¦A©µªø90¤Ñ¨ì7/15¡A«ôµn§Y·|«Å¥¬²×¤îpublic health emergency¡C

2.°ê¹©¼B¸³¦b1/5»¡¦a[¸Ñª¼¦¨¥\]¦A¹L21¤Ñ§Î¦¨±j¯P»ä­·¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/4 ¤W¤È 09:42:25²Ä 1863 ½g¦^À³

2022.3.16 President Biden Signs Into Law Medicare Telehealth Coverage Extension Post-Public Health Emergency

... after the end of the designated public health emergency (¡§PHE¡¨)

www.jdsupra.com/legalnews/president-biden-signs-into-law-medicare-580961

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/11 ¤U¤È 08:12:34²Ä 1893 ½g¦^À³
®×¨Ò:www.sohu.com/a/381736110_120554400

°ò³J¥Íª«¦b2020¦~3¤ë13¤é¡A¬ü国FDA¦P·N¨ü²zPre-EUA¡A¤]µ¹¤Fsubmission number:PEUA 200083FDA ¡A

³Ì«áFDA¼f§åµ²ªG¤£±ÂÅvEUA !

xueqiu.com/1468994395/152988279 °ò³J¥Íª«¤£¦A³QFDA¤¹许开®i·s«a¯f¬r检测

§Ú±ÀÂ_°ê¹©³sPre-eua meeting¤]¨S¦³!!!

---------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/11 ¤U¤È 04:35:10²Ä 1892 ½g¦^À³

...¥ý­n¦³1. FDA Pre-EUA [¦P·N]¨ü²z¸ê®æ¡A¤~¯à¦³2.¥Ó½ÐEUA¡AFDA±ÂÅv»P§_¸ê®æ¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/11 ¤U¤È 04:35:10²Ä 1892 ½g¦^À³
1/5°ê¹©¸Ñª¼°OªÌ·|www.youtube.com/watch?v=R1Xs-SLfu8Q

20¤À05¬í~¼B¸³»¡1¤ë¥÷­n¥Ó½ÐPre-EUAmeeting¡C

©IÆ~Âd¶R­n¨D°ê¹©¤½§i1¤ë¥÷»PFDA Pre-EUA·|ijµ²ªG¡A¦³¨S¦³¦¬¨ìFDA ªºpre-eua acknowledgment letter?

¥ý­n¦³1. FDA Pre-EUA [¦P·N]¨ü²z¸ê®æ¡A¤~¯à¦³2.¥Ó½ÐEUA¡AFDA±ÂÅv»P§_¸ê®æ¡C

1. (Pre-EUA·|ij)FDA¦P·N¨ü²zPre-EUA¥ýµo±iPEUAÃÒ :

PEUAÃÒªø³o¯ë¼Ò¼Ë: www.sohu.com/a/381736110_120554400

( submission number:PEUA XXXXXX)

2. FDA¦P·N±ÂÅvEUA¦Aµo±iEUA ÃÒ®Ñ:

EUAÃҮѪø³o¯ë¼Ò¼Ë: www.fda.gov/media/136522/download

(EUA Number: EUA XXXXXX)

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/21 ¤W¤È 08:01:08²Ä 1807 ½g¦^À³

¦pªG°ê¹©¦b2¤ë¦³¸òFDA¶}pre-EUA Meeting¡Aªì¨B¼f¬d¼Æ¾Ú«á¡A½Ð°ÝFDA¬Oµo[¦P·N]ÁÙ¬O[¤£¦P·N]¨«step 4³o¨B?

¨Ì3/16ªº¼Æ¾Ú¡A§Ú»{¬°¨S¦³step 3 ¡A¦]¬°¦³¦¬¨ìFDA ªºpre-eua acknowledgment letterÅK©w¬OºVÆr¥´¹ªªºµo¥¬!!!

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/19 ¤W¤È 11:56:49²Ä 1804 ½g¦^À³

¡§³Õ¾Ç¤§¡A¼f°Ý¤§¡A·V«ä¤§¡A©ú¿ë¤§¡A¿w¦æ¤§¡¨

..

°ê¹©¥Í§ÞÁ`¸g²z Ĭ¸g¤Ñ¡G...µM«á¸òFDA´N¬O¥Ó½ÐPre-EUAªº·|ij¡C[¦P·N]¡A¨º§Ú­Ì´N·|submit¡A´N¬O¶i¦æ¥Ó½ÐEUAªº°Ê§@¡C¡v

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/11 ¤U¤È 04:19:06²Ä 1891 ½g¦^À³
ÀH®É===>µ¥¤F¦n¤[§r~~³o¨Ç¤j¼t¦bµ¥¤°»ò©O?»°§Öñ¤@ñ¤F°Õ

¤j½L¤£¦n¡A¤£¹L¬Ý°_¨Ó¬O¦³¤HÅU¡C

°£¥»¤½¥qSNP-810(¦w®õ®³

¯k)¥~¡A¥Ø«e¥«³õ¤W©|µL¨ä¥¦Ãþ¦üµL¨x¬r©Ê¤§acetaminophen¤§¤îµhÄvª§²£«~¡C¥Ø«e¥»¤½

¥qSNP-810·sÃĤw»P°ê»Ú¥D­n¤îµhÃĤj¼tñ­q¦³Àv¦X¬ù¡A¦³³Ì·s¶i®i¡A±NÀH®É¤½§i¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/11 ¤W¤È 08:13:19²Ä 1890 ½g¦^À³
ÃĪ«¦³¨S¦³Àø®Ä¦b¦X¦¨®É´Nª`©w¡AÁ{§É¸ÕÅç¥u¬OÅçÃÒ¨ä¦w¥þ»PÀø®Ä¡C

ÂÔ·V°ª¼hªº¸gÀçºÞ²z¸Û«H!(13¦~¿³Âd¤¸¦Ñ)

...«e¥ô¸ê¸Û·|­p®v©ó°õ¦æ[°]°È³øªí¬d®Ö¥~¶Ô]´Á¶¡....

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/12/16 ¤U¤È 05:21:57²Ä 1522 ½g¦^À³

3¨¥2»y»¡¤£²M¡A²Ä6·P­n«¥¯à¸ú¦h»·°{¦h»·!

--------------------------------------------------------------------------------------------

¤½¥q¦WºÙ¡G°ê¹© µo¨¥¤é´Á¡G2021/11/25 µo¨¥®É¶¡¡G16:29:53 µo¨¥¤H¡G´¿¤ì¼W

1.¸³¨Æ·|³q¹L¤é´Á(¨Æ¹êµo¥Í¤é):110/11/25

...

8.Åܧó·|­p®v¤§­ì¦]:¥»¤½¥qÀç¹B¤ÎºÞ²zµ¥¾ãÅé¦Ò¶q

11.³Ìªñ¤G¦~«×¤w¥Ó³ø©Î§Y±N½s»s¤§°]°È³ø§i¬O§_´¿¸g·|­p®v½Õ¾ã©Î´£¥X¤º

³¡±±¨î­«¤j§ï¶i¨Æ¶µ¤§«Øij:

¬O¡C«e¥ô¸ê¸Û·|­p®v©ó°õ¦æ109¦~¦~«×°]°È³øªí¬d®Ö¥~¶Ô´Á¶¡¡A«Øij¥»¤½¥qÀ³¸¨¹ê

Ãö«Y¤H¿ëÃѤκ޲z¡BÀ³±j¤Æ¹ï¤l¤½¥q¤§ºÊ·þ»PºÞ²z§@·~¡B¥Ó½Ð¶U´Ú«e¨Ì¨î«×¹w¦ô¸ê

ª÷»Ý¨D¡BÀ³¸¨¹ê¾P°â­q³æ³B²z¤Î¥æ³f§@·~¡BÀ³¸¨¹ê§ë¸ê§@·~°lÂܤΦs³f¤§²¾°ÊÀ³¥ß

§Y¥¿½T¬ö¿ý¡C¥t¨ä©ó¶i¦æ109¦~¦~«×¤º±±¨î«×¹ê¦a¬d®Ö§@·~¡A«Øij¥»¤½¥qÀ³¸¨¹ê¸³

¨Æ·|¤Î¼f­p©e­û·|¤§¥l¶°µ{§Ç¤Î¤å¥ó»P¬ö¿ý§@·~¡BÀ³¸¨¹êÁ~¹SºÞ²z©e­û·|§@·~¡BÀ³

¸¨¹ê¹ï¤l¤½¥q¤§ºÊ·þ»PºÞ²z§@·~¡BÂç²M¦L¥§¤l¤½¥q¤§§ë¸ê¡BÀ³¸¨¹êÃö«Y¤H¥æ©öºÞ²z

§@·~¡BÀ³¸¨¹ê¾P°â´`Àô§@·~¡B«Ø¥ß¦U¶µ¶O¥Î³ø¤ä¤§ºÞ²z§@·~¡BÀ³¥[±j¤º³¡½]®Ö¤§Â¾

¯à(§t¤º±±¦Ûµû¤§¾É¤J)¤ÎÀ³¸¨¹ê¦LŲºÞ²z§@·~¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/20 ¤W¤È 07:06:12²Ä 533 ½g¦^À³

...ªü¯÷®üÀq¯g³Ð·sÃĪ«¤j¼ú¦n§l¤Þ¤H!°÷¸Þ²§ªº....3¨¥2»y»¡¤£²M¡A«¥¦­¥X²M¨SÁȨS½ß¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/11 ¤W¤È 07:42:23²Ä 1889 ½g¦^À³
开©Ý药业»P°ê¹©Á{§É³]­p¦P¼Ë¥[SOC¡A开©Ý药业733¦W¨ü¸ÕªÌ¬O°ê¹©124¤Hªº5.9­¿¡A733¦W¸Ñª¼¼Æ¾Ú§tP­È(°ê¹©Ãø²£)!

开©Ý药业¥ÎÃIJÕ:GT0918+ SOC / ¹ï·Ó²Õ:¦w¼¢¾¯+ SOC

°ê¹©¥ÎÃIJÕ:Antroquinonol+SOC / ¹ï·Ó²Õ:¦w¼¢¾¯+SOC

clinicaltrials.gov/ct2/show/NCT04870606?term=NCT04870606&draw=2&rank=1

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/10 ¤U¤È 09:55:52²Ä 1888 ½g¦^À³
§Ú²q·QR¤j¬O´£¿ô§ë¸ê¤H¹ï©ó¬ì¾Ç¤W¤ÀªR¦³¦³¾Ì¦³¾Ú¡A¦Ó¤£¬O¥Î¦ü¬O¦Ó«D¨Óª£ªÑ. ¤§«eªº¯E¹©¤¤¸Î¤Ó¶Ë¤F¡C¤Ï¥¿¤£³ßÅw´N§O¬Ý¡A¤£µM·sÄ£¤]¤Ó§N²M¤F

§Úªº¬Ýªk¡A§Ú¥Î¤§«eªº·s»D¨Óµû©T¡A§â¤â¤W³Ñ¤Uªº¹©¤ý³£¥X¥ú¤F

¥D­nµû¦ô«ü¼Ð±d´_²v(recover ratio)¡A¸ÕÅçµ²ªG¦b²Ä14¤Ñ¥ÎÃIJժº±d´_²v¬O100%¡A¹ï·Ó²Õªº±d´_²v¬O96.0%¡C¦¸­nµû¦ô«ü¼Ð¦³ICU­«¯g¯f¤HªvÀø®É¶¡¡AP­È¬°0.5404)¡A¦í°|®É¶¡P­È0.9951¡A§ïµ½®É¶¡P­È0.7034¡A²M°£¯f¬rªº®É¶¡P­È0.5422¡A©I§l§xÃøP­È0.0327¡A¦Ù¦×µmµhP­È0.0525¡A¨ý¶åı³à¥¢P­È0.1059¡C

·|­û¡G¶À±Ò½÷10152632 µoªí®É¶¡:2022/4/8 ¤U¤È 05:13:36²Ä 1873 ½g¦^À³

¥ý©ñ¹L§O¤H¡A¤~¯à©ñ¹L¦Û¤v¡A§_«h¦p§A³o¯ë¥Ã»·³Q°ê¹©ªº¹ï¿ù¡A¸j¦í§Aªº¤H¥Í¡A¦ó­W¨Ó«v¡I

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/10 ¤W¤È 09:22:54²Ä 1887 ½g¦^À³
°ê¹©¦¡ªº¸Ñª¼ PK 开©Ý药业¸Ñª¼P­È

--------------------------------------------------------------------------------------------------

开©Ý药业¤è­±还ªí¥Ü¡A´¶§J鲁Ói¥i¦³®Ä­°§C·s«a±wªÌªº¦í°|/¦º¤`²v¡A¯S别¬O¦b§¹¦¨ªA药¤j¤_7¤Ñªº¨ü试ªÌ¤¤¡]N=693¡^¡A对·Ó组¤Î´¶§J鲁Ói组¦í°|¨Æ¥ó数¤À别为6¨Ò¡]§t¤@¨Ò¦º¤`¡^¤Î0¨Ò¡]p¡à0.02¡^¡A¬Û应«O护²v为100%¡C

´¶§J鲁Ói¦b¦ñ¦³°ª风险¦]¯Àªº¨ü试ªÌ¤¤¡]¯S别¬O¤¤°ª¦~龄组¡^¡A¯à显µÛ­°§C¦í°|/¦º¤`²v¡C¦p¦~龄≥60岁¥B¦ñ¦³¦Ü¤Ö¤@个°ò础¯e¯f¡]¨Ò¦pªÎ­D¡B¿}§¿¯f¡B°ª¦å压µ¥¡^ªº¨ü试ªÌ¡A´¶§J鲁Ói¥i显µÛ­°§C¦í°|/¦º¤`²v¡]p¡à0.02¡^¡A¬Û应«O护²v为100%¥BÆÓ¦í°|©Î¦º¤`¡C

开©Ý药业还ªí¥Ü¡A¬Û对¤_对·Ó组¡A´¶§J鲁Óiªv疗组从给药²Ä3¤Ñ¨ì²Ä28¤Ñ¡A¥i显µÛ«ù续­°§C·s«a¯f¬r载¶q¡]²Ä3¤Ñ¤Î²Ä28¤Ñ¡Ap¡à0.01¡^¡C¦Ó¦b¯g状§ïµ½¤è­±¡A´¶§J鲁Ói组较对·Ó组¥i§ó¦n¦a§ïµ½·s«aªÍª¢ªº³¡¤À¬Û关¯g状¦p发热¡BÉaµu¡B«y¹Â¡A¥B§ïµ½«ù续ɬ¤_对·Ó组¨ì¦Ü¤Ö²Ä28¤Ñ¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/10 ¤W¤È 09:12:48²Ä 1886 ½g¦^À³
Delta¦b¬ü°ê¤wªñ¥Gµ´¸ñ(¥@¬É¦U¦a¦P¬O)¡AÁ{§É¨S¦³¦¬ªvOmicron±wªÌªº¼Æ¾Ú¡A§O¦b°µEUA¤j¹Ú¡C

www.statista.com/chart/27076/coronavirus-variants-in-the-us/

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤U¤È 01:50:12²Ä 1859 ½g¦^À³

¬°¤°»ò²{¦b¥Ó½ÐEUA¼Æ¾Ú¤À¦¨Omicron[«e]»P[«á]¥Î·N???(³o´N¬O§Ú¦b1/22´£°Ý°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æªº­ì·N)

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 02:22:40²Ä 1614 ½g¦^À³

¶K´X«h°T®§¡A§ë¸ê¤H[¿W¥ß«ä¦Ò]²´¤UFDA±ÂÅvEUA¦a±ø¥ó???

1.°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æ?

2. ¬ü°ê¦b2021.11.27«eOmicron¯f¨Ò 0¡A

¬ü°êÁp¨¹¯e¯f¨¾ªv¤¤¤ß(CDC)ºI¦Ü2022.1.1¤é°ê¤º95.4%ªº·s¯f¨Ò¡ADeltaÅܺدf¬r«h³QÀ£ÁY³Ñ¤U4.6%

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/10 ¤W¤È 07:08:02²Ä 1885 ½g¦^À³
开©Ý药业´¶§J鲁Ói(Á{§É3´Á¼Æ¾Ú¨ã¦³ [统计学显µÛ©Ê] ) PK °ê¹©Antroquinonol(Á{§É2´Á ¼Æ¾ÚÃø²£!!!)

------------------------------------------------------------------------------------------------

1. 733¦W¨ü试ªÌ¡A¨ä¤¤¦³727¦W(99.18%)¨t¦b [¬ü国] ¤J组

2.´¶§J鲁Ói¦³®Ä­°§C·s«a±wªÌ¡]¥D­n¨üDelta©MOmicron变ÉÝ®è·P¬V¡^ªº¦í°|²v©M¦º¤`²v¡A¯S别¬O对¤_ªA药¶W过7¤Ñªº¥þ³¡±wªÌ¡A¥H¤Î¦ñ¦³°ª风险¦]¯Àªº¤¤°ª¦~龄·s«a±wªÌ达¨ì100%«O护²v¡A¨ã¦³ [统计学显µÛ©Ê] ¡C

¡@¡@ 数Õu显¥Ü¡A´¶§J鲁Ói对轻¤¤¯g¨k©Ê±wªÌªº¦í°|风险­°§C100%¡A轻¤¤¯g¤k©Ê±wªÌªº¦í°|风险­°§C90%¡F­«¯g·s«a±wªÌªº¦º¤`风险­°§C92%¡A¦í°|¤Ñ数缩µu9¤Ñ¡C

3.¥h¦~7¤ë16¤é¡A´¶§J鲁Ói³Q¤Ú©Ô¦c±Â¤©紧«æ¨Ï¥Î±Â权¡]EUA¡^¡A¥Î¤_·s«a¦í°|±wªÌªºªv疗¡C¥B´¶§J鲁Ói´¿¤@«×ÉO¤é¥»盐³¥ú媺S-217622³Q认为¬O¨ä疗®Ä¦³¥i¯à·B¬ü©ÎªÌ¶W¶V辉·çPaxlovidªº·s«a¤fªA药¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/9 ¤W¤È 06:50:39²Ä 1884 ½g¦^À³
¤£­n§Q¥Î¸ê°T¤£¹ïµ¥¨Ó§|±þ¤@ª¾¥b¸Ñªº§ë¸ê¤H!

½Ð°Ý°ê¹©¦³¨S¦³¦¬ªvOmicron±wªÌªºÁ{§É¼Æ¾Ú¡AÅýFDA¨ü²zpre-EUA???

¡§NCT04870606ªº临§É试从2021¦~4¤ë开©l¤J组¡A当时¡A¦b¬ü国¬y¦æªº¬O·s«a¼wûضð变ÉÝ®è¡F¨ì¤F2021¦~12¤ëªì¡A¬ü国¤S¥H奥±K§J¦¥变ÉÝ®è较为¬y¦æ¡C¡¨开©Ý药业创©l¤H¡B¸³¨Æ长­ÝCEOµ£¤Í¤§³Õ¤h¦b§ë资ªÌ电话会议¤Wªí¥Ü¡A¦]¦¹¡A¡§´Á¤¤¦Ò¡¨Ê^现ªº¡A¥D­n¬O´¶§J鲁Ói对¼wûضð变ÉÝ®èÚÌ诊±wªÌªº®ÄªG¡F¦Ó¡§¥æ¨÷¡¨«eªº¦Z¤T©P¡A«e­z临§É试验ªº¤J组¤H员则¤S¥H奥±K§J¦¥变Éݮ誺ÚÌ诊±wªÌ为¥D¡C

¡@¡@©Ò¥H¡§³Ì终ªº数Õu©Ò现§e现ªº结ªG¬O¼wûضð¡B奥±K§J¦¥¤@°_ªº结ªG

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤U¤È 01:50:12²Ä 1859 ½g¦^À³

...¬°¤°»ò²{¦b¥Ó½ÐEUA¼Æ¾Ú¤À¦¨Omicron[«e]»P[«á]¥Î·N???(³o´N¬O§Ú¦b1/22´£°Ý°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æªº­ì·N)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/9 ¤W¤È 06:25:54²Ä 1883 ½g¦^À³
¦n¦n¾Ç¾Ç¹ï©¤´Á¤¤¦Ò¦¨绩¤£¦n¦ý«i´±­±¹ï¡Aª¾¤v¥¢±Ñ­ì¦]«á¡A¤O©é´Á¥½¦Ò½Âà(¤£­n1±i¼L´N·|¸ò½÷·çPK¸ò·ç¼w¦è­³PK)¡C

2022.4.7 ¥þ²y²Ä¤T´Ú·s«a¤fªA¯S®Ä药­n来¤F¡H开©Ý药业´¶§J鲁Ói¤WºtÕa¤Ñ¤j¤Ï转 ¤½¥qªÑɲ¤@¤é½µf

www.ce.cn/cysc/yy/hydt/202204/07/t20220407_37468284.shtml

¤½¥q将积Ìå¦V¤¤国¡B¬ü国¤Î¨ä¥L国®a©M¦a区ªº国®a药ª«监·þÉóÌÛ¥Ó请紧«æ¥Î药EUA许¥i¡C

...该试验¦@¤J组¤F733¦W¨ü试ªÌ¡A¨ä¤¤¦³727¦W(99.18%)¨t¦b¬ü国¤J组¡C开©Ý药业对¡m¬ì创ªO¤é报¡n记ªÌ进¤@¨Bªí¥Ü称¡A«e­z试验´Á间¡A¬ü国¥ý¦Z¦³¼wûضð¡B奥±K§J¦¥两Ïú·s«a¯f¬r变ÉÝ®è¬y¦æ¡A¦]¦¹¡§该临§É试验关键数Õu¤]证实¤F¡A´¶§J鲁Ói对¼wûضð©M奥±K§J¦¥变Éݮ誺临§É疗®Ä¡C

...´¶§J鲁Ói还¥i显µÛ«ù续­°§C·s«a¯f¬r载¶q

...´¶§J鲁Ói¥æ¥Xªº¡§´Á¥½¦Ò¡¨¦¨绩单¡A让«Ü¦h¤H·P¨ì·N¥~¡C为´N¦b2021¦~©³¡A开©Ý药业´¿¤½§i¤F«e­z临§É试验ªº¡§´Á¤¤¦Ò¡¨¦¨绩¡]§Y¤¤´Á数Õu¡^¡A¤ÀªR结ªG为¡§该项临§É试验¦]为¨Æ¥ó数较¤Ö没¦³达¨ì统计学显µÛ©Ê¡¨.....

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/13 ¤U¤È 05:49:50²Ä 1697 ½g¦^À³

Á{§É¬O¬ì¾Ç¡A¬ì¾Ç¬O¬Ý¼Æ¾Úªº¡A¦Ó¤£¬O¤@¥y¡u­n¸ò½÷·çPK¡v!

ÆQ³¥¸q»¡©ú·|ªº¼Æ¾Ú¡AS-217622¦b­°§C¯f¬r¸ü¶q»PPaxlovid±µªñ¡A¥i¥H»¡¬O¤@­ÓÅå³ß¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 11:39:56²Ä 1882 ½g¦^À³
»´¤¤¯g¯à¤j´T´î¤Ö¯f¬r¶q´N¬O§Ö³t¨úÃÒ¤§¹D!

2022.4.6 ¡nÆQ³¥¸q»sÃĤfªAÁ{§ÉÀø®Ä§ó³Ó½÷·ç»PÀq§J¡I

www.genetinfo.com/international-news/item/57850.html

...90%¥H¤Wªº¨ü¸ÕªÌ©ó²Ä4¤ÑÅ餺¤wÀË´ú¤£¥X¯f¬r¶q....

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 10:31:37²Ä 1858 ½g¦^À³

(²Ä¤@½uÃĪ«)»´¤¤¯g­º­nªvÀø¦b¤j´T´î¤Ö¯f¬r¶q¹w¨¾¶i®i¬°­«¯g¡A¦Ó­«¯gªÌªº­º­nªvÀø¤£¦b´î¤Ö¯f¬r¶q!

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:42:20²Ä 1854 ½g¦^À³

¦X¤@SNS812:³q过ú£¤Ö¯f¬r°ò¦]组©M»E¦X酶mRNAªº«þ贝数¡A§í¨î¯f¬rÎ`¨î¦}ªý断¦Z续·P¬V¡C

IC50

med.sina.cn/article_detail_100_2_113260.html

---------------------------------------------------------------------------------------

¤é¥»ÆQ³¥¸qS-217622(§í¨î·s«a¯f¬rªº¼W´Þ)

EC50

xueqiu.com/3403713237/213884867

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 11:03:06²Ä 1881 ½g¦^À³
·sÃÄ»â°ì«Ü´Ý»Å¡A¥²¶·­n¦³¤H¨«¦b«e­±¶}¸ô¡A¨C­Ó¤H³£§Æ±æ·sÃĶ}µo¦¨¥\ºÉ³t¶i¤J¥«³õ¡B¥[¤J®¾±Ï¥Í©Rªº¦æ¦C¡A¦ý¤½¥q¤£¯à§Q¥Î¸ê°T¤£¹ïµ¥¨Ó§|±þ¤@ª¾¥b¸Ñªº§ë¸ê¤H
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 10:53:56²Ä 1880 ½g¦^À³
3/15 [¤½§i¡j¸É¥R¨ÌÂd¶R¤¤¤ß¨Ó¨ç­n¨D½Ã¥ÍºÖ§Q³¡¯e¯fºÞ¨î¸pÁܽа깩¥X®u

...(µù: 1.¹ï·Ó²Õ¬O±Ä¥Î¼Ð·ÇÀøªk¡A¥i¨Ï¥Î¤w®Ö­ãÃĪ«¡A¥]§t·ç¼w¦è­³¡C

---------------------------------------------------------------------------------------------------

3/15¤½§iÃø¹D¤£¬O¬G·NÁô¿f¥ÎÃIJդ]¥Î¼Ð·ÇÀøªk???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 10:40:39²Ä 1879 ½g¦^À³
¼B¸³©úª¾¥ÎÃIJջP¹ï·Ó²Õ¤GªÌ¬Ò¥[¼Ð·ÇÀøªk(SOC:¥i¨Ï¥Î¤w®Ö­ãÃĪ«¡A¥]§t·ç¼w¦è­³)

½Ð°Ý¼B¸³¬°¦ó­n»~¾É§ë¸êªÌ¥H¬°AntroquinonolÀø®Ä¨Î(4¤Ñ-»´¤¤¯g)¥i»P·ç¼w¦è­³(10¤Ñ-­«¯g)PK?

------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 09:19:59²Ä 1856 ½g¦^À³

Ãø¹D°ê¹©Á{§É³]­p¤£¬OÀu®Ä©Ê³]­p???

2022.3.15°ê¹©¤½§i§ó¥¿:

¥ÎÃIJÕ:Antroquinonol+¼Ð·ÇÀøªk(SOC) PK ¹ï·Ó²Õ:¦w¼¢¾¯+¼Ð·ÇÀøªk(SOC)

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/19 ¤U¤È 01:58:53²Ä 1806 ½g¦^À³

§Ú»¡1­ÓÀ~§A1¸õªº[4¤ÑP-value=0.9951]»P[10¤ÑP<0.001]¯u¬Û!!!

1. www.businesstoday.com.tw/article/category/183029/post/202201260016/

...¼B³Ó«iªí¥Ü¡A³o¥¿¬O°ê¹©ªº¾÷·|¡A¡u§Ú­Ìªº¥ÎÃIJեX°|¤¤¦ì¼Æ¬O[4¤Ñ]¡A·ç¼w¦è­³¬O[10¤Ñ]

stock.pchome.com.tw/news/cat1/20220315/9700004132202203154.html

(µù: 1.¹ï·Ó²Õ¬O±Ä¥Î¼Ð·ÇÀøªk¡A¥i¨Ï¥Î¤w®Ö­ãÃĪ«¡A¥]§t·ç¼w¦è­³¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 07:50:51²Ä 1878 ½g¦^À³
¥h¦~12¤ë§Ú»¡¥[¦¬­«¯gªÌ¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J­«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É¬Ý¬Ý¡C

¤µ¤Ñ±q¸Ñª¼¼Æ¾Ú¨Ó¬Ý [¥h¦~ªº¥[¦¬­«¯gªÌ] ´N¬O[»´¤¤¯g¦³®Ä©Ê«Ü¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É]

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/16 ¤W¤È 07:16:12²Ä 1799 ½g¦^À³

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³

1¤äÃĪ«ªºÁ{§É¹êÅç«ç»ò¸ÑŪ?

1.¦pªG©úÅãÀu©ó(«D±`ÅãµÛ)¹ï·Ó²Õ---FDA·|´£«e²×¤î

...

°ê¹©:DMC«Øij¼W¥[¦¬ªv»Ý­n®ñ®ð¤ä«ù¤§­«¯g¦í°|¯f±w¡C(«D«I¤J©Ê³q®ð¡B°ª¬y¶q®ñ®ð©Î¸­§J½¤)

³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J­«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É¬Ý¬Ý¡C

------------------------------------------------------------------------------------------------

¥[¦¬­«¯g±wªÌ?

2022.1.5: ¦b¦¸­nµû¦ô«ü¼Ð¡]®É¶¡½d³ò¬°28¤Ñ¡^¡AICU­«¯g¯f¤HªvÀø®É¶¡...¥ÎÃIJժºªvÀø®É¶¡ÁYµu¤F9.5¤Ñ (¨S¹ï·Ó²Õ¼Æ¾ÚP­È¬Ý°_¨Ó´N¬Oº}«G)

µ²ªG

2022.3.15:ICU­«¯g¯f¤HªvÀø®É¶¡¡G¸ÕÅçµ²ªG: ¥ÎÃIJժº¯f¤H¤¤¦ì¼ÆªvÀø¤Ñ¼Æ¬°13.5¤Ñ¡A¹ï·Ó²Õ¬°23¤Ñ(P-value=0.5404)¡C

­Y¬O[¥D­n]µû¦ô«ü¼ÐP­Èº}«G«ç¤£¤½¥¬?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 07:31:50²Ä 1877 ½g¦^À³
·s»D:°ê¹©·s«a·sÃÄ¥D«ü¼ÐP­È¿ð¤£¤½¥¬¡A¸Ñª¼ºâ¤£ºâ¹F¼Ð¥~¬ÉÃú¸Ì¬Ýªá

---------------------------------------------------------------------------------------------

¦¸­nµû¦ô«ü¼ÐP­È¥þ³£¤½¥¬¡AµL¿W¦³°¸´N¤Ö¥D­n«ü¼ÐP­È¡A°ê¹©¦³¤°»òÃø¨¥¤§Áô?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 07:08:42²Ä 1876 ½g¦^À³
¥H¦w¼¢¾¯¬°¹ï·Ó¤§¸ûÀu©Ê(superiority)¸ÕÅç¡A¸ÕÅçÃÄ«~­Y¯à¦¨¥\¦aÅã¥Ü»P¦w¼¢¾¯¨ã¦³ÅãµÛªº²Õ¶¡®t²§¡A¨äÀø®Ä¬O¥i¥Hª½±µ½T»{ªº¡C

-------------------------------------------------------------------------------------------------

½Ð°Ý¥D­nµû¦ô«ü¼Ð:¥ÎÃIJÕ100%¡A¹ï·Ó²Õ96.0% ©Ò¿×ªº¸Ñª¼¦¨¥\±q¦ó¦Ó±o?(°ò¨È»P¯E¹©¤]¨S§â¸Ñª¼·d¦¨³o¯ë¥Ð¦a)

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 06:57:41²Ä 1875 ½g¦^À³
FDA [[[strongly]]] recommends that drugs to treat COVID-19 be evaluated in randomized,

placebo-controlled, double-blind clinical trials using a [[[superiority design]]]

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/22 ¤W¤È 09:09:37²Ä 1809 ½g¦^À³

...2020.5.11 FDA COVID-19ÃĪ««ü«n

www.fda.gov/media/137926/download

...FDA ¡§±j¯P«Øij¨Ï¥ÎÀu®Ä©Ê³]­pªºÀH¾÷¡B¦w¼¢¾¯¹ï·Ó¡BÂùª¼Á{§É¸ÕÅçµû¦ô¥Î©óªvÀø©Î¹w¨¾ COVID-19 ªºÃĪ«¡¨¡A¨ÃÀ³¦b©Ò¦³ªvÀø¤è®×¤¤¨Ï¥Î¼Ð·ÇÅ@²z¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 06:39:46²Ä 1874 ½g¦^À³
¤w¦^´_¹L¡A¦A¦^¤@¦¸. ³o¨Ç¤½¥q§â¼s¤j§ë¸êªÌªºÅv¯qÂ\¨º¸Ì?

FDA COVID-19ÃĪ«Á{§É«ü«n²M²M·¡·¡¼gµÛ:±j¯P«Øij¨Ï¥Î[Àu®Ä©Ê]³]­p¦aÁ{§É¡A¬°¦ó¤£´±»¡?

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/8 ¤U¤È 02:43:31²Ä 1665 ½g¦^À³

¦pªG¤£­n¤ÓµeªêÄê«ç·|©Û¤H°v?

¥h¦~6¤ëNRX¤½¥q°ª¼h¤½¥¬ZYESAMI¼Æ¾Ú¥¿¦V­n¥Ó½ÐEUA¡Aµ²ªG³QFDA¥´ºj¡A2022.1¤ë¾D¨ü·l¥¢ªº§ë¸êªÌ´£§i:¸ê®Æ¦s¦b­«¤jµê°²©M»~¾É©Ê...

............................................................................................

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 07:50:58²Ä 1611 ½g¦^À³

¸g¹L°ò¨È»P¯E¹©¨Æ¥ó«á¡A§ë¸ê¤H¹ï¥Í§ÞªÑ¯d¤U¤£¦nªº¦L¶H¡A¤£§Æ±æ¾ú¥v¨Æ¥ó­«ºt!

1. FDA©Úµ´NRxÃļtZyesami¥Î©óªvÀø¦M­«¯f±w¤§EUA

.......

2. 2022.1.20ÃÒ¨é´Û¶B«ß®v¨Æ°È©Ò¥Nªí§ë¸êªÌ«Å¥¬¹ï NRx ¶i¦æ½Õ¬d2021 ¦~ 6 ¤ë¡ANRx «Å¥¬¦V¬ü°êFDA´£¥æ¥Ó½Ð¡A­n¨DÀò

±oZYESAMIªººò«æ¨Ï¥Î±ÂÅvEUA¡A¥HªvÀø±w¦³©I§l°IºÜªº¦M­« COVID-19 ±wªÌ.

2021 ¦~ 11 ¤ë 4 ¤é¡A NRx «Å¥¬ FDA ©Úµ´¬° ZYESAMI µo¥¬ EUA ¡A¡§¦]¬°Ãö©ó¸ÓÃĪ«ªº¤wª¾©M¼ç¦b¯q³B¥H¤Î

ZYESAMI ¦b±w¦³ÄY­« COVID-19©I§l¨t²Î¯e¯fªº±wªÌ¤¤ªº¤wª¾©M¼ç¦b­·ÀIªº¼Æ¾Ú¤£¨¬¥¢±Ñ¡C¡¨

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¶À±Ò½÷10152632  µoªí®É¶¡:2022/4/8 ¤U¤È 05:13:36²Ä 1873 ½g¦^À³
¥ý©ñ¹L§O¤H¡A¤~¯à©ñ¹L¦Û¤v¡A§_«h¦p§A³o¯ë¥Ã»·³Q°ê¹©ªº¹ï¿ù¡A¸j¦í§Aªº¤H¥Í¡A¦ó­W¨Ó«v¡I
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/8 ¤U¤È 03:25:28²Ä 1872 ½g¦^À³
1.¹w´ú¤U¶g4/15¦A©µªø90¤Ñ¨ì7/15¡A«ôµn§Y·|«Å¥¬²×¤îpublic health emergency¡C

2.°ê¹©¼B¸³¦b1/5»¡¦a[¸Ñª¼¦¨¥\]¦A¹L21¤Ñ§Î¦¨±j¯P»ä­·¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 05:28:06²Ä 1657 ½g¦^À³

¦Û2020.3¤ë¬ü°êHHSµo¥¬COVID-19ºò«æª¬ºA°_¤w³sÄò8©u§ó·s©µªø8¦¸(¨C¦¸©µªø90¤Ñ)¡A¤U¤@¦¸(2022.4¤ë)·|«Å¥¬©µªø©Î²×¤îEUA???

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/4/8 ¤U¤È 12:06:17²Ä 1871 ½g¦^À³
³o¦¸Áö¤£¬O±ÂÅv®ø®§¡A¦ý¦b±M§Q¤å«á­±¦LÃÒ±M®aµû¦ô¦Ê»õ¬ü¤¸Äݯu¡I2020¦~¤AñQÓi×ô¾P°â91»õ¬ü¤¸¡A¥H¦Ê¤À¤§4¼Wªø¡A¤µ¦~­è¦n¤@¦Ê»õ¬ü¤¸¡C¦]¬°µL¬r¡A±N¨Ó¼W¥[´T«×·|§ó¤j¡C¨âÃÄÅé¨t¦U¤@¦Ê»õ¬ü¤¸¡A¥ú¤À¼íª÷¤@¦¨¡A´N¹F600»õ¥x¹ô¡C¥HªYÄ£¤pªÑ¥»¨CªÑ¹F850¤¸Àò§Q¡A¯uªº¦³¥i¯à¶Ü¡H¦]¬°§Ú¤]¤£À´¡A½Ð±M·~¤j¤j¶}¥Ü¡AÁÂÁ¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/7 ¤U¤È 11:17:51²Ä 1870 ½g¦^À³
À~§Ú¤@¸õ¡A²r¤@¬Ý¥H¬°¬O±ÂÅv¤F
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/4/7 ¤U¤È 07:27:28²Ä 1869 ½g¦^À³
1.¨Æ¹êµo¥Í¤é:111/04/07

2.¤½¥q¦WºÙ:ªYÄ£¥ÍÂåªÑ¥÷¦³­­¤½¥q

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q¡C

4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î¡C

5.µo¥Í½t¥Ñ:

¥»¤½¥q±µÀò©e¥ô±M§Q¨Æ°È©Ò³qª¾¡A¥»¤½¥qµL¨x¬r¤AñQÓi×ô¤îµh·sÃÄSNP-810(¦w®õ®³¯k)

¨ú±o¼Ú¬w±M§Q¡A±M§Q¦WºÙ:¡uNEW ACETAMINOPHEN COMPOUND COMPOSITION WITHOUT

SIDE EFFECT TO LIVER¡v¡C

6.¦]À³±¹¬I:¤£¾A¥Î¡C

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:

¤@.¥»¤½¥qµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810(¦w®õ®³¯k)¥ý«e¤wÀò±o¬ü°ê¡B¤é¥»¡BÁú°ê

¡B¤¤°ê¡B¼Ú¨È±M§Q²Õ´(«Xù´µ¡B¥Õ«Xù´µ¡B«¢ÂħJ¡B¨È¬ü¥§¨È¡B¨È¶ë«ôµM¡B¦Nº¸¦N´µ

¡B¶ð¦N§J¤Î¤g®w°Ò¦@¤K°ê)¡B¤¤µØ¥Á°êµ¥±M§Q¡A¤µ¤SÀò±o¼Ú¬w±M§Q(¼Ú¬w±M§Q§t­^°ê¡B

¼w°ê¡Bªk°ê¡B·ç¤h¡B·ç¨å¡B¤ñ§Q®É¡B±¶§J¡B¤¦³Á¡B¦è¯Z¤ú¡BªâÄõ¡B·Rº¸Äõ¡B¸q¤j§Q¡B

²üÄõ¡B®¿«Â¡BªiÄõ¡B¸²µå¤ú¡Kµ¥38­Ó·|­û°ê)¡A¨ä¥¦¥@¬É¦U°ê±M§Q¥ç¿n·¥¼f®Ö¤¤¡C

¤G.¥»±M§Q¦³®Ä´Á³Ì¦h¥i©µªø¦Ü¦è¤¸2038¦~¡C

¤T.SNP-810(¦w®õ®³¯k)¥Ø«e¤w¦V¬ü°êFDA´£¥X¼Ï¯Ã¸ÕÅç¥Ó½Ð¡AFDA¿n·¥¼f²z¤¤¡C

¥|.®Ú¾ÚFuture Market Insights 2021¦~¥«³õ²Î­p³ø§i«ü¥X¡A¥þ²yAcetaminophen(¤AñQ

Ói×ô)¤îµhÃÄ¥«³õ³W¼Ò©ó2020¦~¹ê»Ú¬ù¬°91.5»õ¬ü¤¸¡A¦Ó¥D­n¥«³õ¦p¥_¬ü¦û¤ñ¬ù33.0%¡B

¼Ú¬w¬ù26.3% ©M¨È¬w(¥]§tªF¨È©M«n¨È°ê®a)¬ù31.7%¡C­Y¥H¨C¦~¦~§¡½Æ¦X¼Wªø²v(CAGR)

4.1% ­pºâ¡A©ó2031¦~¥þ²y¤îµhÃÄ¥«³õ³W¼Ò¥i¹F140.7»õ¬ü¤¸¡C°£¥»¤½¥qSNP-810(¦w®õ®³

¯k)¥~¡A¥Ø«e¥«³õ¤W©|µL¨ä¥¦Ãþ¦üµL¨x¬r©Ê¤§acetaminophen¤§¤îµhÄvª§²£«~¡C¥Ø«e¥»¤½

¥qSNP-810·sÃĤw»P°ê»Ú¥D­n¤îµhÃĤj¼tñ­q¦³Àv¦X¬ù¡A¦³³Ì·s¶i®i¡A±NÀH®É¤½§i¡C

¤­.·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê­±Á{­·ÀI¡A

§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦h¦h10137435  µoªí®É¶¡:2022/4/6 ¤U¤È 06:56:14²Ä 1868 ½g¦^À³
3¤ëÀ禬¬O0,ªí¥Ü¸ÕÅç¤w§¹¦¨¡H!
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/4/5 ¤U¤È 08:04:35²Ä 1867 ½g¦^À³
¥HªYªY¤pªÑ¥»¡A¬y³qªÑ²¼¤£¦h¡A¦³°í±j¥B©úÅã¥|ÁûÃĹê¤O¡B¤j¼t±ÂÅv¡A¬Û«H¨göt°_¨Óª½©b200¤¸¡A®É¶¡¤£¥²3­Ó¤ë¡A¤j·§2­Ó¤ë¡F§Æ±æ¤j®a¯à¤jÁÈ¡I
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/5 ¤U¤È 03:05:47²Ä 1866 ½g¦^À³
¦pªG¬O¦P°¦¯T?(¥»©ÊÃø²¾)

©R¤¤ª`©w§Ú±N³B©ó©t¿W¡A¯î²D»P±I¹æ¤¤§Ú¾Ç·|¤F§Ô­@¡A§Ú½L½õ©ó¯î­ìªº¤@¨¤¡A¾iºë»W¾U¡B«Ì®§¥H«Ý¡A²×¦³¤@¨è¡A¿E±¡»PÅé¯à·|¥þ­±Ãzµo¡A¤ä¼µ§Ú¨º«i²rªº¤@À»¡C¡m¯T¹D¡n

©¹©¹¨ú±o¦¨¥\ªº´I¤H¡A¥L­Ì³£¦³µÛ³oºØ¯T¹Dºë¯«¡C´I¤H¤§©Ò¥H¯à°÷¨ú±o¦¨¥\¡A°£¤F¦³Áæ¦Ó¤£±Ë¡B¥Ã¤£¨¥±Ñªº¯T¹Dºë¯«¡A©¹©¹ÁÙ¦³³o¤­ºØ¯T©Ê«äºû¡I

¯T©Ê«äºû¤@¡B¦¨¥\¤§¹D¡A¶Q¦b°í«ù...¯T©Ê«äºû¤­¡B¤£°Ê«h¤w¡A¤@»ïÅå¤H¡I

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:25:31²Ä 1852 ½g¦^À³

¦³¤H»¡240¬O·sÃĪº³Ì¤j©@¦b¥~³ò¾Þ§@...¡A±À´ú»P[²ö¼w¯Ç¨Ó¥x³]¤l¤½¥q ¦¸¥@¥N¬Ì­]¹w­p¤U¥b¦~±À¥X]µ´¹ï¦³Ãö«Y?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/4/5 ¤U¤È 01:08:01²Ä 1865 ½g¦^À³
¬Ý¤pªYªY¶W°ê³»¡B¥_·¥¡C¾Ç¤@¤UÁÞg¡A¬°¤W¥«·Ç³Æ
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/5 ¤W¤È 10:46:00²Ä 1864 ½g¦^À³
°ê¹©¥i¥H®³¥XFDA¯S­ã¼Æ¾Ú¤£¥Î»P¦w¼¢¾¯PK¤å¥ó¶Ü?(¬JµM§¹¥þ²Å¦X¬ü°êFDA µo¥¬©ó2020¦~5¤ëªº·s«aªÍª¢Á{§É«ü¾É³W©w)

°ê¹©ºô­¶:

goldenbiotech.com/news-tw/%E5%8F%B0%E7%81%A3%E9%A6%96%E7%99%BC%E5%9C%8B%E9%BC%8E%E7%94%9F%E6%8A%80%E7%BE%8E%E5%9C%8B%E6%96%B0%E5%86%A0%E8%82%BA%E7%82%8E%E4%BA%8C%E6%9C%9F%E8%87%A8%E5%BA%8A%E5%B7%B2%E5%AE%8C%E6%88%90%E7%AC%AC/

°ê¹©¥Í§ÞÁ{§ÉÂå¾Ç³¡³¯¨Ø©gÂå®v«ü¥X...§¹¥þ²Å¦X¬ü°êFDA µo¥¬©ó2020¦~5¤ëªº·s«aªÍª¢Á{§É«ü¾É³W©w¡A°w¹ïÃļt¶}µo·s«aªÍª¢ªºªvÀø©M¹w¨¾ÃĪ«¤Î¥Íª«»s¾¯ªº«ü¾É¡A³W©w¶·±Ä¥Î³Ì°ª¯Åªº³]­p¡A¤]´N¬OÁ{§É¸ÕÅ窺³]­p¥²¶·¬°ÀH¾÷¡BÂùª¼¡B¦Ó¥B¦³¦w¼¢¾¯¹ï·Ó(randomized, placebo-controlled, double-blind clinical trials)ªº¸ÕÅç¡A¤~¬O¥\®Ä©ÊÅçÃҳ̥i«HªºÃÒ¾Ú

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/23 ¤W¤È 07:59:18²Ä 1810 ½g¦^À³

¤C¤ë¥bÀn¡X¡X¤ðª¾¦º¬¡!

2020.5.11 FDA COVID-19ÃĪ«Á{§É«ü«n¤w©ú©ú¥Õ¥Õ¼gµÛ:±j¯P«Øij¨Ï¥Î[Àu®Ä©Ê]³]­p¦aÁ{§É!!!

FDA¤£¬O­nµ¥®Ä©Ê»P¤£¦H©Ê¡A¬O­n[Àu®Ä©Ê]!!!

P2¸Ñª¼ªº¼Æ¾Ú¹L¤£¤Fpre-EUAªùÂe:2¤ëpre-EUA meeting¡AFDA¦Ñ¦­¦³¦^ÂСA¤½¥q¤£»¡¦Ó¤w¡AÁÙ°ø±æ4¤ë¥Ó½ÐEUA¡AÁÙ¦³¼Æ¾Ú¤£­È°µP3ªº

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/4 ¤W¤È 09:42:25²Ä 1863 ½g¦^À³
2022.3.16 President Biden Signs Into Law Medicare Telehealth Coverage Extension Post-Public Health Emergency

... after the end of the designated public health emergency (¡§PHE¡¨)

www.jdsupra.com/legalnews/president-biden-signs-into-law-medicare-5809616/

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/4 ¤W¤È 09:30:58²Ä 1862 ½g¦^À³
Adagio»PRevive¥Ó½ÐEUA¤]¦³¨Ç±ß¡A¦]¬°±q¦U¤è·s»D®ø®§¨Ó¬Ý¡A«ôµn¤£¤é´N·|«Å¥¬²×¤îpublic health emergency¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/4 ¤W¤È 09:06:46²Ä 1861 ½g¦^À³
FDA¯S­ãª½±µ§@P3Á{§Éªºbucillamine ¡A¹w­p2022.Q2¥Ó½ÐEUA ¡C

2022.3.29 finance.yahoo.com/news/revive-therapeutics-provides-phase-3-124500504.html

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/14 ¤U¤È 11:28:48²Ä 1590 ½g¦^À³

µL¤H¯à¥X¨ä¥k¤F!?

»´¤¤¯g¤fªAÃļƾں}«G¡AFDA­n¨DRevive¤½¥q¸õ¹LP1»PP2¡A¯S­ã±qP3Á{§É¹êÅç¡C¦A¥HP3ªº´Á¤¤¼Æ¾Ú¥Ó½ÐEUA.

www.clinicalleader.com/doc/can-revive-overcome-long-odds-with-a-small-molecule-covid-treatment-0001

...In June 2020, we approached the FDA with an IND for COVID. We hoped to move into a Phase 2 study and were surprised when the FDA looked at the data and fast-tracked our request to a Phase 3 study. Being able to skip the Phase 1 and Phase 2 studies was a huge win for our small company.¡¨

---------------------------------------------------------------------------------------------------

Benjamin A. Smith¡G¦b±z¬Ý¨Ó¡ARevive ¬O§_¦³¾÷·|Àò±o EUA¡A±z»{¬°³oºØ¾÷·|¦³¦h¤j¡H

Biomedical_trader¡G¶â¡A¦b¤U¤@¦¸¤¤´Á¤ÀªR¤¤¡]600 ¦W±wªÌ¡A¹w­p±N«Ü§Ö´£¥æ¡^¡A§Ú»{¬°¾÷·|¤£¤j¡C¦ý¬O¡A§Aª¾¹D¡A§Ú³Ì¦nªº²q´ú¬O¡A¤j¬ù»Ý­n 700 ¨ì 900 ¦W±wªÌ¤~¯àÃÒ©ú¥L­ÌªºÃĪ«¦³©Ò¤£¦P¡C¦Ó¥B¡A±zª¾¹D¡A§Ú­Ìª¾¹D¥¬¦è©Ô©úªº¬Y¨Ç¾÷¨î¥i¥H¸Ñ¨M¬Y¨Ç°ÝÃD¡A³o¨Ç°ÝÃD¨Ï¬Y¨Ç±wªÌ¡]¨Ò¦p¿}§¿¯f±wªÌ©M¦Ñ¦~¤H¡^¥X²{ COVID ÄY­«¯gª¬ªº­·ÀI§ó°ª¡C©Ò¥H§Ú½T¹ê»{¬°¥L­Ì¦³¤j¬ù 60% ªº¾÷·|¦b 800¡]±wªÌ¡^¼Ð°O³Bªí²{¥X®t²§¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gmeetav10144056  µoªí®É¶¡:2022/4/4 ¤W¤È 03:10:07²Ä 1860 ½g¦^À³
R¤j¼g¨º»ò¦h¨S¥Îªº¡A¨º¬OºØ«H¥õ¡I

Let it go!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤U¤È 01:50:12²Ä 1859 ½g¦^À³
°ê¹©¤½¥¬ªº¼Æ¾Ú»P§ó¥¿¼Æ¦¸¤£¬O¦b©IÄV§ë¸ê¤H¶Ü?

®t²§¦h¤j¦Û¤v¥h¬Ý¬ü°êÃļt¬O¦p¦ó¤½¥¬¼Æ¾Ú¹F¼Ð¡AÁÙ¦³¬°¤°»ò²{¦b¥Ó½ÐEUA¼Æ¾Ú¤À¦¨Omicron[«e]»P[«á]¥Î·N???(³o´N¬O§Ú¦b1/22´£°Ý°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æªº­ì·N)

2022.3.30 Adagio «Å§G ADG20¡]adintrevimab )Àø®Ä¹F¼Ð¡A²Ä2©u¦VFDA´£¥æEUA¥Ó请!

www.thepharmaletter.com/article/strong-showing-for-adagio-s-adg20-in-pre-and-post-exposure-settings-for-covid-19

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/22 ¤U¤È 02:22:40²Ä 1614 ½g¦^À³

¶K´X«h°T®§¡A§ë¸ê¤H[¿W¥ß«ä¦Ò]²´¤UFDA±ÂÅvEUA¦a±ø¥ó???

1.°ê¹©¤G´ÁÁ{§ÉOmicron¯f¨Ò¤H¼Æ?

2. ¬ü°ê¦b2021.11.27«eOmicron¯f¨Ò 0¡A

¬ü°êÁp¨¹¯e¯f¨¾ªv¤¤¤ß(CDC)ºI¦Ü2022.1.1¤é°ê¤º95.4%ªº·s¯f¨Ò¡ADeltaÅܺدf¬r«h³QÀ£ÁY³Ñ¤U4.6%

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤W¤È 10:31:37²Ä 1858 ½g¦^À³
(²Ä¤@½uÃĪ«)»´¤¤¯g­º­nªvÀø¦b¤j´T´î¤Ö¯f¬r¶q¹w¨¾¶i®i¬°­«¯g¡A¦Ó­«¯gªÌªº­º­nªvÀø¤£¦b´î¤Ö¯f¬r¶q!

S-217622©ó2¤ë25¤é¥Ó½ÐÀò§å¡A¦b2/3´ÁÁ{§É¸ÕÅ礤°w¹ï»´«×©M¤¤«×±wªÌ¶i¦æªº2b´ÁÁ{§É¸ÕÅ礤¡A°ª¾¯¶q©M§C¾¯¶q²Õ¯f¬rºw«×ÅܤƩúÅã¸û°ª»P¦w¼¢¾¯²Õ¬Û¤ñ¡A¹F¨ì¥D­nÀø®Äµû¦ô«ü¼Ð»ù¡C

¥t¤@¤è­±¡A»P¦w¼¢¾¯²Õ¬Û¤ñ¡ACOVID-19 ¯gª¬ªºÁ`¤ÀÅã¥Ü¡A¦b­º¦¸µ¹ÃÄ«á¦Ü 120 ¤p®É¡]²Ä 6 ¤Ñ¡^ªº³æ¦ì®É¶¡Åܤƶq¦³©Ò§ïµ½¡A¦ý¨S¦³²Î­p¾Ç·N¸qªº®t²§¡C

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:42:20²Ä 1854 ½g¦^À³

¦X¤@SNS812:³q过ú£¤Ö¯f¬r°ò¦]组©M»E¦X酶mRNAªº«þ贝数¡A§í¨î¯f¬rÎ`¨î¦}ªý断¦Z续·P¬V¡C

IC50

med.sina.cn/article_detail_100_2_113260.html

---------------------------------------------------------------------------------------

¤é¥»ÆQ³¥¸qS-217622(§í¨î·s«a¯f¬rªº¼W´Þ)

EC50

xueqiu.com/3403713237/213884867

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤W¤È 09:29:43²Ä 1857 ½g¦^À³
¼w°ê¨k¤l¦b1¦~¤º±µ¿æ87¦¸·s«a¬Ì­]!(³Q§ì¥h°µ¬ì¬ã¤F)

www.dw.com/en/german-man-got-covid-jab-87-times-report/a-61338245

...¨C¤Ñ³Ì¦h±µºØ 3 ¦¸¬Ì­]

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤W¤È 09:19:59²Ä 1856 ½g¦^À³
Ãø¹D°ê¹©Á{§É³]­p¤£¬OÀu®Ä©Ê³]­p???

2022.3.15°ê¹©¤½§i§ó¥¿:

¥ÎÃIJÕ:Antroquinonol+¼Ð·ÇÀøªk(SOC)

¹ï·Ó²Õ:¬°¦w¼¢¾¯+¼Ð·ÇÀøªk(SOC)

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/22 ¤W¤È 09:09:37²Ä 1809 ½g¦^À³

FDA ¡§±j¯P«Øij¨Ï¥ÎÀu®Ä©Ê³]­pªºÀH¾÷¡B¦w¼¢¾¯¹ï·Ó¡BÂùª¼Á{§É¸ÕÅçµû¦ô¥Î©óªvÀø©Î¹w¨¾ COVID-19 ªºÃĪ«¡¨¡A¨ÃÀ³¦b©Ò¦³ªvÀø¤è®×¤¤¨Ï¥Î¼Ð·ÇÅ@²z¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤W¤È 08:58:19²Ä 1855 ½g¦^À³
¤£À´¤°»ò¬OÀu®Ä©Ê Á{§É³]­p?(¤£»P¦w¼¢¾¯PK¡A²ª½¬O¤Ñ¤è©]ÃÓ¤@¤d¹s¤@©]ªº¨Æ)

¬ü°êª©¬Ý¤£À´¡A¤¤°êª©Á`¸Ó¬Ý±oÀ´!

2022.2.17¤¤°ê¯e±±³¡µo¥¬: ·s«¬«a状¯f¬rªÍª¢§Ü¯f¬r·s药临§É试验§Þ术«ü导­ì则

(»PFDA 2020.5.11 COVID-19ÃĪ««ü«n¬Û¦ü)

¦P¼Ë [±j¯P] «Øij¨Ï¥Î[Àu®Ä©Ê³]­p] [Àu®Ä©Ê³]­p] [Àu®Ä©Ê³]­p]!!!

suntrap.com/newsinfo/621198.html?templateId=174030

---------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/22 ¤W¤È 09:09:37²Ä 1809 ½g¦^À³

FDA ¡§ [±j¯P] «Øij¨Ï¥Î[Àu®Ä©Ê³]­p] [Àu®Ä©Ê³]­p] [Àu®Ä©Ê³]­p]!!!

°ê¹©ªº¼Æ¾Ú¬O«D¦H®Ä©Ê©ÎÀu®Ä©Ê©Îµ¥®Ä©Ê? 3´ÁÁ{§ÉÃø¨o!

2020.5.11 FDA COVID-19ÃĪ««ü«n

www.fda.gov/media/137926/download

...FDA ¡§±j¯P«Øij¨Ï¥ÎÀu®Ä©Ê³]­pªºÀH¾÷¡B¦w¼¢¾¯¹ï·Ó¡BÂùª¼Á{§É¸ÕÅçµû¦ô¥Î©óªvÀø©Î¹w¨¾ COVID-19 ªºÃĪ«¡¨¡A¨ÃÀ³¦b©Ò¦³ªvÀø¤è®×¤¤¨Ï¥Î¼Ð·ÇÅ@²z¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤W¤È 08:42:20²Ä 1854 ½g¦^À³
¦X¤@SNS812:³q过ú£¤Ö¯f¬r°ò¦]组©M»E¦X酶mRNAªº«þ贝数¡A§í¨î¯f¬rÎ`¨î¦}ªý断¦Z续·P¬V¡C

IC50

med.sina.cn/article_detail_100_2_113260.html

---------------------------------------------------------------------------------------

¤é¥»ÆQ³¥¸qS-217622(§í¨î·s«a¯f¬rªº¼W´Þ)

EC50

xueqiu.com/3403713237/213884867

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤W¤È 08:31:34²Ä 1853 ½g¦^À³
§ÚÀ£:

1.¥þ²y­º¤ä[»óÃú¼Q¾¯] ¦X¤@SNS812¼s®Ä«¬§Ü·s«a¬y·P¤p®Ö»Ä·sÃÄ¡A¤w­n¥Ó½ÐP1

2.¦A¯}¥xÆW·sÃıÂÅv¬ö¿ýªºON101

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/4/3 ¤W¤È 08:25:31²Ä 1852 ½g¦^À³
¦³¤H»¡240¬O·sÃĪº³Ì¤j©@¦b¥~³ò¾Þ§@...¡A±À´ú»P[²ö¼w¯Ç¨Ó¥x³]¤l¤½¥q ¦¸¥@¥N¬Ì­]¹w­p¤U¥b¦~±À¥X]µ´¹ï¦³Ãö«Y?

¤@²¼¤HÁÙ¾K¥Í¹Ú¦º¦b156¨º®a!!!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gmeetav10144056  µoªí®É¶¡:2022/4/1 ¤U¤È 07:29:52²Ä 1851 ½g¦^À³
¨S®ø®§´N240¤F¡A¦³®t¶Ü¡I»¡¦nªº¤WÂd¬ü¬üªº¡I¥_·¥¥«­È³£ºÙ¤ý¤F¡I­n¤£­n¦Ó¤w¡I
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¶ø¥ì´µ¯S10031727  µoªí®É¶¡:2022/4/1 ¤U¤È 02:07:23²Ä 1850 ½g¦^À³
news.cnyes.com/news/id/4844700

¬ü°ê¦ò¦{»PCVSµ¥ÃÄ°Ó´N¾~¤ùÃþÃĪ«©M¸Ñ ª÷ÃB¹F8.78»õ¬ü¤¸

¬ü°ê¦òù¨½¹F¦{¤w»P CVS Health Corp (CVS-US) ©M¥t¥~ 3 ®a»sÃĤ½¥q¹F¦¨¶W¹L 8.78 »õ¬ü¤¸ªº©M¸Ñ¨óij¡A¥H¸Ñ¨M¦³Ãö¦b¸Ó¦{§Uªø¾~¤ùÃþÃĪ«ÀݥΤ¤©Ò§êºt¨¤¦âªº¯Á½ß¡C

¦ò¦{Á`À˹îªø¿p­} (Ashley Moody) µo¥¬Án©úªí¥Ü¡ACVS ±N¤ä¥I 4.84 »õ¬ü¤¸¡ATeva Pharmaceutical Industries Ltd (TEVA-US) ±N¤ä¥I 1.948 »õ¬ü¤¸¡AAbbvie Inc (ABBV-US) ©ÒÄݪº¦ãº¸«Ø (Allergan) ³¡ªù±N¤ä¥I 1.342 »õ¬ü¤¸¡AEndo International Plc (ENDP-US) ±N¤ä¥I 6500 ¸U¬ü¤¸¡C

¤j³¡¤À¸êª÷±N¥Î©ó´î¤Ö¾~¤ùÃþÃĪ«¡CTeva ÁÙ±N´£¨Ñ 8400 ¸U¬ü¤¸ªº¾Ç¦WÃÄ Narcan »ó¼QÃú¾¯¡A³o´Ú¼QÃú¾¯¥i¥H¼È®É½w¸Ñ¾~¤ùÃþÃĪ«¹L¶q¨Ï¥Îªº¼vÅT¡C

©Ò¦³¤½¥q¦b¦P·N©M¸Ñ¤§»Ú³£§_»{´¿¦³¤£·í¦æ¬°¡C

ù¼w®q¦{»P Teva ©M¦ãº¸«Ø 9 ¤Ñ¹F¦¨Ãþ¦üªº©M¸Ñ¨óij¡A»ù­È¬° 1.07 »õ¬ü¤¸¡C

CVS ªí¥Ü¡A©M¸Ñ²Å¦X¦U¤è³Ì¤j§Q¯q¡A¨Ã¥B±N¤j¤O®Â½Ã»P¾~¤ùÃþÃĪ«¦³Ãöªº¨ä¥L¶D³^¡CTeva ªí¥Ü¡A¥¦¡uÄ~Äò¿n·¥¨ó°Ó¸Ñ¨MÃþ¦ü¯Á½ßªº¥þ°ê¸Ñ¨M¤è®×¡v¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/3/30 ¤U¤È 06:47:09²Ä 1849 ½g¦^À³
ÁÞ°òÄ_Ä_ªÑ»ù¦b¤T­Ó¤ë¤º±q80¤¸º¦¨ì210¤¸ªñ¤T­¿¡F±q¥Í§ÞªÑ¤ñ»ùÃö«Y¡A¬Û¹ï¤ñ»ùªYÄ£¬O«K©yªº¡B¬O¦nªº¡Aµ¥µo¥¬±ÂÅv®ø®§¡A¦³¤W½Ä200¤¸¦X²z¹w´Á¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/3/28 ¤U¤È 09:51:40²Ä 1848 ½g¦^À³
©_©Ç¤F¡A¿}°ò³£½Ä¤F¡A¦ó®É½ü¨ì·sÃħr?
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G½²ºû¤¯10143700  µoªí®É¶¡:2022/3/28 ¤U¤È 01:54:05²Ä 1847 ½g¦^À³
²{¦bªYÄ£ªÑ»ù¦ì¶¥¨ä¹ê¬O«Ü§Cªº¡A±N¨Ó¥|ÁûÃÄÁ`±ÂÅv¥u­n0¡E4»õ¬ü¤¸´N¬O²{¦b¦æ±¡¡F²Ê¦ô¥|ÁûÃÄ¥[Á`20»õ¬ü¤¸±ÂÅv¤£Ãø¡A©Ò¥H¡AªÑ»ù¦³50­¿¤Wº¦ªÅ¶¡¡C¦]¦¹¡AªYÄ£ªÑ²¼­È±o¬ÃÂáA¤]¤£¼Ö¨£³Q¨ÖÁÊ¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/26 ¤U¤È 09:41:24²Ä 1846 ½g¦^À³
1. 2021.5.6 Tylenol to arrive in Australia

www.facebook.com/watch/?v=842161146647362

¬[¤W¥þ¬OGSK´¶®³¯k

2.2020.6.25 www.smh.com.au/business/companies/us-painkiller-to-be-sold-in-australian-pharmacies-to-shore-up-supply-20200624-p555kx.html

¥þ²y»sÃÄ¥¨ÀY±j¥Í¤½¥q¤wÀò­ã¦b¿D¤j§Q¨ÈÃÄ©±¾P°â¨ä¬ü°ê¤îµhÃÄ«~µP Tylenol

..¥Ñ©ó¨ÑÀ³µu¯Ê¡A¥]¬A¿ÕµØ©M½÷·ç¦b¤ºªº³\¦h¨ä¥L¤j«¬»sÃĨÑÀ³°Ó¤]Àò­ã¶i¤f¤@¨t¦CÃÄ«~¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/26 ¤U¤È 09:27:43²Ä 1845 ½g¦^À³
§Ú¤§«e¤]¥H¬°¬Ý½Ö®a¥X»ù°ª´Nµ¹½Ö®a¡Aª½¨ì³o«h·s»D:2021¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ!(¨º2021.5¤ë«e?)

¼Ú¬w­^°ê...¥i¥H¦n¦n«ä¦Ò¤@¤U!

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:44:54²Ä 1216 ½g¦^À³

GSKªº´¶®³¯k¦P¼Ë½æ¨ìÀ~À~¥s!

¦]¬°¯Ê³f¡A¨Ï±oJ&J¶X¶Õ¶i¤J¿D¬w¥«³õ(¥h¦~¥Ó½Ð¡A¤µ¦~5¤ë¥¿¦¡¤W¬[)

2020.6.25

www.smh.com.au/business/companies/us-painkiller-to-be-sold-in-australian-pharmacies-to-

shore-up-supply-20200624-p555kx.html

....

J&Jªº¤@¦ì¤kµo¨¥¤Hªí¥Ü¡A¸Ó¤½¥q«Ü°ª¿³¦b«D³B¤èÃÄ¡§«e©Ò¥¼¦³ªº»Ý¨D¡¨®É´Á¬°¿D¤j§Q¨È¤H´£¨Ñ³o¨Ç²£«~¡C¡§·í§Ú­Ì·NÃѨ켳¼ö®§µhµu¯Ê®É¡A§Ú­Ì¬°¤F¤½¦@°·±dªº§Q¯q¦V TGA ´£¥X¤F¥Ó½Ð¡A¡¨

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:13:39²Ä 1215 ½g¦^À³

...¤µ¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ¡A³Ì«Ü¤j¦]¯À´N¬OGSKªº´¶®³¯k¨ÑÀ³µu¯Ê

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡Gdk10140377  µoªí®É¶¡:2022/3/26 ¤U¤È 03:30:28²Ä 1844 ½g¦^À³
«Ü¦n©_¡A¼Ú¬w©M¬ü°ê¤j¼t©Î¬O¤é¥»¡A¤À°Ï±ÂÅvÁÙ­n¦Ò¶q¤°»ò¤½²³§Q¯q¡C¥ý¤½§i³¡¥÷°Ï°ì«á³Ñ¤Uªº°Ï°ì¬O¤£¬O´N¤£¦n½Í¤F¡A­Y¬O³o¼Ë°®¯Üµ¹¤@®a³Ì¦nªº±ÂÅvª÷¤£´N¦n¤F
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/26 ¤W¤È 09:36:37²Ä 1843 ½g¦^À³
¦X¤@¦~³ø²Ä73­¶

800±i¡A±b­±¡B¤½¤¹»ù­È³£¬O65296¤d¤¸

¤@¯ë¨Ó»¡¡A±b­±»ù­È¬°ªì¦¸¨ú±o®Éªº»ù®æ¡C

¤½¤¹»ù­È¬°¥iÃÒ©úªº»ù­È¡A¦p¤W¥«Âd¦³¤½¶}»ù®æ¡C

¤½¤¹»ù­ÈÀH®É·|»P±b­±»ù­È¤£¦P¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/26 ¤W¤È 08:57:12²Ä 1842 ½g¦^À³
www.onenessbio.com/download/Financial/110_Q3_Financial_Report_TC.pdf

800±i ±b­±ª÷ÃB53,640 ¤½¤¹»ù­È53,640

¨S¬Ý¨ì­ì©l§ë¸êª÷ÃB?

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/3/26 ¤W¤È 07:30:32²Ä 1841 ½g¦^À³
·PÁÂR¤j°]³ø»¡©ú¡A

°£¤F³o¨â®a°ê»Ú¤jÃļt¡AªYÄ£¤]¥¿¦b¬¢½Í¥]¬A¤é°Ó¦b¤ºªº¦h®a¦X§@¤½¥q¡C

§Æ±æ¤À°Ï°ì¦X§@±ÂÅv¯à³v¨B¶}ªá¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/26 ¤W¤È 07:24:31²Ä 1840 ½g¦^À³
800±i¡A±b­±»ù­È¡A¤½¤¹»ù­È³£¬O65296¤d¤¸

©Ò¥H§¡»ù81.62¤¸¡A¬O»{ÁÊ¡HÁÙ¬O¶R¶i¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/25 ¤U¤È 10:38:59²Ä 1839 ½g¦^À³
¼W¸ê»ù75¤¸¡A¦X¤@³o81.6¤¸???

-----------------------------------------------------------------------------------------------

·|­û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/3/14 ¤W¤È 11:19:07²Ä 1788 ½g¦^À³

·PÁÂdk¤j¦^À³¡A§Ú¬Ý¦X¤@°Ýµª¨ºÃä¬O¼g»{80¸UªÑ = 800±i

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/25 ¤U¤È 02:38:41²Ä 1838 ½g¦^À³
¦X¤@¦~³ø¤½§G

«ùªYÄ£800±i¡A¨CªÑ¥­§¡81.6¤¸¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/25 ¤W¤È 11:16:20²Ä 1837 ½g¦^À³
­Ó¤H¬Ýªk¡A¶È¨Ñ°Ñ¦Ò¡I

³o2¤H»{ÁʤF75¤¸ªº²{ª÷¼W¸ê1¸U±i

»Ý­n7.5»õ¥x¹ô

¦pªG¨S¦³¹ï¤½¥q¥Ø«eªºª¬ªp¬Û·í¤F¸Ñ

¥B²`¨ã«H¤ßªº¸Ü¡]©Ò¿×ªº¸ê°T¤½¶}¤£¹ïºÙ¡^

¤£¤Ó¥i¯àªá¤j§â¶r²¼»{ÁÊ

¥H¥Ø«eªº¦¨¥æ¶q¡A1¸U±i­n½æ¨ì¥Á°ê´X¦~¡H

©Ò¥H©w­n«ùªÑ£¸¬q´Á¶¡¡A¥B»Ý­n¦³°ò¥»­±°µ¤ä¼µ¡C

»P¨ä»{ÁÊ»ù­n¦³¤j´T«×¶ZÂ÷¡A¥B»Ý¦³¤j¦¨¥æ¶q¤~¯à¾_Àú¥X²æ¡C

·íµM¡A³Q¨ÖÁʤ]¦³¥i¯àµo¥Í¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¤p¨k¤H10151116  µoªí®É¶¡:2022/3/25 ¤W¤È 09:41:10²Ä 1836 ½g¦^À³
§Ú«ä¦Ò¤F¤@¤U;¥i¯à¤­¤ë¦hªº110ªÑªF·|¦~³ø·|¦³¨ÇºÝ­Ù§a?
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 11:37:52²Ä 1835 ½g¦^À³
ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 10:59:16²Ä 1834 ½g¦^À³
¤H¤§«ä¼{¦³­­¡A¥H¤U½×­z©Î¦³»~!

-----------------------------------------------------------------------------------------------

¤G¡BP34. ©Ó¿Õ¨Æ¶µ ©e°U¬ã¨s¦X¬ù©|»Ý¤ä¥I$33,752¤Î$29,024 ¬O»Ý¤ä¥I¬ì§Þ³¡±ÂÅvª÷¶Ü?

P24.¤U­±¦³»¡©ú±M§Q§Þ³N¶O(¤ä¥I¬ì§Þ³¡±ÂÅvª÷À³¸Ó¬O¦C¦b³o¸Ì)

³o2µ§°U¬ã¨s¦X¬ù¶O¥Î:§Ú­Ó¤H°¾¦V¬OSNP-810¬ãµo¨½µ{¸O¸Ì­±--¤G­Ó¾Ç³N«¬Á{§É¹êÅç³q¹L¤TÁ`Á{§É¹êÅç­Û²z©e­û·|¼f¬dªºÁ{§É¶O

¤T¡BP39. ¥xÆW¥Ò«È¤á109¦~¦¬¤J$462---¦b109°]³ø:«È¤á¦X¬ù¤§¦¬¤J°Ó«~¾P³f¦¬¤J¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 10:36:34²Ä 1833 ½g¦^À³
¤@¡BP21 ¸Õ²£¶O$4,012 ³o¬O¸Õ²£¤°»ò²£«~? --§Ú¤]»{¬°¬O6¨t¦C¸Õ²£¶O.

-------------------------------------------------------------------------------------------

·|­û¡G¤p¨k¤H10151116 µoªí®É¶¡:2021/8/21 ¤U¤È 02:35:48²Ä 1371 ½g¦^À³

§Ú§Æ±æ¬O6¨t¦C

3.°ê»ÚÃļt¦X§@ÂX¤j­ì®Æ¥Í²£¶i¦æ¤¤

----------------------------

P17¹w¥I¸Õ²£¶O346¸U

----------------------------

ªÑªF·|¤º®e¬ù²¤¦p¤U

1.¬°¤F¤WÂd·Ç³Æ¦Ó¼W¸ê,­ìªÑªF©M¯S©w¤H³£«Ü¤ä«ù

2.630©ú¤Ñ¶}©l¤TÁ`¶i¦æ¤@´ÁÁ{§É

3.°ê»ÚÃļt¦X§@ÂX¤j­ì®Æ¥Í²£¶i¦æ¤¤

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/24 ¤U¤È 08:59:28²Ä 1832 ½g¦^À³
R¤j

ǢǢǢ

­ì¨Ó§Ú¤]·Q¬O¤£¬O¸ò¦X§@ªº¨â¤jÃļt¦³Ã±«O±K¨óij

»{Áʲ{¼W«ùªÑ¡A¦ý¤£¯à¤½¶}¡C

«á¨Ó·Q·Q¡A¬O¦Û¤v½M²q¡I

¦¶¸³¤£®e©ö°Ý¨ì¡I

¥t¥~¡A¦p¤£¯u¹ê¤½§i¡A®£¹H³W©w¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¾¾¹À©OÎN¹À«¡10150521  µoªí®É¶¡:2022/3/24 ¤U¤È 06:50:14²Ä 1831 ½g¦^À³
½Ð°Ý110 Q4°]³ø¤º®e:

¤@¡BP21 ¸Õ²£¶O$4,012 ³o¬O¸Õ²£¤°»ò²£«~?

¤G¡BP34. ©Ó¿Õ¨Æ¶µ ©e°U¬ã¨s¦X¬ù©|»Ý¤ä¥I$33,752¤Î$29,024 ¬O»Ý¤ä¥I¬ì§Þ³¡±ÂÅvª÷¶Ü?

¤T¡BP39. ¥xÆW¥Ò«È¤á109¦~¦¬¤J$462 ¬O½æ¤°»òÃÄ?ÁÙ¬O³Ò°È¦¬¤J?

¤A«È¤á¦b¬ü°ê¡A¤þ«È¤á¬°¼Ú¬w

·PÁÂ

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 05:43:50²Ä 1830 ½g¦^À³
·|­û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/3/24 ¤U¤È 05:03:38²Ä 1829 ½g¦^À³

¨Î¯C³¡¤À¥Ø«eÁÙ¬O7¤d¦h±i¡A¨Ã¨S¦³§ï¤½§i¦¨9¤d¦h±i¡C

----------------------------------------------------------------------------------------------

¨º¬O¤£¬O³o2¦W¤]¦b«e10¤j¤§¦C¡A¤@¼ËÁÙ¨S¦³§ï¤½§i? §Ú¤]§Æ±æ¬O¬Y¤j¼t»{ªÑ¡A¦ý³oºØ¦n¨Æ«ç¥i¯à¤£¤½§i.

»P¨ä²q¨Ó²q¥h¤£¦p°Ý°Ý¦¶¸³!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/24 ¤U¤È 05:03:38²Ä 1829 ½g¦^À³
³o¬O¥h¦~²{¼W»{Áʳ¡¤À

ªL¥ý¥Íªì¦¸¨ú±o¡A¨ä«ùªÑ¤½§i¸Ì¦³¡AÄÝ©ó¤jªÑªF¡C

¨Î¯C³¡¤À¥Ø«eÁÙ¬O7¤d¦h±i¡A¨Ã¨S¦³§ï¤½§i¦¨9¤d¦h±i¡C

¦Ó³o¨â¦ì³£ÁÙ¬O¦b¤½§i¤ºªº10¤H¡A§Y¨Ï¦A¦©±¼¨Î¯C»{Áʪº1970±i¡C

¨º¶°«O¤¤ªº12¤H¤¤ªº¥t2¦ì¡A¦©°£1970±i«á¡A¤]ÁÙ¦³8¤d±i®tÃB¡C

¬O½Ö©O¡H¬°¤°»ò¤£¤½§i¡H

¬O§_À³¸Ó½Ð¤½¥q»¡©ú¡I

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 03:17:29²Ä 1828 ½g¦^À³
·|­û¡G¤p¨k¤H10151116 µoªí®É¶¡:2021/7/28 ¤U¤È 01:58:34²Ä 1341 ½g¦^À³

­ì¨Ó¨Î®m¥þ»{¤F

--------------------------

1.³Q¨ú±oªÑ¥÷¤§¤½¥q¡GªYÄ£¥ÍÂåªÑ¥÷¦³­­¤½¥q¡A¤wµo¦æªÑ¥÷Á`ÃB¡G68

,592,500ªÑ¡C

2.¨ú±o¤H¸ê®Æ¡G

A.¨ú±o¤H¡G¨Î®m§ë¸êªÑ¥÷¦³­­¤½¥q

(1) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¡G7,202,165ªÑ

(2) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ

¡G13.87%

(3) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¡G7,196,165ªÑ

(4) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ¡G

10.49%

B.¨ú±o¤H¡GªL®a§»

(1) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¡Gªì¦¸¨ú±o¤£¾A¥Î

(2) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ

¡Gªì¦¸¨ú±o¤£¾A¥Î

(3) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¡G1,970,331ªÑ

(4) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ¡G

2.87%

C.¦X­p¡G

(1) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¡G7,202,165ªÑ

(2) «e¤@¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ

¡G13.87%

(3) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¡G9,166,496ªÑ

(4) ¥»¦¸¤½§i®É«ùªÑÁ`ÃB¥e³Q¨ú±oªÑ¥÷¤½¥q¤wµo¦æªÑ¥÷Á`ÃB¦Ê¤À¤ñ¡G

13.36%

3.¨ú±o©Î¼W´î¤§ªÑ¼Æ¡B¤é´Á¤Î¤è¦¡¡G©ó109¦~12¤ë29¤é¸g¥ÑÂd¶R¥«³õ

¥æ©ö½æ¥X¤è¦¡´î¤Ö6,000ªÑ¤Î110¦~7¤ë26¤é¸g¥Ñ²{ª÷¼W¸ê¤è¦¡¼W¥[1,9

70,331ªÑ¡C

4.·s¼W©Î´î¤Ö¤§¦@¦P¨ú±o¤H¡G·s¼WªL®a§»¬°¦@¦P¨ú±o¤H¡C5.¨ú±oªÑ¥÷

¤§¥Øªº¡G§ë¸ê ¡C

6.¹w­p©ó1¦~¤º¦A¨ú±oªÑ¥÷¤§¼ÆÃB¤Î¤è¦¡¡G±N¦ÛÂd¶R¥«³õ¨Ì¦X²z¤§ªÑ

»ù«ùÄò¶i¦æµû¦ô¡C

7.¸êª÷¨Ó·½©ú²Ó¡G¦Û¦³¸êª÷¡C

8.¨ú±oªÑ¥÷¤§ªÑÅv¦æ¨Ï­pµe¡G µL¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/24 ¤U¤È 03:12:07²Ä 1827 ½g¦^À³
R¤j»¡ªº¬O

²{¦æ³W©w¬O§_­n¿í¦u¡H

6.9¸U±iªºªÑ¥»¡A³o¨â¤H«ùªÑ°ª¹F¸U±i¡C

10%¬O6¤d9¦Ê±i¡AÅãµM¦Ü¤Ö¦³1¦ì«ùªÑ¶W¹L¡H

©Î¬O­è¦n¨â¦ì³£¥¼¹F10%¡H

¦ý³o¤S»P¤½¥q¤½§iªº¤jªÑªF«ùªÑ³Ì§CªÌ¥u¦³1¤d¦h±i¬Û½Ä¬ð¡C

¦Ü¤Ö³o¨â¦ì«ùªÑ³£¤ñ¥L­ÌÁÙ­n°ª«Ü¦h¡A²z½×¤WÀ³¸Ó¬O­n¤½§i³o¨â¦ì¤~¬O¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 02:59:34²Ä 1826 ½g¦^À³
³q±`³£¬O¸³ºÊ¨Æ©ñ±ó»{ÁʦӥѯS©w¤H»{ÁÊ¡A³o¤£µ¥¦P¨ä¥L¤jªÑªF¤]±o«Å§i©ñ±ó»{ÁÊ¡C
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 02:49:47²Ä 1825 ½g¦^À³
ªÑ¥»6.91»õ=6.91¸U±i¡A·í«e¤Q¤jªÑªF»{ÁÊ>419±i¡A³o2¤H´N¦³¸ó¹L<10%ªº¤½§iªùÂe¡A¨ä¹ê¤£Ãø¡C

¤£¹L2023¦~°_ªùÂe±N­°¬°5%!

2022.01.12 udn.com/news/story/7239/6026768

ªÑªF«ùªÑ5%¶·¥ß§Y¥Ó³ø¡Kª÷ºÞ·|´ª¥X¤W¥«ÂdÂÃÃè¤H

¨Ì²{¦æ³W©w¡A«ùªÑ10%¥H¤W¤jªÑªF¡A±o¦Û¦æ¦V³Q§ë¸ê¤½¥q¥Ó³ø¡A¥Ñ³Q§ë¸ê¤½¥q¹ï¥~¤½§i¡F2023¦~°_«h¬O«ùªÑ5%¥H¤W´N±o¥Ó³ø¡A­Y¥¼¥Ó³ø¡B«h·|³B¥÷¸ÓªÑªF¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/9/25 ¤W¤È 08:37:18²Ä 1424 ½g¦^À³

1000±i¥H¤W¤H¼Æ¼W2¦W¡A±i¼Æ¼W¥[14219.715±i/¼W¸ê16000±i=¥e¤ñ88.87%¡A¤£¥X·N¥~¤j¦h¼Æ¤pªÑªF©ñ±ó¤F!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/24 ¤U¤È 01:54:07²Ä 1824 ½g¦^À³
N¤j

¤£ºÞ¬O¦P¶°¹Î

©Î¬O¤º³¡Ãö«Y¤H

¥H2¤H«ùªÑ°ª¹F¸U±i

³£À³¸Ó­n¤½§i

Ãø¹D¬O¶°«O¤½¥q²Î­p¿ù»~¶Ü¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GNtumgk10151447  µoªí®É¶¡:2022/3/24 ¤U¤È 01:24:07²Ä 1823 ½g¦^À³
¤£¦P¤H¡A¦P¤@³æ¦ì~
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/24 ¤U¤È 01:20:58²Ä 1822 ½g¦^À³
N¤j

³o¨â®a³£¦³¦b3¸U1¤d±iªº¤½§i¦W³æ¤W¡A¤jªÑªF¤d±i³Ì§C¤]¤~1¤d¦h±i¡C

¥u¬O©_©Ç¡I

¥t¥~¨º2¤H¦³¸U±i¡A¦Ó¥B¬O¦b¥h¦~75¤¸¼W¸ê«á¤~¥X²{¡C

¥H«ùªÑ¤ñ²vºâ¡AÀ³¸Ó¬OÄÝ©ó¤jªÑªF¡A«ç¥i¤£¤½§i¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤U¤È 12:04:49²Ä 1821 ½g¦^À³
²³¤H¬Òª¾[©ñªø½u³¨¤j³½]ªº¹D²z¡A¦ý¦³´X¤H¯àªø´Á«ù¦³?

²bªÅªk®v¡G¡i¯B°Êªº¤ß¥Í·Ð´o¡A¯u¤ß¤£°Ê¥Í´¼¼z¡j

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/2/27 ¤W¤È 09:46:03²Ä 879 ½g¦^À³

·sÃħë¸ê¤£­n¤Ó¦b·NÄw½X¨Ó¨Ó¥h¥h(µu½uªÌ«äºû)¡A¯u·Qµo¤j°]»Ý­nªº¬Oºë½T¬Ý·Ç¦³µo®i¼ç¤O»PÄvª§¤OªÌ!

¥hÆ[¹î¥_·¥¬P2020.03.6~2021.02.26Äw½XÅÜ°Ê,ªÑ»ù10¤¸¦h¡A¦Ê±i¤d±i¤j¤á«ùªÑ´î¡A2021.3.3°_ªºµo®i¤w¥i·Q¦Óª¾!

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GNtumgk10151447  µoªí®É¶¡:2022/3/24 ¤W¤È 11:44:55²Ä 1820 ½g¦^À³
´N¬OÆp¥Û¥Í§Þ¸ò¨Î®m¡A¤£¥Î·Q¤Ó¦h
¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡G¦V«e¦æ10140498  µoªí®É¶¡:2022/3/24 ¤W¤È 11:29:31²Ä 1819 ½g¦^À³
½Ð±ÐR¤j

¸³ºÊ¨Æ¤Î¤jªÑªF«ùªÑÀ³¤½§i¡I

ªYÄ£¤½§iªº¤d±i«ùªÑªÌ¥u¦³10¤H¡A¦@3¸U1¤d¦h±i¡C

¶°«Oªº´¦¥Ü¤d±i¦³12¤H¡A¦@4¸U1¤d¦h±i¡C

ªí¥Ü¦³2¤H«ù¦³1¸U±i¡A¦Ó³o2¤Hªº«ùªÑ¤ñ¨ä¥L¤jªÑªFªº«ùªÑÁÙ¦h¡C

¬°¤°»ò³o2¤H«ùªÑ¥i¥H¤£»Ý¤½§i¡H¬O¦ó¤è¯«¸t¡H

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤W¤È 08:19:23²Ä 1818 ½g¦^À³
©úÅãÁ×­«´N»´!!!

add-on:Á{§É¹êÅç¥ÎÃIJլ°Antroquinonol+¼Ð·ÇÀøªk(SoC)¡A¹ï·Ó²Õ«h¬°¦w¼¢¾¯+¼Ð·ÇÀøªk(SoC)¡C

­«¤¤¤§­«¬O³o¬q:FDA strongly recommends that drugs to treat COVID-19 be evaluated in randomized,

placebo-controlled, double-blind clinical trials using a superiority design

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
·|­û¡GROGER588910148151  µoªí®É¶¡:2022/3/24 ¤W¤È 08:03:54²Ä 1817 ½g¦^À³
3/23°ê¹©§ó¥¿¤½§i:(3)¥»¤½¥q¤§Á{§É¹êÅç¥ÎÃIJլ°Antroquinonol+¼Ð·ÇÀøªk(SoC)¡A¹ï·Ó²Õ«h¬°¦w¼¢¾¯+¼Ð·Ç

Àøªk¡A²Å¦X¬ü°êFDA©Ò­n¨Dªº [ªþ¥[©Ê(add-on)¸ÕÅç³]­p]...

ªþ¥[©Ê(add-on)¸ÕÅç³]­p¬O¤°»ò? ´N¬O­nsuperiority studies[Àu®Ä©Ê]!

FDA strongly recommends that drugs to treat COVID-19 be evaluated in randomized,

placebo-controlled, double-blind clinical trials using a superiority design

[trials in these populations should generally be designed as placebo-controlled superiority studies

with an add-on design ]

[trials in these populations should generally be designed as placebo-controlled superiority studies

with an add-on design ]

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/3/23 ¤W¤È 07:59:18²Ä 1810 ½g¦^À³

¤C¤ë¥bÀn¡X¡X¤ðª¾¦º¬¡!

2020.5.11 FDA COVID-19ÃĪ«Á{§É«ü«n¤w©ú©ú¥Õ¥Õ¼gµÛ:±j¯P«Øij¨Ï¥Î[Àu®Ä©Ê]³]­p¦aÁ{§É!!!

FDA¤£¬O­nµ¥®Ä©Ê»P¤£¦H©Ê¡A¬O­n[Àu®Ä©Ê]!!!

P2¸Ñª¼ªº¼Æ¾Ú¹L¤£¤Fpre-EUAªùÂe:2¤ëpre-EUA meeting¡AFDA¦Ñ¦­¦³¦^ÂСA¤½¥q¤£»¡¦Ó¤w¡AÁÙ°ø±æ4¤ë¥Ó½ÐEUA¡AÁÙ¦³¼Æ¾Ú¤£­È°µP3ªº¡C

¦^ÂÐ¥»¤å ¦^¿³Âd°Q½×°Ï1­¶
²Ä¤@­¶¤W¤Q­¶¤W¤@­¶789101112131415¤U¤@­¶³Ì«á¤@­¶

         

¡@

§Ú¡@¡@­n¡@¡@¦^¡@¡@À³¡@¡@¥»¡@¡@¸Ü¡@¡@ÃD

·| ¡@­û¡G

  

§@ ªÌ ¡G

 

¬ÛÃöªÑ²¼¤½¥q¦WºÙ ¡G

ªYÄ£¥ÍÂå

¤º¡@ ®e¡G

¡@
½Ð¥ýµn¤J ­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹ ¡@
¡@

°Q½×°Ï¬ÛÃö³W©w¡G
    1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«Øij¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
    2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    4.¬°ÁקK®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C


¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178   ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѠ ¬ÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ  ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß  ¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!